<SEC-DOCUMENT>0001558370-24-003640.txt : 20240320
<SEC-HEADER>0001558370-24-003640.hdr.sgml : 20240320
<ACCEPTANCE-DATETIME>20240320172054
ACCESSION NUMBER:		0001558370-24-003640
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20240514
FILED AS OF DATE:		20240320
DATE AS OF CHANGE:		20240320

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CAPRICOR THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001133869
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34058
		FILM NUMBER:		24768644

	BUSINESS ADDRESS:	
		STREET 1:		8840 WILSHIRE BLVD
		STREET 2:		2ND FLOOR
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90211
		BUSINESS PHONE:		(310) 358-3200

	MAIL ADDRESS:	
		STREET 1:		8840 WILSHIRE BLVD
		STREET 2:		2ND FLOOR
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Nile Therapeutics, Inc.
		DATE OF NAME CHANGE:	20070920

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SMI PRODUCTS INC
		DATE OF NAME CHANGE:	20010206
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>capr-20240514xpre14a.htm
<DESCRIPTION>PRE 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 10.5.0.8 -->
<!-- Based on: iXBRL 1.1 -->
<!-- Created on: 3/20/2024 9:14:06 PM -->
<!-- iXBRL Library version: 1.0.8703.18788 -->
<!-- iXBRL Service Job ID: 81b9ae41-f03e-440e-81a8-5aba6f807e12 -->
<html xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:capr="http://capricor.com/20240514" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrldi="http://xbrl.org/2006/xbrldi"><head><meta content="text/html" http-equiv="content-type"/><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" name="dei:EntityCentralIndexKey" id="Tc_fWGd7LvZW0eeigUib6EMGQ_1_1">0001133869</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" name="dei:AmendmentFlag" id="Tc_gysJpaGv8ESNLTYDC1857A_2_1">false</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" name="dei:DocumentType" id="Hidden_2U85oGuSBEi_hmh9e-qaBg">PRE 14A</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="capr-20240514.xsd"/></ix:references><ix:resources><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsValueInCompensationTableForApplicableYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_wXZQP7jdBkGCt0F5kdShAQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsValueInCompensationTableForApplicableYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsValueInCompensationTableForApplicableYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_cEC076xukUytfkW6cWT2KA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsValueInCompensationTableForApplicableYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_6kMrJSUzRk-2rzXtu-uQoQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_vivQmo6mSEqaFXP36wEMAQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_jTaas2oZLUy-SpJe52-InA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_6WX4KT36CUuWW8akt2OzpQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_9g7ebvuxWUuUBmptPCym_Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_iZz8cM0530OzLK0ZzEASJg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_JVXrFv5_2EudBAVwqdyZ2A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_GMfsyW9GaUCnLGYWUh9fgw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_POPZu7IOokG--5f06Nf35Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_YRkU1KZG4UO6jQ9ifR2OSw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsValueInCompensationTableForApplicableYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_MAkj2PFc4UiOEFAPTIh5pg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsValueInCompensationTableForApplicableYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsValueInCompensationTableForApplicableYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_jBy47SmJK0WpDadoHCHhRQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsValueInCompensationTableForApplicableYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_mc5TENp2S0GocHnLHwEEAg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_2uiDN3rZh0q31boqSbzn8w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_PAfo8DhqG0yF5jcQg_sh5A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_VZO4GqyxeE-CglPDohkklg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_QawlbdeG70CMcZ9CqoR_vg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_STUyIoqE2EGW3AifSYCqjw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_lVWOxIS-1UCfBNJY-IhXHQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_3WyJGzK71kS8TSaL8PNShA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_IhAZ2jr6Qk6yvGRNYnpPNQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_w4nlAZfmVkuUTMVwdrsohA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001133869</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_1856ec34_aa94_4383_bbf7_c83d1ab5344f"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;text-indent:0pt;border-bottom:1px solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Washington, D.C. 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_2U85oGuSBEi_hmh9e-qaBg;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">SCHEDULE 14A</b></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Proxy Statement Pursuant to Section&#160;14(a)&#160;of the Securities</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;">Filed by the Registrant <span style="font-family:'Times New Roman';">&#8999;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;">Filed by a Party other than the Registrant <span style="font-family:'Wingdings';">&#168;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;">Check the appropriate box:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="font-size:6pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-family:'Wingdings';">x</span></p></td><td style="vertical-align:bottom;width:97.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Preliminary Proxy Statement</p></td></tr><tr><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:3pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:97.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:3pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-family:'Wingdings';font-weight:bold;">&#168;</b></p></td><td style="vertical-align:bottom;width:97.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</b></p></td></tr><tr><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-family:'Wingdings';font-size:3pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:97.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:3pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-family:'Wingdings';">&#168;</span></p></td><td style="vertical-align:bottom;width:97.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Definitive Proxy Statement</p></td></tr><tr><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:3pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:97.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:3pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-family:'Wingdings';">&#168;</span></p></td><td style="vertical-align:bottom;width:97.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Definitive Additional Materials</p></td></tr><tr><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:3pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:97.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:3pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-family:'Wingdings';">&#168;</span></p></td><td style="vertical-align:bottom;width:97.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Soliciting Material Pursuant to &#167;240.14a-12</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" name="dei:EntityRegistrantName" id="Narr_Sqc0V1gOEkGvRuuMuQFqrw"><b style="font-weight:bold;">Capricor Therapeutics,&#160;Inc.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;">(Name of Registrant as Specified In Its Charter)</p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:6pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:100%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">(Name of Person(s)&#160;Filing Proxy Statement, if other than the Registrant)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 6pt 0pt;">Payment of Filing Fee (Check all boxes that apply):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:97.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Wingdings';">x</span></p></td><td style="vertical-align:bottom;width:97.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">No fee required.</p></td></tr><tr><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:3pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:97.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:3pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Wingdings';">&#168;</span></p></td><td style="vertical-align:bottom;width:97.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fee paid previously with preliminary materials.</p></td></tr><tr><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:3pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:97.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:3pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Wingdings';">&#168;</span></p></td><td style="vertical-align:bottom;width:97.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</p></td></tr><tr><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:3pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:97.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:3pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1px solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:2pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:67.11pt;"><a id="_40cc0d47_ad8d_4b8c_9cca_5d1db13362d1"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;"><img src="capr-20240514xpre14a002.jpg" alt="Graphic" style="display:inline-block;height:67.11pt;width:172.36pt;"/></b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">To Be Held on May 14, 2024</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Dear Stockholders of Capricor Therapeutics,&#160;Inc.:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">You are cordially invited to attend the Annual Meeting of Stockholders (the &#8220;<span style="font-style:italic;font-weight:bold;">Annual Meeting</span>&#8221;) of Capricor Therapeutics,&#160;Inc., a Delaware corporation (the &#8220;<span style="font-style:italic;font-weight:bold;">Company</span>&#8221;), which will be held on May&#160;14, 2024 at 10:00&#160;a.m.&#160;(PDT), or any adjournment or postponement thereof. The Annual Meeting will be held at the Company&#8217;s principal executive office located at 10865 Road to the Cure, Suite 150, San Diego, California 92121. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">The Annual Meeting will be held for the following purposes, which are more fully described in the accompanying proxy statement:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">1.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">To elect the nine (9) nominees named in this proxy statement to the Company&#8217;s board of directors to serve for a one-year term expiring at our 2025 Annual Meeting of Stockholders;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">To ratify the appointment of Rose, Snyder &amp; Jacobs LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2024;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">3.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">To approve, by non-binding advisory vote, the resolution approving named executive officer compensation; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">4.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">To approve an amendment in the form set forth on </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex A</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> to this proxy statement (the &#8220;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Charter Amendment</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221;) to the Company&#8217;s Certificate of Incorporation, as amended from time to time (the &#8220;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Certificate of Incorporation</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221;) to increase the number of authorized shares of our common stock from 50,000,000 to 100,000,000; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">5.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.</span></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">The Company&#8217;s board of directors has set the Record Date (as defined below) as March&#160;18, 2024. Only stockholders that owned Capricor Therapeutics, Inc. common stock at the close of business on that day are entitled to notice of and may vote at the Annual Meeting or any adjournments or postponements thereof. </p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:100%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">rules&#160;issued by the Securities and Exchange Commission, we are providing access to our proxy materials both by sending you this full set of proxy materials and by notifying you of the availability of our proxy materials on the Internet.</span><span style="text-decoration-line:none;"><br/></span><span style="text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:100%;border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting to be Held on May 14, 2024:</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">The proxy statement and the enclosed proxy card are available at</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">https://www.capricor.com/investors/sec-filings</b><b style="font-weight:bold;"><br/></b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Under rules&#160;issued by the Securities and Exchange Commission, we are providing access to our proxy materials both by sending you this full set of proxy materials and by notifying you of the availability of our proxy materials on the Internet.</span><span style="text-decoration-line:none;"><br/></span><span style="text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">You may vote your shares at the Annual Meeting only if you are present in person or if you are represented by proxy. All stockholders are invited to attend the Annual Meeting in person. Whether or not you plan to attend the Annual Meeting in person, please complete, date and sign the enclosed proxy and return it in the enclosed envelope as promptly as possible. We urge you to carefully read this entire Proxy Statement, including the documents that we refer to in this Proxy Statement. If you attend the Annual Meeting, you may withdraw the proxy and vote in person. If you have any questions regarding the completion of the enclosed proxy or would like directions to the Annual Meeting, please call (858) 727-1755.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">We hope that you will be able to participate in the Annual Meeting. Thank you for your continued support. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-size:12pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">By Order of the Board of Directors,</p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">CAPRICOR THERAPEUTICS,&#160;INC.</b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:50%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">/s/ Linda Marb&#225;n, Ph.D.</p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Linda Marb&#225;n, Ph.D.</p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Chief Executive Officer and a Director</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">San Diego, California</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">March&#160;[&#9679;], 2024</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_b47174e2_9f27_4fa3_8335_6754eda072c7"></a><a id="TOC"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">TABLE OF CONTENTS</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:95.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:4.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:95.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#COMMONLYASKEDQUESTIONSANDANSWERSABOUTTHE"><span style="font-style:normal;font-weight:normal;">COMMONLY ASKED QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING</span></a></p></td><td style="vertical-align:bottom;width:4.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">5</p></td></tr><tr><td style="vertical-align:top;width:95.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#BOARDOFDIRECTORSANDCORPORATEGOVERNANCE_4"><span style="font-style:normal;font-weight:normal;">INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE</span></a></p></td><td style="vertical-align:bottom;width:4.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">10</p></td></tr><tr><td style="vertical-align:top;width:95.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#PROPOSALNO1_149663"><span style="font-style:normal;font-weight:normal;">PROPOSAL 1 &#8211; ELECTION OF DIRECTORS</span></a></p></td><td style="vertical-align:bottom;width:4.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">11</p></td></tr><tr><td style="vertical-align:top;width:95.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#EXECUTIVEOFFICERS_48870"><span style="font-style:normal;font-weight:normal;">INFORMATION REGARDING EXECUTIVE OFFICERS</span></a></p></td><td style="vertical-align:bottom;width:4.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">23</p></td></tr><tr><td style="vertical-align:top;width:95.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#EXECUTIVECOMPENSATION_516063"><span style="font-style:normal;font-weight:normal;">EXECUTIVE COMPENSATION</span></a></p></td><td style="vertical-align:bottom;width:4.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">24</p></td></tr><tr><td style="vertical-align:top;width:95.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#NONEMPLOYEEDIRECTORCOMPENSATION_370719"><span style="font-style:normal;font-weight:normal;">NON-EMPLOYEE DIRECTOR COMPENSATION</span></a></p></td><td style="vertical-align:bottom;width:4.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">31</p></td></tr><tr><td style="vertical-align:top;width:95.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#CertainRelationshipsandRelatedPartyTrans"><span style="font-style:normal;font-weight:normal;">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</span></a></p></td><td style="vertical-align:bottom;width:4.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">31</p></td></tr><tr><td style="vertical-align:top;width:95.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#PROPOSALNO2_635199"><span style="font-style:normal;font-weight:normal;">PROPOSAL 2 &#8211; RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></a></p></td><td style="vertical-align:bottom;width:4.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">33</p></td></tr><tr><td style="vertical-align:top;width:95.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#AUDITCOMMITTEEREPORT_712392"><span style="font-style:normal;font-weight:normal;">AUDIT COMMITTEE REPORT</span></a></p></td><td style="vertical-align:bottom;width:4.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">35</p></td></tr><tr><td style="vertical-align:top;width:95.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#PROPOSALNO3_761835"><span style="font-style:normal;font-weight:normal;">PROPOSAL 3 &#8211; ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS</span></a></p></td><td style="vertical-align:bottom;width:4.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">36</p></td></tr><tr><td style="vertical-align:top;width:95.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#PROPOSALNO4_737675"><span style="font-style:normal;font-weight:normal;">PROPOSAL 4 &#8211; AMENDMENT TO CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES</span></a> </p></td><td style="vertical-align:bottom;width:4.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">37</p></td></tr><tr><td style="vertical-align:top;width:95.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#STOCKOWNERSHIPINFORMATION_372723"><span style="font-style:normal;font-weight:normal;">STOCK OWNERSHIP INFORMATION</span></a></p></td><td style="vertical-align:bottom;width:4.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">39</p></td></tr><tr><td style="vertical-align:top;width:95.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#OTHERINFORMATION_374960"><span style="font-style:normal;font-weight:normal;">OTHER INFORMATION</span></a></p></td><td style="vertical-align:bottom;width:4.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">42</p></td></tr><tr><td style="vertical-align:top;width:95.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#ANNEXA_478450"><span style="font-style:normal;font-weight:normal;">ANNEX A</span></a></p></td><td style="vertical-align:bottom;width:4.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">43</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_71644e4d_1f8d_4e9a_8ea7_b4a9d79b3fd6"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">PROXY STATEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FOR THE 2024 ANNUAL MEETING OF THE STOCKHOLDERS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">TO BE HELD ON MAY 14, 2024</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="COMMONLYASKEDQUESTIONSANDANSWERSABOUTTHE"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">COMMONLY ASKED QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Why am I receiving these materials?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have sent you these proxy materials because the board of directors (the &#8220;<span style="font-style:italic;font-weight:bold;">Board</span>&#8221;) of Capricor Therapeutics,&#160;Inc. (sometimes referred to as &#8220;<span style="font-style:italic;font-weight:bold;">we</span>&#8221;, &#8220;<span style="font-style:italic;font-weight:bold;">us</span>&#8221;, or the &#8220;<span style="font-style:italic;font-weight:bold;">Company</span>&#8221;) is soliciting your proxy to vote at the 2024 Annual Meeting of Stockholders (the &#8220;<span style="font-style:italic;font-weight:bold;">Annual Meeting</span>&#8221;), including at any adjournments or postponements of the Annual Meeting. You are invited to attend the Annual Meeting in person to vote on the proposals described in this proxy statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We intend to mail the proxy solicitation materials, combined with the Annual Report on Form&#160;10-K for our fiscal&#160;year ended December&#160;31, 2023, including financial statements, to stockholders on or about April&#160;[&#9679;], 2024. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">How do I attend the Annual Meeting?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Annual Meeting will be held on May&#160;14, 2024, at 10:00&#160;a.m.&#160;PDT. You may attend in person, at our principal executive offices located at 10865 Road to the Cure, Suite 150, San Diego, California 92121. Information on how to vote in person at the Annual Meeting is discussed below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Attending in Person:</i> You will need to have a government-issued photo identification along with either your Notice and Access Card or proof of ownership of our shares of common stock as of the Record Date in order to enter the Annual Meeting. Proof of ownership may be any of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">A brokerage statement or letter from a bank or broker indicating ownership on the Record Date;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">A printout of the proxy distribution email (if you received your materials electronically); or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A voting instruction form received from your bank, broker or nominee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">You are also encouraged to take health and safety considerations into account in determining whether to attend the Annual Meeting in person, and to comply with any laws, executive orders or governmental guidelines in effect in the City of San Diego, the County of San Diego, the State of California, the United States of America, and stockholders&#8217; jurisdictions of residence.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Who can vote at the Annual Meeting?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Only stockholders of record at the close of business on March&#160;18, 2024 (the &#8220;<span style="font-style:italic;font-weight:bold;">Record Date</span>&#8221;) will be entitled to vote at the Annual Meeting. On the Record Date, there were 31,502,972 shares of our common stock outstanding and entitled to vote. Stockholders will be entitled to one (1) vote on each matter to be voted on for each share of common stock owned as of the close of business on the Record Date. There is no cumulative voting. No other securities are entitled to be voted at the Annual Meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Stockholder of Record: Shares Registered in Your Name</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If at the close of business on the Record Date, your shares were registered directly in your name with our transfer agent, Equiniti Trust Company, LLC, then you are a stockholder of record. As a stockholder of record, you may vote in person at the Annual Meeting or vote by proxy. Whether or not you plan to attend the Annual Meeting in person, we urge you to vote by proxy as instructed below to ensure your vote is counted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Agent</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">If at the close of business on the Record Date your shares were held, not in your name, but rather in an account at a brokerage firm, bank, dealer or other similar organization, then you are the beneficial owner of shares held in &#8220;street name&#8221; and the Notice is being forwarded to you by that organization. The organization holding your account is considered to be the stockholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker, bank or other agent regarding how to vote the shares in your account. You are also invited to attend the </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Annual Meeting in person. However, since you are not the stockholder of record, you may not vote your shares in person at the Annual Meeting unless you request and obtain a valid proxy from your broker, bank or other agent.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">What am I voting on?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">There are four (4)&#160;matters scheduled for a vote:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">1.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Election of nine (9)&#160;nominees named in this proxy statement to the Board;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Ratification of the Audit Committee&#8217;s selection of Rose, Snyder&#160;&amp; Jacobs LLP as the Company&#8217;s independent registered public accounting firm for the fiscal&#160;year ending December&#160;31, 2024; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">3.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">To approve a non-binding resolution on our named executive officer compensation; and </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">4.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">To approve an amendment to the Certificate of Incorporation to increase the number of authorized shares of our common stock from 50,000,000 to 100,000,000. </span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">What if another matter is properly brought before the Annual Meeting?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the Annual Meeting, it is the intention of the persons named in the accompanying proxy to vote on those matters in accordance with their best judgment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">What is the Board&#8217;s voting recommendation?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Board recommends that you vote your shares:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8220;For&#8221; the election of each of the nine (9)&#160;nominees named in this proxy statement to the Board;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8220;For&#8221; the ratification of the Audit Committee&#8217;s selection of Rose, Snyder&#160;&amp; Jacobs LLP as the Company&#8217;s independent registered public accounting firm for the fiscal&#160;year ending December&#160;31, 2024; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8220;For&#8221; the approval, on a non-binding basis, of the Company&#8217;s named executive officer compensation; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8220;For&#8221; the approval of an amendment to the Certificate of Incorporation to increase the number of authorized shares of our common stock from 50,000,000 to 100,000,000.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">How do I vote?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">With respect to the election of directors, you may either vote &#8220;For&#8221; all the nominees to the Board or you may &#8220;Withhold&#8221; your vote for any nominee you specify. For the ratification of the Audit Committee&#8217;s selection of Rose, Snyder &amp; Jacobs LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2024, for the approval of executive officer compensation, and for the approval of an amendment to the Certificate of Incorporation to increase the number of authorized shares of our common stock from 50,000,000 to 100,000,000, you may vote &#8220;For&#8221; or &#8220;Against&#8221; or abstain from voting. The procedures for voting are fairly simple and depend upon whether your shares are registered in your name or are held by a bank, broker or other agent.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Stockholder of Record: Shares Registered in Your Name</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If you are a stockholder of record, you may vote in person at the Annual Meeting or vote by proxy. Whether or not you plan to attend the Annual Meeting in person, we urge you to vote by proxy to ensure your vote is counted. You may still attend the Annual Meeting and vote in person even if you have already voted by proxy.</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">To vote in person, come to the Annual Meeting and we will give you a ballot when you arrive.</span></td></tr></table></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">6</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">To vote using the proxy card, simply complete, sign and date the proxy card and return it promptly in the envelope provided. If you return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Beneficial Owner: Shares Registered in the Name of Broker, Bank or Other Agent</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you should have received a notice containing voting instructions from that organization rather than from us. Simply follow the voting instructions in the notice to ensure that your vote is counted. To vote in person at the Annual Meeting, you must obtain a valid proxy from your broker, bank or other agent. Follow the instructions from your broker, bank or other agent included with these proxy materials, or contact your broker, bank or other agent to request a proxy form.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">How many votes do I have?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On each matter to be voted upon, you have one (1)&#160;vote for each share of common stock you own as of the close of business on March&#160;18, 2024, the Record Date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">What if I return a proxy card or otherwise vote but do not make specific choices?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If you return a signed and dated proxy card without marking any voting selections, your shares will be voted in accordance with the recommendations of the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Who is paying for this proxy solicitation?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We will pay for the entire cost of soliciting proxies. In addition to these proxy materials, our directors and employees may also solicit proxies in person, by mail, by telephone, by email or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">What does it mean if I receive more than one Notice?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If you receive more than one Notice, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on each Notice to ensure that all of your shares are voted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Can I change my vote after submitting my proxy?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Yes. You can revoke your proxy at any time before the final vote at the Annual Meeting. If you are the record holder of your shares, you may revoke your proxy in any one of the following ways:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">You may submit another properly completed proxy card with a later date;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">You may send a timely written notice that you are revoking your proxy to our Corporate Secretary at 10865 Road to the Cure, Suite 150, San Diego, California 92121; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">You may attend the Annual Meeting and vote in person. Simply attending the Annual Meeting will not, by itself, revoke your proxy.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 36pt;">Your most current proxy card is the one that is counted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">If your shares are held by your broker, bank or other agent, you should follow the instructions provided by your broker, bank or other agent.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">How are votes counted?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">Votes will be counted by the inspector of election appointed for the Annual Meeting, who will separately count, for Proposal No. 1, &#8220;For,&#8221; &#8220;Withhold&#8221; and broker non-votes; for Proposal No. 2, &#8220;For,&#8221; &#8220;Against&#8221; and abstentions; for Proposal No. 3, &#8220;For,&#8221; &#8220;Against,&#8221; abstentions and broker non-votes; and for Proposal No. 4, &#8220;For,&#8221; &#8220;Against&#8221; and abstentions.</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">7</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">What are &#8220;broker non-votes&#8221;?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Broker non-votes occur when a beneficial owner of shares held in &#8220;street name&#8221; does not give instructions to the broker, bank or other agent holding the shares as to how to vote on matters deemed &#8220;non-routine.&#8221; Generally, if shares are held in street name, the beneficial owner of the shares is entitled to give voting instructions to the broker, bank or other agent holding the shares. If the beneficial owner does not provide voting instructions, the broker, bank or other agent can still vote the shares with respect to matters that are considered to be &#8220;routine,&#8221; but not with respect to &#8220;non-routine&#8221; matters. Under the rules and interpretations of the New York Stock Exchange, which generally apply to all brokers, banks or other nominees, &#8220;non-routine&#8221; matters are matters that may substantially affect the rights or privileges of stockholders, such as mergers, stockholder proposals, elections of directors (even if not contested), amendments to equity plans, and executive compensation, including advisory stockholder votes on executive compensation and on the frequency of stockholder votes on executive compensation. We believe that the ratification of the selection of the independent registered public accounting firm and the approval of an amendment to the Certificate of Incorporation to increase the number of authorized shares of our common stock from 50,000,000 to 100,000,000 will generally be considered to be &#8220;routine&#8221; matters for which brokers, banks or other nominees generally have discretionary voting power. The other proposals are considered non-routine matters. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Broker non-votes will be counted for the purpose of determining whether a quorum is present at the Annual Meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">How many votes are needed to approve each proposal?</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Directors are elected by a plurality of the votes of the shares present in person or represented by proxy at the Annual Meeting and entitled to vote for directors. Therefore, for the election of directors, the nine (9)&#160;nominees receiving the most &#8220;For&#8221; votes (from the holders of the votes of the shares present in person or represented by proxy and entitled to vote for directors) will be elected. Only votes &#8220;For&#8221; or &#8220;Withheld&#8221; will affect the outcome. Broker non-votes will have no effect.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">To be approved, Proposal No. 2, the ratification of the Audit Committee&#8217;s selection of Rose, Snyder &amp; Jacobs LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024, requires the affirmative vote of a majority of the votes cast on the proposal, meaning that the proposal must receive more votes &#8220;For&#8221; the proposal than votes &#8220;Against&#8221; the proposal. Abstentions will have no effect. Brokers generally have discretionary authority to vote shares on this proposal. Therefore, we do not expect any broker non-votes on Proposal No.&#160;2.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">To be approved, Proposal No. 3, the advisory approval of the compensation of our named executive officers, requires the affirmative vote of a majority of the votes cast on the proposal, meaning that the proposal must receive more votes &#8220;For&#8221; the proposal than votes &#8220;Against&#8221; the proposal. Abstentions and broker non-votes will have no effect. Although the advisory vote on Proposal No. 3 is non-binding, the Board will review the results of the votes and will consider the results in making a determination concerning future executive compensation. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">To be approved, Proposal No. 4, the approval of an amendment to the Certificate of Incorporation to increase the number of authorized shares of our common stock from 50,000,000 to 100,000,000, requires the affirmative vote of a majority of the votes cast on the proposal, meaning that the proposal must receive more votes &#8220;For&#8221; the proposal than votes &#8220;Against&#8221; the proposal. Abstentions will have no effect. Brokers generally have discretionary authority to vote shares on this proposal. Therefore, we do not expect any broker non-votes on Proposal No. 4.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">What is the quorum requirement?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if stockholders holding a majority of the voting power of the outstanding shares entitled to vote on a matter are present at the Annual Meeting in person or represented by proxy. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other agent) or if you vote in person at the Annual Meeting. Abstentions and broker non-votes will be counted towards the quorum requirement. If there is no quorum, the holders of a majority of shares present at the Annual Meeting in person or represented by proxy may adjourn the Annual Meeting to another date.</p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">8</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">How can I find out the results of the voting at the Annual Meeting?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Preliminary voting results will be announced at the Annual Meeting. In addition, final voting results will be published in a Current Report on Form&#160;8-K that we expect to file with the Securities and Exchange Commission (the &#8220;<span style="font-style:italic;font-weight:bold;">SEC</span>&#8221;) within four (4)&#160;business&#160;days after the Annual Meeting. If final voting results are not available to us in time to file a Form&#160;8-K with the SEC within four (4)&#160;business&#160;days after the Annual Meeting, we intend to file a Form&#160;8-K to publish preliminary results and, within four (4)&#160;business&#160;days after the final results are known to us, file an additional Form&#160;8-K to publish the final results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">I also have received a copy of the Company&#8217;s Annual Report on Form&#160;10-K for the fiscal&#160;year ended December&#160;31, 2023. Is that a part of the proxy materials?</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We filed our Annual Report on Form&#160;10-K for the fiscal&#160;year ended December&#160;31, 2023, with the SEC on March&#160;11, 2024. A copy of our Annual Report accompanies this proxy statement. This document constitutes our Annual Report to Stockholders, and is being made available to all stockholders entitled to receive notice of and to vote at the Annual Meeting. Except as otherwise stated, the Annual Report is not incorporated into this proxy statement and should not be considered proxy solicitation material.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">When are stockholder proposals due for next&#160;year&#8217;s annual meeting?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Stockholders may submit proposals on matters appropriate for stockholder action at the 2025 Annual Meeting of Stockholders consistent with Rule 14a-8 promulgated under the Securities Exchange Act of 1934, as amended (the &#8220;<span style="font-style:italic;font-weight:bold;">Exchange Act</span>&#8221;). To be timely and considered for inclusion in proxy materials for our 2025 Annual Meeting of Stockholders, a stockholder proposal must be submitted in writing no later than December [&#9679;], 2024 to our Corporate Secretary at 10865 Road to the Cure, Suite 150, San Diego, California 92121. However, if the date of the 2025 Annual Meeting of Stockholders is convened more than 30 days before, or delayed by more than 30 days after, May 14, 2025, to be considered for inclusion in proxy materials for our 2025 Annual Meeting of Stockholders, a stockholder proposal must be submitted in writing to our Corporate Secretary at 10865 Road to the Cure, Suite 150, San Diego, California 92121 a reasonable time before we begin to print and send our proxy materials for our 2025 Annual Meeting of Stockholders. If you would like to submit a matter for consideration at our 2025 Annual Meeting of Stockholders (including any stockholder proposal not submitted under Rule 14a-8 or any director nomination) that will not be included in the proxy statement for that annual meeting, it must be received by our Corporate Secretary a reasonable period of time prior to the 2025 Annual Meeting of Stockholders. Please review our Bylaws, which contain requirements regarding advance notice of stockholder proposals. You may view our Bylaws by visiting the SEC&#8217;s Internet website at www.sec.gov. In addition to satisfying the foregoing requirements under our Bylaws, to comply with the universal proxy rules stockholders who intend to solicit proxies in support of director nominees other than management&#8217;s nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than April [&#9679;], 2025.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">9</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_caad4be8_4acb_4844_b225_df9c0283d754"></a><a id="BOARDOFDIRECTORSANDCORPORATEGOVERNANCE_4"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following table sets forth each member of our Board:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:72.35%;background:#ffffff;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:37.17%;margin:0pt;padding:0pt 0pt 1pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt 0pt 1pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:bottom;width:60.25%;margin:0pt;padding:0pt 0pt 1pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:37.17%;background:#ffffff;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.56%;background:#ffffff;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:60.25%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Positions</b></p></td></tr><tr><td style="vertical-align:top;width:37.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Linda Marb&#225;n, Ph.D.</p></td><td style="vertical-align:bottom;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:60.25%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">President, Chief Executive Officer and Director</p></td></tr><tr><td style="vertical-align:top;width:37.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Frank Litvack, M.D.</p></td><td style="vertical-align:bottom;width:2.56%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:60.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Executive Chairman and Director</p></td></tr><tr><td style="vertical-align:top;width:37.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Earl M. (Duke) Collier&#160;Jr., J.D.</p></td><td style="vertical-align:bottom;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:60.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:top;width:37.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">David B. Musket</p></td><td style="vertical-align:bottom;width:2.56%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:60.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:top;width:37.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">George W. Dunbar Jr., M.B.A.</p></td><td style="vertical-align:bottom;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:60.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:top;width:37.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Karimah Es Sabar</p></td><td style="vertical-align:bottom;width:2.56%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:60.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr style="height:3.7pt;"><td style="vertical-align:top;width:37.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Paul Auwaerter, M.D., M.B.A.</p></td><td style="vertical-align:bottom;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:60.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:top;width:37.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Philip Gotwals, Ph.D.</p></td><td style="vertical-align:bottom;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:60.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr style="height:3.7pt;"><td style="vertical-align:top;width:37.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Michael Kelliher</p></td><td style="vertical-align:bottom;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:60.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We believe that in order for our Board to effectively guide us through our continued growth as a development-stage biopharmaceutical company, it should be composed of individuals with sophistication and experience in the many disciplines that impact our business. In order to best serve our stockholders, we seek to have a Board, as a whole, that is competent in key corporate disciplines, including accounting and financial acumen, business judgement, governance, leadership, risk management, social responsibility and reputational issues, strategy and strategic planning. Additionally, we desire that the Board have specific knowledge related to our industry, such as expertise in healthcare, medical technology, and manufacturing. While we do not have a formal policy on diversity, when considering the selection of director nominees, the Nominating and Governance Committee considers individuals with diverse backgrounds, viewpoints, accomplishments, cultural backgrounds and professional expertise, among other factors. Further, our Board is committed to actively seeking highly qualified women and individuals from underrepresented minority groups to include in the pool from which new candidates are selected. Of our seven directors, two directors self-identify as female and one director self-identifies as a racial or ethnic minority. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">10</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_17db60c5_a104_470a_a638_1f494ebaf7de"></a><a id="PROPOSALNO1_149663"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">PROPOSAL NO. 1: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">ELECTION OF DIRECTORS </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our Board recommends that the nominees below be elected as member of the Board at the Annual Meeting:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;background:#ffffff;"><tr><td style="vertical-align:bottom;width:26.89%;background:#ffffff;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:top;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:10.17%;background:#ffffff;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Age*</b></p></td><td style="vertical-align:top;white-space:nowrap;width:1.84%;background:#ffffff;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:43.6%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Positions&#160;Held</b></p></td><td style="vertical-align:top;width:1.86%;background:#ffffff;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:13.76%;background:#ffffff;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Director of Company Since</b></p></td></tr><tr><td style="vertical-align:top;width:26.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Linda Marb&#225;n, Ph.D.</p></td><td style="vertical-align:bottom;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:10.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 3pt 0pt 0pt;">60</p></td><td style="vertical-align:bottom;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:43.6%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">President, Chief Executive Officer and Director</p></td><td style="vertical-align:top;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:13.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2013</p></td></tr><tr><td style="vertical-align:top;width:26.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Frank Litvack, M.D.</p></td><td style="vertical-align:bottom;width:1.85%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 3pt 0pt 0pt;">68</p></td><td style="vertical-align:bottom;width:1.84%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:43.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Executive Chairman and Director</p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:13.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2013</p></td></tr><tr><td style="vertical-align:top;width:26.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Earl M. (Duke) Collier,&#160;Jr., J.D.</p></td><td style="vertical-align:bottom;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:10.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 3pt 0pt 0pt;">76</p></td><td style="vertical-align:bottom;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:43.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td><td style="vertical-align:top;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:13.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2013</p></td></tr><tr><td style="vertical-align:top;width:26.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">David B. Musket</p></td><td style="vertical-align:bottom;width:1.85%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 3pt 0pt 0pt;">66</p></td><td style="vertical-align:bottom;width:1.84%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:43.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:13.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2013</p></td></tr><tr><td style="vertical-align:top;width:26.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">George W. Dunbar Jr., M.B.A.</p></td><td style="vertical-align:bottom;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:10.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 3pt 0pt 0pt;">77</p></td><td style="vertical-align:bottom;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:43.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td><td style="vertical-align:top;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:13.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2013</p></td></tr><tr><td style="vertical-align:top;width:26.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Karimah Es Sabar</p></td><td style="vertical-align:bottom;width:1.85%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 3pt 0pt 0pt;">66</p></td><td style="vertical-align:bottom;width:1.84%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:43.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:13.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2021</p></td></tr><tr><td style="vertical-align:top;width:26.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Paul Auwaerter, M.D., M.B.A.</p></td><td style="vertical-align:bottom;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:10.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 3pt 0pt 0pt;">62</p></td><td style="vertical-align:bottom;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:43.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td><td style="vertical-align:top;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:13.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2023</p></td></tr><tr><td style="vertical-align:top;width:26.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Philip Gotwals, Ph.D.</p></td><td style="vertical-align:bottom;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 3pt 0pt 0pt;">61</p></td><td style="vertical-align:bottom;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:43.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:13.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2023</p></td></tr><tr><td style="vertical-align:top;width:26.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Michael Kelliher</p></td><td style="vertical-align:bottom;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:10.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 3pt 0pt 0pt;">47</p></td><td style="vertical-align:bottom;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:43.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td><td style="vertical-align:top;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:13.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2023</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">*Ages as of March 18, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Nominating and Corporate Governance Committee recommended, and the Board approved, each of the nominees for election to the Board at the 2024 Annual Meeting of Stockholders. There are no family relationships between or among any of our executive officers, directors or nominees for director.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Directors are elected by a plurality of the votes of the shares present in person or represented by proxy and entitled to vote for directors. The nine (9) nominees receiving the highest number of affirmative votes will be elected. Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the nine (9) nominees named below. Broker non-votes will have no effect on whether any nominee is elected. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If elected by our stockholders, each nominee will serve for a one-year term expiring at our 2025 Annual Meeting of Stockholders. Each director will hold office until his or her successor has been elected and qualified or until the director&#8217;s earlier resignation, removal or disqualification. If any nominee becomes unavailable for election as a result of an unexpected occurrence, your shares will be voted for the election of a substitute nominee proposed by the Board. Each person nominated for election has agreed to serve if elected. Our management has no reason to believe that any nominee will be unable to serve.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">FOR</b>&#8221; EACH NAMED NOMINEE.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;width:36pt;"></span>We look to our directors to lead us through our continued growth as a development-stage public biopharmaceutical company. Our directors bring their leadership experience from a variety of life science and other companies and professional backgrounds which we require to continue to grow and bring value to our stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Director Nominees</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Nominating and Corporate Governance Committee seeks to assemble a Board that, as a whole, possesses the appropriate balance of professional and industry knowledge, financial expertise and high-level management experience necessary to oversee and direct our business. The brief biographies below include information, as of the date of this proxy statement, regarding the specific and particular experience, qualifications, attributes or skills of each nominee that led the Nominating and Corporate Governance Committee to recommend that person as a nominee, and for the Board as a whole to approve the nomination of that person to the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Linda Marb&#225;n, Ph.D.</span> Dr.&#160;Marb&#225;n is currently serving as our Chief Executive Officer, and has served in that capacity and on the Board since November 2013. As co-founder of Capricor, Inc., our wholly-owned subsidiary, Dr. Marb&#225;n has been with Capricor, Inc. since 2005 and became its Chief Executive Officer in 2010. Dr. Marb&#225;n has been in the biotechnology field for more than 20 years and brings extensive experience across research, product development and business development to the Company. From 2003-2009, Dr. Marb&#225;n held various senior roles at Excigen, Inc., a gene therapy biotechnology company, where she was responsible for operations and business development and where she </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">11</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">oversaw the development of a biologic pacemaker for the heart. Prior to Excigen, Dr. Marb&#225;n worked in academic science, first at the Cleveland Clinic Foundation working on the development of contractile dysfunction in heart failure due to myocarditis, followed by a postdoctoral fellowship at Johns Hopkins University. While at Johns Hopkins, she advanced to the rank of Research Assistant Professor in the Department of Pediatrics, specializing in the mechanism of the biophysical properties of cardiac muscle. Her tenure at Johns Hopkins ran from 2000 to 2003. Dr. Marb&#225;n earned a Ph.D. from Case Western Reserve University in cardiac physiology and her Bachelor of Science from the University of Maryland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Dr. Linda Marb&#225;n was selected to serve as a member of the Board in part due to her wealth of knowledge in research and development, especially for the treatment of cardiovascular diseases, her experience in early-stage life sciences companies spanning over a decade, as well as her business development expertise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Frank Litvack, M.D., FACC.</span>&#160;Dr.&#160;Litvack joined the Capricor, Inc. board in 2012 and since November 2013 has been serving as the Company&#8217;s Executive Chairman. Dr. Litvack is a native of Canada. He completed medical school and residency at McGill University in Montreal and a Cardiovascular Fellowship at Cedars-Sinai Medical Center in Los Angeles, where he subsequently became co-director of the Cardiovascular Intervention Center and Professor of Medicine at UCLA. There he led a prominent clinical and research program known for its excellence in innovation, care, and leadership in Translational Medicine. Dr. Litvack was board-certified in Internal Medicine, Cardiovascular Diseases, and Interventional Cardiology. He has published more than one hundred research articles and chapters and is the recipient of several awards, including an American Heart Association Young Investigator Award, the Leon Goldman Medical Excellence Award for contributions to the field of biomedical optics, and the United States Space Technology and Space Foundation Hall of Fame for pioneering work with the excimer laser. Dr. Litvack left full-time practice and academics in 2000 to concentrate on entrepreneurial activities. Dr. Litvack has founded and operated several healthcare ventures, both as chairman and/or chief executive officer, including Progressive Angioplasty Systems Inc., a medical device company that was acquired by United States Surgical Corp. in 1998; Savacor, Inc., a medical device company that was acquired by St. Jude Medical in 2005; and Conor Medsystems, Inc., a publicly-traded medical device company that was acquired by Johnson &amp; Johnson in 2007. He presently sits on the boards of several early-stage healthcare companies, including Credence MedSystems, a drug delivery company; V Wave Medical, a heart failure company; and as Director of Levation Pharma, a specialty pharmaceutical company in the area of facial aesthetics which he co-founded. Additionally, he was a Board Member of MedAvail Inc., a pharmacy technology company. Dr. Litvack was a former director of Nile Therapeutics, Inc. (predecessor entity to the Company) from 2009 to 2012. Dr. Litvack was formerly a Member of the Management Company of Pura Vida Investments, LLC, a healthcare hedge fund. Since 2023, he is the Managing Member of Wilhareka Partners LLC. He is serving as a Director on the board of Cardiovascular Research Foundation, a non-profit research and education entity and on the Advisory Board of the Tannenbaum Open Science Institute at McGill University.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Dr. Frank Litvack, our Executive Chairman, was selected to serve as a member of the Board in part due to his wealth of business-building experience and medical expertise that anchors our activities in sound scientific research and solid business planning and practices. Additionally, as an accomplished veteran of the healthcare industry who has orchestrated the founding, development, financing and sale of several medical technology companies, we believe that Dr. Litvack provides invaluable knowledge and leadership to the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Earl M. (Duke) Collier&#160;Jr.</span> Mr.&#160;Collier has been a member of the Capricor, Inc. board since 2011 and became a member of the Company&#8217;s Board in November 2013. He is a member of the Company&#8217;s Compensation Committee and Chairman of the Nominating and Corporate Governance Committee. From 2010-2014, he served as the Chief Executive Officer of 480 Biomedical, a medical device company developing products used in the treatment of peripheral artery disease, and the executive chairman of Arsenal Medical, Inc., a medical device company. Mr. Collier was formerly Executive Vice President at Genzyme Corporation, a biotechnology company acquired by Sanofi for $20.1 billion in 2011. Mr. Collier also served as President of Vitas Healthcare, a hospice provider, as a partner at the Washington, DC-based law firm of Hogan and Hartson, and as Deputy Administrator of the Health Care Finance Administration (now CMS) in the U.S. Department of Health &amp; Human Services. He is Chair Emeritus of the Innovation Advisory Board of Mass General Brigham. Additionally, he is a member of the board of the Boston Athenaeum. Previously, Mr. Collier served as a director of publicly-traded Decode Genetics Inc. (DGI Resolution, Inc.), a biopharmaceutical company; GenSight, a gene therapy company in Paris that trades on the French Euronext exchange; and Tesaro, Inc., a publicly-traded biopharmaceutical company. Mr. Collier earned a Bachelor of Arts degree at Yale University and received a law degree from the University of Virginia Law School.</p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">12</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Mr. Collier was selected to serve as a member of the Board in part due to his significant experience with early stage private and public companies and depth of knowledge in building stockholder value, growing a company from inception and navigating significant corporate transactions and the public company process. Additionally, Mr. Collier has extensive experience in the pharmaceutical industry, allowing him to contribute significant operational experience.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">David B. Musket.</span>&#160;Mr.&#160;Musket has been a member of the Capricor, Inc. board since 2012 and a member of the Company&#8217;s Board since November 2013. He is Chairman of the Company&#8217;s Audit and Compensation Committees. Mr. Musket has vast experience in strategic finance and has been following developments in the pharmaceutical and medical device industries for over 30 years. Mr. Musket began his investment career as an equities research analyst at Goldman Sachs &amp; Co. following the pharmaceutical industry. From 1991 through 2016 he served as President of Musket Research Associates, a registered broker/dealer focused exclusively on venture banking transactions for emerging healthcare companies. In 1996 he co-founded ProMed Management, a healthcare-focused investment management company that he continues to run today. He has served on the boards of several private and public companies throughout his career. From 1999 to 2007, Mr. Musket served on the board of directors of publicly-traded Conor MedSystems, Inc. a medical device company sold to Johnson &amp; Johnson in 2007 for $1.4 billion. Mr. Musket holds a Bachelor of Arts degree in Biology and Psychology from Boston College.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Mr. Musket was selected to serve as a member of the Board in part due to his venture capital and investment banking backgrounds and expertise in financing and growing early-stage biopharmaceutical companies. Additionally, Mr. Musket has significant experience with early stage private and public companies and brings a depth of knowledge in building stockholder value, growing a company from inception and navigating significant corporate transactions and the public company process.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">George W. Dunbar&#160;Jr. </span>Mr.&#160;Dunbar has been a member of the Capricor, Inc. board since 2012 and a member of the Company&#8217;s Board since November 2013. He is a member of the Company&#8217;s Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. He is Managing Partner of The Dunbar Group, LLC, and provides advisory services to healthcare and life science investors and companies who recognize they need short-term or interim industry expertise as they grow in order to be capital efficient. Mr. Dunbar has extensive healthcare and life sciences operating experience and has served as a director or chief executive officer with private and public life science companies specializing in diagnostics, specialty pharma, cell therapy and biologics, two as chief executive officer, where he led initial public offerings. He served as chief executive officer of ISTO Technologies and ISTO Biologics, two private orthobiologics companies acquired by Thompson Street Capital Partners. Prior to ISTO, Mr. Dunbar served as a Venture Partner with Arboretum Ventures, a leading healthcare venture capital firm. Mr. Dunbar is currently a board member of Progenitor Life Sciences, a private next-generation immunotherapy development company, and Executive Chairman of Akadeum Life Sciences, a private next-generation sample prep/separations tools company with a focus on cell and gene therapy. Mr. Dunbar attended Auburn University where he graduated with a Bachelor of Science degree in Electrical Engineering and later received his M.B.A. He served on the Harbert College of Business M.B.A. Advisory Board and is an advisor with Life Science Tennessee and to Vanderbilt University&#8217;s Center for Technology Transfer and Commercialization.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Mr. Dunbar was selected to serve as a member of the Board in part due to his significant experience with early stage private and public companies and depth of knowledge in building stockholder value, growing a company from inception and navigating significant corporate transactions and the public company process. Additionally, Mr. Dunbar has extensive experience in the pharmaceutical industry, allowing him to contribute significant operational experience.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Karimah Es Sabar. </span>Ms.&#160;Es Sabar joined the Company&#8217;s Board in July 2021 and is a member of the Audit Committee and Nominating and Corporate Governance Committees. Since 2016 she has been the CEO and General Partner at Quark Venture LP, a venture capital investment firm, leading their global health sciences enterprise. Prior to Quark Venture, Ms. Es Sabar was President and CEO at the Centre for Drug Research and Development (CDRD), Canada&#8217;s national drug development and commercialization center, responsible for developing and executing on the overall strategic direction. Ms. Es Sabar has held senior management positions with multinational pharmaceutical companies, most notably as Director International Division, and later Global Head Marketing and Business Development at Pasteur Merieux Connaught (Sanofi Pasteur) based in Toronto. She holds degrees in Neurochemistry from the Institute of Psychiatry, University of London, in Biochemistry and Chemistry from the University of Salford Manchester, and an Executive Certificate in Management and Leadership from the MIT Sloan School of Management. Ms. Es Sabar is also the Chair of the Health Biosciences Economic Strategy Table (Government of Canada) and she serves on the board of directors of several biosciences companies.</p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">13</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Ms. Es Sabar was selected to serve as a member of the Board in part due to her significant experience with early stage private and public companies and brings a depth of knowledge in building stockholder value, growing a company from inception and navigating significant corporate transactions and the public company process. Additionally, Ms. Es Sabar has expertise in the innovation ecosystem and has extensive experience in the pharmaceutical industry, allowing her to contribute significant operational experience.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Paul G. Auwaerter, M.D., M.B.A., FIDSA.</span> Dr. Paul Auwaerter joined the Company&#8217;s Board in July 2023. Dr. Auwaerter was first identified as a candidate for director by Louis Manzo, a former Capricor board member. Since 2013, Dr. Auwaerter has been the Sherrilyn and Ken Fisher Professor of Medicine at the Johns Hopkins University School of Medicine, serving as the Clinical Director for the Division of Infectious Diseases and Director of the Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases. Dr. Auwaerter has served since 2003 as the Executive Director and Chief Medical Officer of the Johns Hopkins Point of Care-Information Technology (POC-IT) Center, producing the Johns Hopkins ABX (Antibiotic), JH HIV, JH Osler, JH Psychiatry and JH Diabetes Guides. Dr. Auwaerter has also served as Editor-in-Chief of the ABX Guide since 2017. Dr. Auwaerter&#8217;s research and clinical interests include improving the diagnosis and care for patients with infectious diseases, specifically Lyme disease, respiratory infections, surgical infections, prosthetic joint infections, Epstein-Barr virus, and fever of unknown origin. He has served as Chair of the Infectious Diseases Society of America Foundation and has been on the Board of Directors of the American Lyme Disease Foundation since 2018. He is a Past President of the Infectious Diseases Society of America (IDSA), the largest professional society worldwide related to infectious diseases, serving from 2017 to 2018. Dr. Auwaerter has been a member of the Board of Directors of the Baltimore Area Council of the Boy Scouts of America and has been awarded the National Distinguished Eagle Scout award. Dr. Auwaerter holds undergraduate and medical degrees from Columbia University and subsequent training in medicine and infectious diseases at Johns Hopkins, where he has been employed since 1988; he also trained in the virology and immunology laboratory of Dr. Diane Griffin. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Dr. Paul Auwaerter was selected to serve as a member of the Board in part due to his extensive medical background, including expertise in infectious diseases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Philip J. Gotwals, Ph.D.</span> Dr. Philip Gotwals joined the Company&#8217;s Board in July 2023. Dr. Gotwals was first identified as a candidate for director by a third-party search firm. Dr. Gotwals has experience in drug development, research, corporate strategy and business development with a career spanning nearly 30 years in the biotechnology industry. Dr. Gotwals has been a Partner at RedSky Partners, LLC, which provides advisory services to the biotechnology industry in the areas of corporate strategy and business development since 2023. Previously, Dr. Gotwals served as the Global Head, Vice President of Business Development and Licensing at Novartis Institutes for Biomedical Research (NIBR) from 2019 to 2023, where he oversaw business development efforts for all disease areas and technology platforms. Prior to that, Dr. Gotwals was Global Head of Search and Evaluation of NIBR from 2017 to 2019. &#160;Dr. Gotwals also served as Executive Director, Immuno-Oncology, at NIBR from 2009 to 2017. Under Dr. Gotwals&#8217; leadership, NIBR business development and licensing executed over 50 major strategic transactions which included licensing deals, collaborations, acquisitions and new company creations. These transactions led to significant corporate evolution and growth. During his 13 years at NIBR, Dr. Gotwals was instrumental in building the company&#8217;s immuno-oncology strategic research area and spearheading the collaboration with the University of Pennsylvania to develop chimeric antigen receptor (CAR) T-cell therapies. Prior to NIBR, he was Vice President of Program Management at Altus Pharmaceuticals from 2006 to 2009, where he was responsible for all product development project management activities. Prior to Altus, he was Senior Director of Program and Alliance Management at Biogen, from 1994 to 2006, where he oversaw leadership of internal and allied early product development teams in the autoimmune, neurology and oncology therapeutic areas. Dr. Gotwals has a B.A. in Biology from Amherst College, holds a Ph.D. in Genetics from the University of California at Berkeley, completed postdoctoral research at the Massachusetts Institute of Technology, business training at Harvard Business School and has published extensively in the area of integrin biology.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Dr. Gotwals was selected to serve as a member of the Board in part due to his significant experience with early stage private and public companies and brings a depth of knowledge in building stockholder value, growing a company from inception and navigating significant corporate transactions and the public company process. Additionally, Dr. Gotwals has extensive experience in the pharmaceutical industry, allowing him to contribute significant operational experience.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Michael Kelliher.</span> Michael Kelliher joined the Company&#8217;s Board in September 2023. Mr. Kelliher was first identified as a candidate for director by a third-party search firm. &#160;Mr. Kelliher is an experienced business development and finance professional with expertise in corporate strategy, mergers and acquisitions, strategic partnerships and licensing, </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">14</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">with a career spanning more than 20 years with leading biotechnology and global pharmaceutical companies. He most recently served as Group Vice President, M&amp;A and Business Development, at Horizon Therapeutics (now Amgen), a global biotechnology company focused on researching, developing and commercializing medicines for rare, autoimmune and severe inflammatory diseases. During Mr. Kelliher&#8217;s 9-year tenure at Horizon, he led an aggressive growth and expansion agenda through acquisitions, development collaborations and other transactions. He was instrumental in transforming Horizon into a $28.0 billion innovation-driven biotech company. Prior to his time at Horizon, from 2009 to 2014, Mr. Kelliher held progressive financial roles at Elan Corporation (now Perrigo Company), a leading global pharmaceutical company where he oversaw strategic partnerships and collaborations and advised its Board of Directors and senior leadership on investments, business development, product commercialization and asset monetization. Mr. Kelliher began his career in banking, public accounting and corporate finance and holds a Bachelor of Commerce degree from the University College Cork (Ireland). He is also an Associated Chartered Accountant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Mr. Kelliher was selected to serve as a member of the Board in part due to his significant experience with early stage private and public companies and brings a depth of knowledge in building stockholder value, growing a company from inception and navigating significant corporate transactions and the public company process. Additionally, Mr. Kelliher has extensive experience in the pharmaceutical industry, allowing him to contribute significant operational experience.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Independence of the Board of Directors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the independence rules&#160;of The Nasdaq Stock Market LLC (&#8220;<span style="font-style:italic;font-weight:bold;">Nasdaq</span>&#8221;), a majority of the members of a listed company&#8217;s board of directors must qualify as &#8220;independent,&#8221; as affirmatively determined by the board of directors. The Board consults with our counsel to ensure that the Board&#8217;s determinations are consistent with relevant securities and other laws and regulations regarding the definition of &#8220;independent,&#8221; including those set forth in pertinent listing standards of Nasdaq, as in effect from time to time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Consistent with these considerations, after review of all relevant identified transactions or relationships between each director, or any of his or her family members, and us, our senior management and our independent auditors, the Board has affirmatively determined that the following eight directors are independent directors within the meaning of the applicable Nasdaq listing standards: Dr. Frank Litvack, Mr.&#160;Earl Collier, Mr.&#160;David Musket, Mr.&#160;George Dunbar, Ms. Es Sabar, Dr. Paul Auwaerter, Dr. Philip Gotwals and Mr. Michael Kelliher. The Board also determined that Mr. Louis Manzo, who served as a director during fiscal year 2023 prior to his resignation, effective July 11, 2023, was independent within the meaning of the applicable Nasdaq listing standards. In making this determination, the Board found that none of these directors had a material or other disqualifying relationship with us. In addition to transactions required to be disclosed under SEC rules, the Board considered certain other relationships in making its independence determinations, and determined in each case that such other relationships did not impair the director&#8217;s ability to exercise independent judgment on our behalf. Each of our standing Board committees entirely consist of, and throughout fiscal year 2023 consisted of, independent directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Dr.&#160;Linda Marb&#225;n, our President and Chief Executive Officer, is not an independent director by virtue of her employment with the Company. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Board Meetings and Committees</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During the last fiscal&#160;year, the Board met ten (10) times and took action by unanimous written consent ten (10)&#160;times. All directors, except Dr. Philip Gotwals attended at least 75% of the aggregate number of meetings of the Board and of the committees on which they served that were held during the portion of the last fiscal&#160;year for which they were directors or committee members, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">It is our policy to invite directors and nominees for director to attend the Annual Meeting of Stockholders either in person or by telephone. Dr.&#160;Linda Marb&#225;n attended the 2023 Annual Meeting of Stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As required under applicable Nasdaq listing standards, our independent directors periodically meet in executive session at which only they are present.</p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">15</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The Board has three primary committees: an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. Each committee operates pursuant to a written charter, which are available in the Corporate Governance section of our website at www.capricor.com. The information contained on, or that can be accessed through, our website is not incorporated by reference and is not a part of this proxy statement. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The following table provides membership and meeting information for 2023 for each of these committees of the Board:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nominating and</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">    </b><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Audit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Corporate Governance</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Linda Marb&#225;n, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Frank Litvack, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Earl M. (Duke) Collier Jr., J.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">X</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">X</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">*</p></td></tr><tr><td style="vertical-align:bottom;width:58.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">David B. Musket</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">X</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">X</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">George W. Dunbar Jr., M.B.A.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">X</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">X</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">X</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Karimah Es Sabar</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">X</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">X</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Paul Auwaerter, M.D., M.B.A.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Philip Gotwals, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Michael Kelliher</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total meetings held in 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total actions by unanimous written consent in 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">*Committee Chairperson</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Below is a description of each primary committee of the Board. Each of these committees has authority to engage legal counsel or other experts or consultants, as it deems appropriate to carry out its responsibilities. The Board has determined that each member of each of these committees meets the applicable Nasdaq listing standards&#160;and regulations regarding &#8220;independence&#8221; and that the members of the Audit Committee and Compensation Committee meet the heightened independence standards applicable to those committees under the rules promulgated by the SEC and the Nasdaq listing standards. The Board has additionally determined that each committee member is free of any relationship that would impair his or her individual exercise of independent judgment with regard to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;font-weight:normal;">Audit Committee</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The current members of our Audit Committee are Mr.&#160;David Musket (Chair), Mr.&#160;George Dunbar and Ms.&#160;Karimah Es Sabar. Mr. Louis Manzo served as a member of our Audit Committee until his resignation from the Board and all Board committees, effective July 11, 2023. The Board has determined that Mr.&#160;Musket qualifies as an &#8220;audit committee financial expert,&#8221; as defined by the applicable rules&#160;of the SEC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Audit Committee of the Board is a separately-designated standing audit committee established by the Board in accordance with Section&#160;3(a)(58)(A)&#160;of the Exchange Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Audit Committee acts on behalf of the Board in fulfilling the Board&#8217;s oversight responsibilities with respect to our accounting and financial reporting processes and audits of financial statements, and also assists the Board in its oversight of the quality and integrity of our financial statements and reports and the qualifications, independence and performance of our independent registered public accounting firm. For this purpose, the Audit Committee performs several functions. A summary of the responsibilities of the Audit Committee include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">selecting, appointing, determining the compensation of, retaining and overseeing the work of our independent registered public accounting firm and any other registered public accounting firm engaged for the purpose of preparing or issuing an audit report or performing other audit, review or attest services for us;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">prior to engagement of any prospective registered public accounting firm, reviewing and discussing with the prospective independent registered public accounting firm a written disclosure by the prospective independent registered public accounting firm of all relationships between us, or persons in financial oversight roles, and such independent registered public accounting firm or their affiliates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">pre-approving engagements of the independent registered public accounting firm, prior to commencement of the engagement, and the scope of and plans for the audit;</span></td></tr></table></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">16</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">monitoring the rotation of partners of the independent registered public accounting firm on our audit engagement team;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing with management and the independent registered public accounting firm any fraud, whether or not material, that includes management or employees who have a significant role in our internal control over financial reporting and any significant changes in internal controls or other factors that could significantly affect internal controls, including any corrective actions in regards to significant deficiencies or material weaknesses;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or other auditing matters and the confidential and anonymous submission by our employees of concerns regarding questionable accounting or auditing matters;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing our compliance with applicable laws and regulations and reviewing and overseeing any policies, procedures or programs designed to monitor such compliance;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and discussing with management and the independent registered public accounting firm the annual audited financial statements (including the related notes) and any major issues regarding accounting principles and financial statement presentation and all other matters required to be discussed under generally accepted accounting standards, the results of the independent registered public accounting firm&#8217;s review of our quarterly financial information prior to public disclosure and our disclosures in our periodic reports filed with the SEC; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">performing, at least annually, an evaluation of the performance of the Audit Committee and its members, including a review of the Audit Committee&#8217;s compliance with its charter.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Audit Committee reviews, discusses and assesses its own performance at least annually, including a review of its compliance with its charter. The Audit Committee also, at least annually, reviews and assesses its charter and recommends any proposed changes to the charter to the Board for its consideration.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;font-weight:normal;">Compensation Committee</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The current members of our Compensation Committee are Mr.&#160;David Musket (Chair), Mr.&#160;Earl Collier and Mr.&#160;George Dunbar. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Compensation Committee acts on behalf of the Board to discharge the Board&#8217;s responsibilities relating to the compensation of our executives, including by designing, recommending to the Board for approval and evaluating our compensation plans, policies and programs. The Compensation Committee is also responsible for reviewing, discussing with management and approving our disclosures relating to executive compensation for use in our reports filed with the SEC. A summary of the responsibilities of the Compensation Committee include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing, at least annually, our compensation philosophy;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">determining and approving (or, if the Compensation Committee deems appropriate, recommending to the Board for determination and approval) corporate goals and objectives relating to the compensation of the Chief Executive Officer, evaluating the performance of the Chief Executive Officer in light of those goals, and determining or recommending the compensation of our Chief Executive Officer, including seeking to achieve an appropriate level of risk and reward in determining the long&#160;-term incentive component of the Chief Executive Officer&#8217;s compensation;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">determining and approving (or, if the Compensation Committee deems appropriate, recommending to the Board for determination and approval) the compensation for all other executive officers and senior management, taking into consideration such person&#8217;s success in achieving his or her individual goals and objectives and the corporate performance goals and objectives deemed relevant to such executive officers and senior management;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and approving (or, if it deems appropriate, making recommendations to the Board regarding) the terms of employment agreements, severance agreements, change-of-control protections and other compensatory arrangements for our executive officers and senior management;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and approving the type and amount of compensation to be paid or awarded to non-employee directors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and approving the adoption, amendment and termination of our stock option plans, stock appreciation rights plans, pension and welfare benefit plans, incentive plans, stock bonus plans, stock purchase plans, bonus plans, deferred compensation plans and similar programs, as applicable, and administering all such plans, setting performance targets, selecting participants, approving grants and awards and exercising such other power and authority as may be permitted or required under such plans;</span></td></tr></table></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">17</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">establishing and reviewing policies concerning perquisite benefits;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing our incentive compensation arrangements to determine whether such arrangements encourage excessive risk-taking, and reviewing and discussing the relationship between our risk management policies and practices and compensation, and evaluating compensation policies and practices that could mitigate any such risk, at least annually;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and recommending to the Board for approval the frequency with which we conduct a vote on executive compensation, taking into account the results of the most recent stockholder advisory vote on the frequency of the vote on executive compensation, and reviewing and approving the proposals and frequency of the vote on executive compensation to be included in our annual meeting proxy statements, when necessary;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">periodically reviewing the need for a Company policy regarding compensation paid to the Company&#8217;s executive officers in excess of limits deductible under Section&#160;162(m)&#160;of the Internal Revenue Code of 1986, as amended, when applicable;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">determining the Company&#8217;s policy with respect to change of control or parachute payments;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">managing and reviewing executive officer indemnification and insurance matters; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">evaluating the Committee&#8217;s own performance and reviewing and assessing the Compensation Committee Charter.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Compensation Committee holds regular or special meetings as its members deem necessary or appropriate. The Compensation Committee, through the chairperson of the Compensation Committee, reports all material activities of the Compensation Committee to the Board from time to time, or whenever so requested by the Board. The charter of the Compensation Committee grants the Compensation Committee authority to select, retain and obtain, at our expense, advice and assistance from internal and external legal, accounting or other advisors and consultants and other external resources that the Compensation Committee considers necessary or appropriate in the performance of its duties. In particular, the Compensation Committee has the sole authority to retain and terminate any compensation consultants to assist in its evaluation of director, chief executive officer or senior executive compensation, including sole authority to approve the consultant&#8217;s reasonable fees and other retention terms. The Compensation Committee is directly responsible for the appointment, compensation and oversight of the work of any internal or external legal, accounting or other advisors and consultants retained by the Compensation Committee. The Compensation Committee may select an internal or external legal, accounting or other advisor or consultant only after considering the independence of such internal or external legal, accounting or other advisor or consultant using factors established by law and the rules&#160;and regulations of the SEC and Nasdaq.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Under its charter, the Compensation Committee may form, and delegate authority to, one or more subcommittees as appropriate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;font-weight:normal;">Nominating and Corporate Governance Committee</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The &#160;current members of our Nominating and Corporate Governance Committee are Mr. Earl Collier (Chair), Mr. George Dunbar, and Ms. Karimah Es Sabar. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Nominating and Corporate Governance Committee acts on behalf of the Board to fulfill the Board&#8217;s responsibilities in overseeing all aspects of our nominating and corporate governance functions. A summary of the responsibilities of the Nominating and Corporate Governance Committee include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">determining the minimum qualifications, qualities, skills and other expertise required for service on the Board;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">identifying, reviewing and evaluating candidates to serve on the Board, including prior to each annual meeting of stockholders at which directors are to be elected, recommending to the Board for nomination such candidates as the Nominating and Corporate Governance Committee has found to be well qualified and willing and available to serve, and after a vacancy arises on the Board or a director advises the Board of his or her intention to resign, recommending to a prospective member for appointment to the Board;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">developing and recommending to the Board for approval standards for determining whether a director has a relationship with the Company that would impair his or her independence;</span></td></tr></table></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">18</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">evaluating the performance of the members of the committees of the Board, reviewing the composition of such committees and recommending to the Board annually the chairmanship and membership of each committee;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">considering and recommending the removal of a director for cause, in accordance with the applicable provisions of the Company&#8217;s Certificate of Incorporation and Bylaws;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">overseeing the Board in its annual review of its performance and making appropriate recommendations to improve performance;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">developing and recommending to the Board such policies and procedures with respect to the nomination of directors or other corporate governance matters as may be required to be disclosed pursuant to any rules&#160;promulgated by the SEC or otherwise considered to be desirable and appropriate;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">developing and reviewing corporate governance principles to be applicable to the Company and periodically reviewing Company policy statements to determine their adherence to the Company&#8217;s Code of Business Conduct and Ethics;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">overseeing and reviewing the processes and procedures used by the Company to provide information to the Board and its committees;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">developing and recommending to the Board plans for succession to the offices of the Company&#8217;s Chief Executive Officer and other executive officers and making recommendations to the Board with respect to the selection of appropriate individuals to succeed to these positions; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and reassessing its Charter at least annually and submitting any recommended changes to the Board for its consideration.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">It is the responsibility of the Nominating and Corporate Governance Committee to periodically, and at least annually, review, discuss and assess the performance of the Board and committees of the Board. In fulfilling this responsibility, the Nominating and Corporate Governance Committee seeks input from senior management, the full Board and others. In assessing the Board, the Nominating and Corporate Governance Committee evaluates the overall composition of the Board, the Board&#8217;s contribution as a whole and its effectiveness in serving our best interests and the best interests of our stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Nominating and Corporate Governance Committee believes that candidates for director should have certain minimum qualifications, including having the ability to read and understand basic financial statements, being over 21&#160;years of age and having the highest personal integrity and ethics. The Nominating and Corporate Governance Committee also considers such factors as possessing relevant expertise upon which to be able to offer advice and guidance to management, having sufficient time to devote to our affairs, demonstrated excellence in his or her field, having the ability to exercise sound business judgment and having the commitment to rigorously represent the long-term interests of our stockholders. However, the Nominating and Corporate Governance Committee retains the right to modify these qualifications from time to time. Candidates for director nominees are reviewed in the context of the current composition of the Board, our operating requirements and the long-term interests of our stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In conducting this assessment, the Nominating and Corporate Governance Committee considers such factors as it deems appropriate given the current needs of the Board and us, to maintain a balance of knowledge, experience and capability, as well as diversity. The Nominating and Corporate Governance Committee views diversity broadly to include diversity of experience, skills and viewpoint, as well as traditional diversity concepts such as race or gender, and sexual orientation. In the case of new director candidates, if applicable, the Nominating and Corporate Governance Committee also determines whether the nominee is independent for Nasdaq purposes, which determination is based upon applicable Nasdaq listing standards, applicable SEC rules&#160;and regulations and the advice of counsel, if necessary. The Nominating and Corporate Governance Committee conducts any appropriate and necessary inquiries into the backgrounds and qualifications of possible candidates after considering the function and needs of the Board. The Nominating and Corporate Governance Committee meets to discuss and consider the candidates&#8217; qualifications and then selects a nominee for recommendation to the Board by majority vote.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">At least annually, the Nominating and Corporate Governance Committee will review, discuss and assess its own performance and composition and review and assess the adequacy of its charter, including its roles and responsibilities as outlined in its charter, and recommend any proposed changes to the Board for its consideration and approval.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">It is the policy of the Nominating and Corporate Governance Committee to consider director candidates recommended by our stockholders in accordance with the procedures described under &#8220;When are stockholder proposals due for next year&#8217;s annual meeting?&#8221; above. The Nominating and Corporate Governance Committee does not intend to </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">19</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">alter the manner in which it evaluates candidates, including the minimum criteria set forth above, based on whether or not the candidate was recommended by a stockholder. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Board Diversity</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In accordance with Nasdaq&#8217;s board diversity listing standards, the below disclosure includes aggregated statistical information about the members of our Board as voluntarily identified to us by each of our directors. </p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:41.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:41.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Board Diversity Matrix (as of March 18, 2024)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total Number of Directors:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:56.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">9</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Female </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Male</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Non-Binary</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:12.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Did Not Disclose Gender</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Part I: Gender Identity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Directors</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 7</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Part II: Demographic Background</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">African American or Black</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Alaskan Native or Native American</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;">Asian</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;">Hispanic or Latinx</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;">Native Hawaiian or Pacific Islander</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;">White</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.75pt 0pt 0pt;"><span style="font-size:11pt;">1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.75pt 0pt 0pt;"><span style="font-size:11pt;">7</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;">Two or More Races or Ethnicities</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;">LGBTQ+</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:56.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;">Did Not Disclose Demographic Background</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:56.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Board Leadership Structure</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Board may choose to combine or separate the positions of Executive Chairman of the Board and Chief Executive Officer. While our Bylaws do not require the position of Executive Chairman of the Board and Chief Executive Officer to be separate, our Board believes that separation of these positions reinforces the independence of our Board from management, creates an environment that encourages objective oversight of management&#8217;s performance and enhances the effectiveness of our Board as a whole. As such, Dr. Linda Marb&#225;n serves as our Chief Executive Officer and President, while Dr. Frank Litvack serves as our Executive Chairman of the Board. Our Board has concluded that our current leadership structure is appropriate at this time. However, our Board continues to periodically review our leadership structure and may make such changes in the future as it deems appropriate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The duties of our Executive Chairman of the Board include the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Approve board of directors meeting agenda;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Work with committee chairs on committee matters, considering strategic issues facing the Company, and with input from other directors and the Chief Executive Officer;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Preside over board of directors&#8217; meetings;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Attend committee meetings as appropriate;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Coordinate effective communication between respective committee chairs and management;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Oversee orientation for new directors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Oversee that the board of directors receives accurate, timely, and clear information on:</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="font-family:'Courier New';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">o</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Company&#8217;s performance;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="font-family:'Courier New';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">o</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The issues, challenges, and opportunities facing the Company; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="font-family:'Courier New';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">o</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Matters reserved to it for decision;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Facilitate effective communication and constructive relationships between the board of directors and management; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Meet with stockholders when engagement is requested.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">20</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Hedging and Pledging Policies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As part of our Insider Trading Policy, our officers, directors, employees and consultants are prohibited from engaging in short sales of our securities and our officers, directors and employees are prohibited from engaging in hedging transactions involving our securities. Our Insider Trading Policy further prohibits officers, directors and employees from pledging securities as collateral for a loan unless pre-cleared by the compliance officer for the Insider Trading Policy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Role of the Board in Risk Oversight</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We face a variety of risks, including liquidity and operational risks. The Board and each of its committees are involved in overseeing risk associated with our business operations. The Audit Committee reviews and discusses with management and the independent registered public accounting firm our guidelines and policies with respect to risk assessment and risk management, including our major financial risk exposures and the steps taken by management to monitor and control such exposures. The Audit Committee determines and approves, prior to commencement of the audit engagement, the scope and plan for the internal audit and confers with management and the independent registered public accounting firm regarding the scope, adequacy and effectiveness of internal controls over financial reporting, including any special audit steps taken in the event of a material control deficiency. The Audit Committee also reviews with management and the independent registered public accounting firm any fraud, whether or not material, that includes management or other employees who have a significant role in our internal controls over financial reporting and any significant changes in internal controls or other factors that could significantly affect internal controls, including any corrective actions in regard to significant deficiencies or material weaknesses. Furthermore, the Audit Committee establishes procedures for the receipt, retention and treatment of complaints that we receive regarding accounting, internal accounting controls or auditing matters and the confidential and anonymous submission by our employees of concerns regarding questionable accounting or auditing matters.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">It is the role of the Nominating and Corporate Governance Committee to review, discuss and assess, along with input from senior management, the performance of the Board and the committees of the Board at least annually. The Nominating and Corporate Governance Committee is responsible for developing and making recommendations to the Board for approval, and periodically reviewing with our Chief Executive Officer, the plans for succession to the offices of our Chief Executive Officer and other executive officers and the selection of appropriate individuals to succeed to executive positions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">It is the role of the Compensation Committee to review, at least annually, our compensation philosophy and to review and approve (or, if it deems appropriate, recommend to the Board for determination and approval) the compensation of our executive officers, senior management and non-employee directors, taking into consideration the individual&#8217;s success in achieving his or her individual performance goals and objectives and the corporate performance goals and objectives deemed relevant to him or her, as established by the Compensation Committee, in addition to other factors. The Compensation Committee reviews and recommends to the Board for approval the frequency with which we conduct say-on-pay votes, taking into account the results of the most recent stockholder advisory vote on the frequency of such say-on-pay votes, and reviews and approves the proposals regarding the say-on-pay vote and the frequency of the say-on-pay vote to be included in each of our annual meeting proxy statements, as applicable. It is also the role of the Compensation Committee to review, at least annually, our incentive compensation arrangements to determine whether they encourage excessive risk-taking, review and discuss the relationship between our risk management policies and practices and compensation, and evaluate compensation policies and practices that could mitigate such risk.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Code of Business Conduct and Ethics</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Board has adopted a Code of Business Conduct and Ethics (the &#8220;<span style="font-style:italic;font-weight:bold;">Code of Ethics</span>&#8221;) that applies to all directors, officers, employees, consultants, contractors and agents, wherever they are located and whether they work for us on a full- or part-time basis. The Code of Ethics was designed to help such directors, employees and other agents to resolve ethical issues encountered in the business environment. The Code of Ethics covers topics such as conflicts of interest, compliance with laws, confidentiality of Company information, encouraging the reporting of any violations of the Code of Ethics, fair dealing and protection and use of Company assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">A copy of the Code of Ethics, as adopted by the Board, and revised in April 2021, is available at the Corporate Governance page of our website at <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">www.capricor.com</span>. We may post amendments to or waivers of the provisions of the Code of Ethics, if any, made with respect to any directors and employees on that website. Please note that information </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">21</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">contained on, or that can be accessed through, our website is not incorporated by reference and is not a part of this proxy statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Stockholder Communications with the Board of Directors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Historically, we have not adopted a formal process related to stockholder communications with the Board. Nevertheless, every effort has been made to ensure that the views of our stockholders are heard by the Board or individual directors, as applicable, and that appropriate responses are provided to our stockholders in a timely manner. In order to communicate with the Board as a whole, with non-management directors or with specified individual directors, correspondence may be directed to our Corporate Secretary at 10865 Road to the Cure, Suite 150, San Diego, California 92121. Each communication will be reviewed by our Corporate Secretary to determine whether it is appropriate for presentation to the Board or such director. Communications determined by our Corporate Secretary to be appropriate for presentation to the Board or such director will be submitted to the Board or the director on a periodic basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">22</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_0be351a2_3f6a_4984_a584_79a696b03fd8"></a><a id="EXECUTIVEOFFICERS_48870"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">INFORMATION REGARDING EXECUTIVE OFFICERS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Below is a list of the names, ages, positions, and a description of the business experience of each of our executive officers as of March&#160;18, 2024:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;background:#ffffff;"><tr><td style="vertical-align:bottom;width:24.09%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.78%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:3.71%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Age</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.78%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:66.61%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Positions</b></p></td></tr><tr><td style="vertical-align:bottom;width:24.09%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Linda Marb&#225;n, Ph.D.</p></td><td style="vertical-align:top;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.71%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 3pt 0pt 0pt;">60</p></td><td style="vertical-align:top;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:66.61%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">President, Chief Executive Officer and Director</p></td></tr><tr><td style="vertical-align:bottom;width:24.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Anthony Bergmann, M.B.A.</p></td><td style="vertical-align:top;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 3pt 0pt 0pt;">38</p></td><td style="vertical-align:top;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:66.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer</p></td></tr><tr><td style="vertical-align:bottom;width:24.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Karen G. Krasney, J.D.</p></td><td style="vertical-align:top;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 3pt 0pt 0pt;">71</p></td><td style="vertical-align:top;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:66.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Executive Vice President and General Counsel</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A description of the business experience of <span style="font-style:italic;font-weight:bold;">Linda Marb&#225;n </span>is provided above under the heading &#8220;Proposal No.&#160;1: Election of Directors.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Anthony Bergmann, M.B.A.</b> Mr.&#160;Bergmann has served as our Chief Financial Officer since 2018 and has been involved in the biotechnology industry for over a decade. He also serves as the Company&#8217;s corporate treasurer. Mr. Bergmann joined Capricor, Inc. in 2011 and held various roles of increasing responsibility throughout his tenure. Prior to joining Capricor, Inc., Mr. Bergmann had experience in accounting, finance and operations management of companies ranging in size from start-ups to mid-size companies. Prior to Capricor, Inc., he was with the business management firm, Gettleson, Witzer, and O&#8217;Connor, in Beverly Hills, California, where he focused on accounting and finance for several production studios generating motion picture releases and worldwide revenue that exceeded $1.0 billion. The firm&#8217;s clients included international foundations, actors, writers, producers and directors across the entertainment industry. While at the firm, he focused on asset management, budgeting and tax forecasting. Earlier in his career, Mr. Bergmann served in financial positions in various industries. During his time at Capricor, Mr. Bergmann coordinated the Company&#8217;s reverse merger and subsequent uplisting to the Nasdaq Capital Market and has completed equity financings yielding over $100 million, to date. Mr. Bergmann oversees the Company&#8217;s finance, accounting and human resource functions. Mr. Bergmann graduated from Providence College with a Bachelor of Science degree in Management and a minor in Finance. He has an M.B.A. from the University of Southern California&#8217;s Marshall School of Business. He is actively involved in various venture capital and entrepreneurial associations throughout the Southern California area.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;">Karen G. Krasney, J.D.</b> Ms.&#160;Krasney has served as our Executive Vice President, Secretary and General Counsel since 2012. Ms. Krasney&#8217;s career spans over 40 years serving as general counsel for numerous corporations and private companies engaged in a wide variety of industries. Her extensive background and vast experience has been focused on domestic and international corporate and business law, as well as litigation. Ms. Krasney has been involved in the medical technology arena since the mid 1990s, representing several medical technology companies developing products for the treatment of cardiovascular disease. Commencing in 2002, Ms. Krasney served as legal counsel for Biosensors International Group Ltd., a multinational medical device company that developed, manufactured and sold medical devices for cardiology applications. In 2006, she accepted the position of General Counsel and Executive Vice President of Biosensors and served in that capacity until 2010. During her tenure at Biosensors Ms. Krasney, among other things, headed the legal team that facilitated the company&#8217;s successful initial public offering in Singapore and was responsible for negotiating and documenting all agreements for the company worldwide, including licensing agreements with major medical device companies and agreements required for the company&#8217;s international clinical trials. During her tenure at Capricor, Ms. Krasney has been responsible for overseeing all legal matters involving the Company including, business transactions, corporate governance, and intellectual property and has played an integral role in all transactional matters involving the Company. Ms. Krasney also serves as a director on the board of Cardiovascular Research Foundation, a non-profit research and education entity, and as a director for a private non-profit charitable foundation. Ms. Krasney received her Bachelor of Arts degree from the University of California, Los Angeles and her Juris Doctorate from the University of Southern California.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">23</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_1dac6af4_dff7_4610_8bbb_dae8d432fbd2"></a><a id="EXECUTIVECOMPENSATION_516063"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">EXECUTIVE COMPENSATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">2023 Executive Compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following summary compensation table reflects cash and non-cash compensation for the 2023&#160;and 2022 fiscal&#160;years awarded to or earned by (i)&#160;our principal executive officer for the fiscal&#160;year ended December&#160;31, 2023; and (ii)&#160;the two most highly-compensated individuals, other than our principal executive officer, that served as an executive officer at the end of the fiscal&#160;year ended December&#160;31, 2023 and who received in excess of $100,000 in total compensation during such fiscal&#160;year. We refer to these individuals as our &#8220;named executive officers&#8221; or &#8220;NEOs.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 0pt 18pt;">Summary Compensation Table</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:33.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Option&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">All&#160;Other&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:33.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Name and Principal Position</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Salary&#160;($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Bonus&#160;($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Awards($)</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Compensation&#160;($)</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total&#160;($)</b></p></td></tr><tr><td style="vertical-align:bottom;width:33.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Linda Marb&#225;n, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 220,500</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 50,115</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 466,695</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 10,005</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 747,315</span></p></td></tr><tr><td style="vertical-align:bottom;width:33.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Chief Executive Officer</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 210,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 63,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,051,123</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 9,300</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,333,423</span></p></td></tr><tr><td style="vertical-align:bottom;width:33.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:33.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Karen Krasney, J.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 362,250</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 52,400</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 314,047</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 12,072</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 740,769</span></p></td></tr><tr><td style="vertical-align:bottom;width:33.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Executive Vice President&#160;&amp; General Counsel</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 345,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 78,500</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(5)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 233,911</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 11,032</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 668,443</span></p></td></tr><tr><td style="vertical-align:bottom;width:33.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:33.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Anthony Bergmann, M.B.A.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 362,250</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 63,350</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(6)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 293,845</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 11,400</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 730,845</span></p></td></tr><tr><td style="vertical-align:bottom;width:33.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Chief Financial Officer</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 345,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 103,500</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 464,538</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 10,650</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 923,688</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Amounts reflect the grant date fair value of awards granted under the 2021 Equity Incentive Plan, computed pursuant to Financial Accounting Standards Board&#8217;s Accounting Standards Codification 718 </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">&#8220;Compensation&#160;&#8211; Stock Compensation.&#8221;</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> Assumptions used in the calculation of these amounts are included in Note&#160;4&#160;&#8211; &#8220;Stock Awards, Warrants and Options,&#8221; of the Notes&#160;to Consolidated Financial Statements included in the Annual Report on Form&#160;10-K as filed with the Securities and Exchange Commission on March&#160;11, 2024. See the </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">&#8220;Outstanding Equity Awards at Fiscal&#160;Year-End&#8221;</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> table for information regarding all option awards outstanding as of December&#160;31, 2023.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Represents premiums contributed by the Company for the employee&#8217;s health reimbursement account and matching contributions contributed by the Company to each NEO&#8217;s account in the Company&#8217;s 401(k) Plan.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Dr. Marb&#225;n elected to forego a portion of her cash bonus in exchange for a stock option award. She elected to convert $26,985 of her cash bonus into stock options in lieu of receiving the cash. Pursuant to this election, she received an option award for 9,633 shares of common stock that were deemed fully vested upon the grant date of January 2, 2024.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Ms. Krasney elected to forego a portion of her cash bonus in exchange for a stock option award. She elected to convert $20,000 of her cash bonus into stock options in lieu of receiving the cash. Pursuant to this election, she received an option award for 7,140 shares of common stock that were deemed fully vested upon the grant date of January 2, 2024.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(5)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Ms. Krasney elected to forego a portion of her cash bonus in exchange for a stock option award. She elected to convert $25,000 of her cash bonus into stock options in lieu of receiving the cash. Pursuant to this election, she received an option award for 11,878 shares of common stock that were deemed fully vested upon the grant date of January 3, 2023.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(6)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Mr. Bergmann elected to forego a portion of his cash bonus in exchange for a stock option award. He elected to convert $27,150 of his cash bonus into stock options in lieu of receiving the cash. Pursuant to this election, he received an option award for 9,692 shares of common stock that were deemed fully vested upon the grant date of January 2, 2024.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Employment Agreements and Potential Payments Upon Termination or Change in Control</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Linda Marb&#225;n, Ph.D.&#160;&#8212;&#160;President and Chief Executive Officer</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Dr.&#160;Linda Marb&#225;n&#8217;s employment as our Chief Executive Officer is subject to the terms of that certain restated and amended employment agreement dated June&#160;5, 2019, by and between Capricor,&#160;Inc. and Dr.&#160;Marb&#225;n. In accordance with the agreement, Dr.&#160;Marb&#225;n was initially entitled to an annual salary of $150,000. Effective January&#160;1, 2022, Dr.&#160;Marb&#225;n&#8217;s annual base salary was increased to $210,000. Dr. Marb&#225;n received a $63,000 bonus for 2022 services which was paid on March 3, 2023. Effective January 1, 2023, Dr. Marb&#225;n&#8217;s annual base salary was increased to $220,500. Dr.&#160;Marb&#225;n also received a $77,100 bonus for 2023 services, of which $26,985 was converted into a fully vested option </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">24</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">award on January 2, 2024 and $50,115 was paid on March 4, 2024. Effective January 1, 2024, Dr.&#160;Marb&#225;n&#8217;s annual base salary was increased to $229,300. Dr.&#160;Marb&#225;n&#8217;s employment is at will and she has also signed an employee invention assignment, non-disclosure, non-solicitation and non-competition agreement. In the event the employment agreement is terminated during the term other than for cause, death or disability, or if Dr.&#160;Marb&#225;n resigns for good reason, she would be entitled to receive a severance payment equal to six&#160;months&#8217; salary then in effect (ignoring any decrease that forms the basis of Dr.&#160;Marb&#225;n&#8217;s resignation for good reason, if applicable).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Karen Krasney, J.D.&#160;&#8212;&#160;Executive Vice President, General Counsel</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Karen Krasney&#8217;s employment as our Executive Vice President and General Counsel is subject to the terms of that certain employment agreement dated May&#160;14, 2019. Under the agreement, Ms.&#160;Krasney was initially entitled to an annual salary of $300,000. Effective January&#160;1, 2022, Ms.&#160;Krasney&#8217;s annual base salary was increased to $345,000. Ms.&#160;Krasney received a $103,500 bonus for 2022 services, of which $25,000 was converted into a fully vested option award on January 3, 2023 and $78,500 was paid on March 3, 2023. Effective January&#160;1, 2023, Ms.&#160;Krasney&#8217;s annual base salary was increased to $362,250. Ms. Krasney also received a $72,400 bonus for 2023 services, of which $20,000 was converted into a fully vested option award on January 2, 2024 and $52,400 was paid on March 4, 2024. Effective January 1, 2024, Ms. Krasney&#8217;s annual base salary was increased to $376,700. In addition, Ms.&#160;Krasney has signed an at-will employment, confidential information, invention assignment and arbitration agreement. In the event the employment agreement is terminated during the term other than for cause, death or disability, or if Ms.&#160;Krasney resigns for good reason, she would be entitled to receive a severance payment equal to six&#160;months&#8217; salary then in effect (ignoring any decrease that forms the basis of Ms.&#160;Krasney&#8217;s resignation for good reason, if applicable).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Anthony Bergmann, M.B.A.&#160;&#8212;&#160;Chief Financial Officer</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Anthony Bergmann&#8217;s employment as our Chief Financial Officer is subject to the terms of that certain employment agreement dated May&#160;14, 2019. Under the agreement, Mr.&#160;Bergmann was initially entitled to an annual salary of $200,000. Effective January&#160;1, 2022, Mr.&#160;Bergmann&#8217;s annual base salary was increased to $345,000. Mr.&#160;Bergmann also received a $103,500 bonus for 2022 services which was paid on March 3, 2023. Effective January&#160;1, 2023, Mr.&#160;Bergmann&#8217;s annual base salary was increased to $362,250. Mr. Bergmann also received a $90,500 bonus for 2023 services, of which $27,150 was converted into a fully vested option award on January 2, 2024 and $63,350 was paid on March 4, 2024. Effective January 1, 2024, Mr. Bergmann&#8217;s annual base salary was increased to $376,700. In addition, Mr.&#160;Bergmann has signed an at-will employment, confidential information, invention assignment and arbitration agreement. In the event the employment agreement is terminated during the term other than for cause, death or disability, or if Mr.&#160;Bergmann resigns for good reason, he would be entitled to receive a severance payment equal to six&#160;months&#8217; salary then in effect (ignoring any decrease that forms the basis of Mr.&#160;Bergmann&#8217;s resignation for good reason, if applicable). </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">25</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Outstanding Equity Awards at Fiscal&#160;Year-End</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The following table sets forth information concerning unexercised stock options held by the named executive officers at December&#160;31, 2023:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:39.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Equity&#160;Incentive&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Plan&#160;Awards:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Securities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Securities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Securities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Underlying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Underlying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Underlying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unexercised</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unexercised</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unexercised</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Option</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unearned</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Option</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unexercisable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Price&#160;($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Expiration&#160;Date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Linda Marb&#225;n, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 25,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.39</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">03/03/2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(12)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 19,999</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.39</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">01/03/2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(12)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 9,998</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.39</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">01/02/2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)(12)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 25,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.39</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">08/08/2029</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)(12)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 353,096</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 15,353</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.39</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">02/12/2030</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(5)(13)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 334,463</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 124,230</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3.74</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">01/04/2031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(6)(13)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 181,043</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 196,787</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3.18</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">01/03/2032</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(7)(14)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 30,937</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 104,063</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3.85</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">01/03/2033</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(8)(14)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Karen Krasney, J.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.39</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">03/03/2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(12)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.39</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">06/02/2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(9)(12)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,500</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.39</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">01/03/2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(12)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,500</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.39</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">01/02/2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(10)(12)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 14,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.39</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">08/08/2029</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(11)(12)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 100,536</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4,372</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.39</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">02/12/2030</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(5)(13)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 69,776</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 25,917</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3.74</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">01/04/2031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(6)(13)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 40,288</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 43,792</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3.18</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">01/03/2032</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(7)(14)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 30,211</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 61,667</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3.85</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">01/03/2033</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(8)(14)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Anthony Bergmann, M.B.A.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,500</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.39</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">03/03/2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(12)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.39</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">06/02/2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(9)(12)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,500</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.39</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">01/03/2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(12)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.39</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">01/02/2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(10)(12)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 14,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.39</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">08/08/2029</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(11)(12)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 115,002</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5,001</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.39</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">02/12/2030</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(5)(13)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 69,776</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 25,917</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3.74</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">01/04/2031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(6)(13)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 80,011</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 86,969</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3.18</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">01/03/2032</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(7)(14)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 19,479</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 65,521</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3.85</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">01/03/2033</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(8)(14)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Vesting schedule is as follows: The shares of common stock subject to this option vest 1/48th per&#160;month commencing April&#160;1, 2015. This option became fully vested on March&#160;1, 2019.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Vesting schedule is as follows: The shares of common stock subject to this option vest 1/48th per&#160;month commencing February&#160;1, 2017. This option became fully vested on January 1, 2021.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Vesting schedule is as follows: 3,351 of the shares of common stock subject to this option vest 1/12th per&#160;month commencing February&#160;1, 2018, with the last 1/12th vesting on December&#160;31, 2018. 6,647 of the shares of common stock subject to this option vest 1/48th per&#160;month commencing on February&#160;1, 2018. This option became fully vested on January 1, 2022.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Vesting schedule is as follows: 20% of the shares of common stock subject to this option vested immediately, with the remainder vesting&#160;monthly over 48&#160;months commencing September&#160;1, 2019.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(5)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Vesting schedule is as follows: The shares of common stock subject to this option vest 1/48</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per&#160;month commencing March&#160;1, 2020.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(6)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Vesting schedule is as follows: The shares of common stock subject to this option vest 1/48</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per&#160;month commencing February&#160;1, 2021.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(7)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Vesting schedule is as follows: The shares of common stock subject to this option vest 1/48</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per month commencing February 1, 2022. </span></td></tr></table></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">26</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(8)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Vesting schedule is as follows: The shares of common stock subject to this option vest 1/48</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per month commencing February 1, 2023. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(9)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Vesting schedule is as follows: The shares of common stock subject to this option vest 1/48th per&#160;month commencing July&#160;1, 2016. This option became fully vested on June&#160;1, 2020.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(10)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Vesting schedule is as follows: The shares of common stock subject to this option vest 1/48th per&#160;month commencing February&#160;1, 2018. This option became fully vested on January 1, 2022. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(11)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Vesting schedule is as follows: 4,666 shares of common stock subject to this option vested immediately, with the remainder vesting&#160;monthly over 48&#160;months commencing September&#160;1, 2019.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(12)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The options issued under the 2012 Restated Equity Incentive Plan are subject to early exercise. If the option holder elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Company if the option holder&#8217;s service to the Company terminates prior to vesting.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(13)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The options issued under the 2020 Equity Incentive Plan are subject to early exercise. If the option holder elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Company if the option holder&#8217;s service to the Company terminates prior to vesting.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(14)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The options issued under the 2021 Equity Incentive Plan are subject to early exercise. If the option holder elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Company if the option holder&#8217;s service to the Company terminates prior to vesting. </span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Pay Versus-Performance Table and Discussion</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The following table sets forth additional compensation information of our Principal Executive Officer (&#8220;PEO&#8221;) and our non-PEO named executive officers, along with total stockholder return, and net loss results for our fiscal years ending in 2023 and 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_1b2484da_59a7_497d_aa8c_789c8e5b476e"></a><a id="Tc_m2pKrTFehEKffZ5oCIzLQw_1_14"></a><a id="Tc_3CEAkX_WaE2CVbVKexDGaQ_2_14"></a><a id="Tc_H2n3j2lUpUCplVTqvoKecQ_3_2"></a><a id="Tc_qpe1DPsSJkCEMUKtyVsMVQ_3_5"></a><a id="Tc_tskpvzckHUKIRVmGTbL3DA_3_8"></a><a id="Tc_0DDJRlJujUqpurtSscx0Tw_3_11"></a><a id="Tc_tHU5Gp4r7EiNP_7fVuO-jQ_3_14"></a><a id="Tc_qrQIDsBBeE6SEblZRwuJ9w_4_2"></a><a id="Tc_z-ZdRwua_k2CKXyhau91YQ_4_5"></a><a id="Tc_YOg40eTTzUSSk9GlPmNv2g_4_8"></a><a id="Tc_fRTs8XBTlU2NxHDRpFrXEQ_4_11"></a><a id="Tc_0jnsj3XK_kG5hKGDzeNDAQ_4_14"></a><a id="Tc_XBRgCkuALkavEQb6zwT-kg_4_17"></a><a id="Tc_YEZ0jCaZ7EmdHslgBUirig_5_0"></a><a id="Tc_-OqTrVfjnkSzX1jM4_LBFg_5_2"></a><a id="Tc_jlSeeIAhfUKKbr9_AfOy3g_5_5"></a><a id="Tc_1p-qKQbRNkeAxKtPqLgkVw_5_8"></a><a id="Tc_R4g3ovis8ki2GMue1QhFBQ_5_11"></a><a id="Tc_LWcK3wzDJ0m-cCezgR-MIg_5_14"></a><a id="Tc_sI_rGHF7GUWx6SCwivykzA_5_17"></a><a id="Tc_zcn1RTOlH021baepBBfBNg_6_0"></a><a id="Tc_kOUXeTMeiUqMPRJVsmaYlA_6_2"></a><a id="Tc_sM7MO374C0exhcQrhgb4wA_6_5"></a><a id="Tc_Pd35tlUXHEWD84L9mCEkgA_6_8"></a><a id="Tc_neYwYW6BTkiGd1RiFD2Ukw_6_11"></a><a id="Tc_5R_tzG4WDUCOeuT3vjoevw_6_14"></a><a id="Tc_U9W94T6STE2LJ_EFDZjMLw_6_17"></a><a id="Tc_8NoCebPDFU-SRwe-_km9yA_7_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" name="ecd:PvpTableTextBlock" id="Tb_3Y0YmAeOyUG53E6LybuRLg" escape="true"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:5.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:22.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:15.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:13.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:23.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value&#160;of&#160;Initial&#160;Fixed $100&#160;Investment </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:15.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:13.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:23.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Based&#160;On:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Summary</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:9.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average&#160;Summary</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:14.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average&#160;Compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:23.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Compensation&#160;Table</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Actually</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Compensation&#160;Table&#160;Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Actually&#160;Paid&#160;to</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:23.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stockholder</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total&#160;for&#160;PEO </b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Paid&#160;to&#160;PEO </b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">for&#160;Non-PEO NEO </b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-PEO&#160;NEO </b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:23.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Return </b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Income/(Loss) </b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" decimals="0" format="ixt:numdotdecimal" name="ecd:PeoTotalCompAmt" scale="0" id="Tc_-9FlUNi4nE2VsCFvoHrurg_6_3">747,315</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" decimals="0" format="ixt:numdotdecimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" id="Tc_yw264W7T6kGOeOhI_MchAQ_6_6">1,123,804</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" decimals="0" format="ixt:numdotdecimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" id="Tc_RqmBb7tVDEO1ooOsBHlgkQ_6_9">735,807</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" decimals="0" format="ixt:numdotdecimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" id="Tc_wwNNQv-ZJE-FJyV-Rj4Ijw_6_12">754,663</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" decimals="0" format="ixt:numdotdecimal" name="ecd:TotalShareholderRtnAmt" scale="0" id="Tc_rYSv1f6Q4UOrtj5MdVC8_A_6_15">167</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_wKFQLOBWw06Ont1RHNJIEw_6_18">22,287,542</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng" decimals="0" format="ixt:numdotdecimal" name="ecd:PeoTotalCompAmt" scale="0" id="Tc_VIBLFXxI4UaMlW270lcHsw_7_3">1,333,423</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng" decimals="0" format="ixt:numdotdecimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" id="Tc_qVdQwCXYaEagt2cMdTbdzA_7_6">2,190,786</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng" decimals="0" format="ixt:numdotdecimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" id="Tc_Ui9YuUU3RUm0txgz7ebQfw_7_9">796,066</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng" decimals="0" format="ixt:numdotdecimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" id="Tc_thy3gt1NjUOKfmbXqEVhFQ_7_12">820,990</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng" decimals="0" format="ixt:numdotdecimal" name="ecd:TotalShareholderRtnAmt" scale="0" id="Tc_SDskBhrjOkOuyxkwVpmI7g_7_15">132</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="0" id="Tc_0zA0cDklIUGqzPumRAsZjQ_7_18">29,019,532</ix:nonFraction>)</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" name="ecd:NamedExecutiveOfficersFnTextBlock" id="Tb_Tm0c_p28z0auT-K5qkGoNw" escape="true"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" name="ecd:PeoName" id="Narr_RZ0LxXYdKkaXVmrUsWcHXw"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Linda Marb&#225;n</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> served as our CEO for the entirety of 2023 and 2022. The other NEOs for 2023 and 2022 were Anthony Bergmann and Karen Krasney.</span></td></tr></table></ix:nonNumeric><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The SEC&#8217;s rules require certain adjustment be made to the &#8220;Summary Compensation Table&#8221; totals to determine &#8220;compensation actually paid&#8221; as reported in the &#8220;Pay Versus Performance Table&#8221; above. For purposes of the equity award adjustments shown below, no equity awards were cancelled due to a failure to meet vesting conditions and no dividends or other earnings paid on stock or option awards in the covered fiscal year prior to the vesting date were not otherwise included in the total compensation for the covered fiscal year. In calculating the &#8220;compensation actually paid&#8221; amounts reflected in these columns, the fair value or change in fair value, as applicable, of the equity award adjustments included in such calculations was computed in accordance with FASB ASC Topic 718. The valuation assumptions used to calculate such fair values did not materially differ from those disclosed at the time of grant. The following tables detail the applicable adjustments that were made to the determine &#8220;compensation actually paid&#8221; (all amounts are averages for the NEOs other than the PEO).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Cumulative total shareholder return (&#8220;TSR&#8221;) assumes an initial investment of $100 on December 31, 2021.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Net loss attributable to the Company is reflected as reported in the Company&#8217;s consolidated financial statements included in our 2023 Annual Report on Form 10-K.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </span></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">27</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_5463e82e_1fb5_404f_9f03_2e1877080a9b"></a><a id="Tc_1g5IJgptW0Kw9_zWheUsFQ_1_0"></a><a id="Tc_hLsQDuPkokKKHqLGXRf1fg_1_2"></a><a id="Tc_RSLuWveMUE6jBPhLlRhf6Q_1_5"></a><a id="Tc_VaJ3K7ALAkiI-LdHR_z-aQ_1_8"></a><a id="Tc_INkexC2Q3kqa7FyJqtipvQ_1_11"></a><a id="Tc_-WTj0Ho9bES3j2IzXQkJOg_2_0"></a><a id="Tc_9CjgIYw070u5NwlkzYeMgQ_2_2"></a><a id="Tc_H01IF1OT7kS3yccPYQ6nJw_2_5"></a><a id="Tc_eDfJZuMr50-HldPmRX6zSw_2_8"></a><a id="Tc_TZqyQydQlEScvtc8IIoM5Q_2_11"></a><a id="Tc_ctx1eBwLlUGsJzvE0FNmFQ_3_0"></a><a id="_3f580de4_05ed_4c30_9304_bcf3923f3a6d"></a><a id="Tc_AtIzZz36rkOSZQhEUWBIIg_1_0"></a><a id="Tc_VRWMMTZ-aUah0Iz4RuyCJw_1_2"></a><a id="Tc_yPgj7ZD9MkCvJquikNBKYQ_1_5"></a><a id="Tc_WbqQu2RYq0WRpICyJYuJFQ_1_8"></a><a id="Tc_ZJq4WsxtXESJGZYLj-nJKg_1_11"></a><a id="Tc_ioQ8HykQmk6EmGYtY-5reA_1_14"></a><a id="Tc_De7KkAwOt0axXZ3CJYL8KQ_2_0"></a><a id="Tc_2xiEPzmd-E-BarnNumux6w_2_2"></a><a id="Tc_ZJdCaEady0ux0HiZ9sZvdw_2_5"></a><a id="Tc_MYzMnDIRX0qOR8p97TAJ_A_2_8"></a><a id="Tc_vA-cN2T7RE2xuPEDo77mtw_2_11"></a><a id="Tc_TwQhEd80kUChiK_VuXU0Ow_2_14"></a><a id="Tc_neAp2Jvxt0q63RF4yD4qeg_3_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" name="ecd:AdjToPeoCompFnTextBlock" id="Tb_LwKiPm8F2E-U37FNwfskvg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Compensation Actually Paid to PEO:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:34.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:34.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:13.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Summary Compensation Table Total for PEO</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:13.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deduct Option Awards </b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(A)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:13.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Equity Award Adjustment </b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(B)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:13.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Compensation Actually Paid to PEO</b></p></td></tr><tr><td style="vertical-align:bottom;width:34.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" decimals="0" format="ixt:numdotdecimal" name="ecd:PeoTotalCompAmt" scale="0" id="Tc_sK0teNQ9v0iFfMVQYA5HwQ_2_3">747,315</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsValueInCompensationTableForApplicableYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_wXZQP7jdBkGCt0F5kdShAQ" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" sign="-" scale="0" id="Tc_nLWXkardLEGj-BorqQRY0A_2_6">466,695</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_jTaas2oZLUy-SpJe52-InA" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_9g1YHW-N30G5I3ZbfQmRew_2_9">843,184</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" decimals="0" format="ixt:numdotdecimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" id="Tc_PPm44CYEB0CiuV1RSHN9oA_2_12">1,123,804</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:34.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng" decimals="0" format="ixt:numdotdecimal" name="ecd:PeoTotalCompAmt" scale="0" id="Tc_ZYkHPPENBE2qO9uQDY6x6Q_3_3">1,333,423</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsValueInCompensationTableForApplicableYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_MAkj2PFc4UiOEFAPTIh5pg" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" sign="-" scale="0" id="Tc_5V21Ufkr-0-CmBbP37Q-RA_3_6">1,051,123</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_PAfo8DhqG0yF5jcQg_sh5A" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_ldLMwbE1ZEqHqq_9YAPrYQ_3_9">1,908,486</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng" decimals="0" format="ixt:numdotdecimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" id="Tc_uZqZ8ipQDkaK1pAkvghwNg_3_12">2,190,786</ix:nonFraction></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(A)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Represents the amounts reported in the Option Awards column in the Summary Compensation Table for the applicable year. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(B)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Represents the stock award adjustments (deductions and additions) for PEO stock awards for each applicable year calculated as follows:</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">PEO Equity Award Adjustment:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:29.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year-End Fair Value of Outstanding and Unvested Equity Awards Granted during the Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> Change in Fair Value of Outstanding and Unvested Equity Awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Equity Award Adjustments</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_6kMrJSUzRk-2rzXtu-uQoQ" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_tqPyhqJy3E2u69t0-D91Xg_2_3">409,592</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_9g7ebvuxWUuUBmptPCym_Q" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_ffn7AMkB-ESZ9xuknOapqg_2_6">328,818</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_JVXrFv5_2EudBAVwqdyZ2A" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_0JTGS6vVKU6RszEHSlN46g_2_9">111,307</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_POPZu7IOokG--5f06Nf35Q" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" sign="-" scale="0" id="Tc_byVmv7fgyEyOynh2mSsILg_2_12">6,533</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_jTaas2oZLUy-SpJe52-InA" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_mZ7t07z0Z0W6Y0Zb-qnCYQ_2_15">843,184</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:29.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_mc5TENp2S0GocHnLHwEEAg" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_dckGYPk0ckeLK_wvsJwprQ_3_3">930,816</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_QawlbdeG70CMcZ9CqoR_vg" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_bxZhDb8GEEG8OOnxAoLtuw_3_6">301,185</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_lVWOxIS-1UCfBNJY-IhXHQ" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_QmqAOF7tfEq7mesmDbEMzw_3_9">328,436</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_IhAZ2jr6Qk6yvGRNYnpPNQ" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_4a_GDeE3LU-i_pqpUE5MMw_3_12">348,049</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_PAfo8DhqG0yF5jcQg_sh5A" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_KkZEf-v5ekWB8wnBUzVERw_3_15">1,908,486</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_60701882_33ec_4124_95a3_54a22cc42edb"></a><a id="Tc_YpKXp0mfCk2MY62M85ayow_1_0"></a><a id="Tc_a8-GMIhObUyuXxwg8SFGnw_1_2"></a><a id="Tc_dfuSJYHmbkmONKCS7Q7asA_1_5"></a><a id="Tc_o3EE3KIy8kyp9letcE8hWg_1_8"></a><a id="Tc_w99HGdOgNkGn8yVU1PokZw_1_11"></a><a id="Tc_umD-uCKBnkiwtUtpb3UdnA_2_0"></a><a id="Tc_5MXNCAm5o0i1bU5ac_EJUQ_2_2"></a><a id="Tc_siQgchC0RkCJUS4_FMk-PA_2_5"></a><a id="Tc_WAySqz-qEUSNw8VGb6YhlA_2_8"></a><a id="Tc_8UQB32ZYaU-W6Gkrdx-lbg_2_11"></a><a id="Tc_h7iqFnEmVEGVQqZf8h8Mbg_3_0"></a><a id="_72538dfd_a87b_476a_8036_33cd476a2dd3"></a><a id="Tc_LF_k2InlQU2YAmDiViOkww_1_0"></a><a id="Tc_zjXnvT5KkkSlSD82jFGjzA_1_2"></a><a id="Tc_gr5woXpaVUimlU15xMmtaw_1_5"></a><a id="Tc_nltmSKRTU02tc4Mj0alL0Q_1_8"></a><a id="Tc_unq9aAHr4kijk9E8LZwDXA_1_11"></a><a id="Tc_HfHcEWYWr0KdOaMVrk1v9A_1_14"></a><a id="Tc_XeeZ3-TXFUCff-LbmV4QwQ_2_0"></a><a id="Tc_w--mgVLDU0ukFVBT0xYHwg_2_2"></a><a id="Tc_HzMozMwnc0a5KKDN5AtI6Q_2_5"></a><a id="Tc_lVMo9QgWxE2-A5dOQ4dyAw_2_8"></a><a id="Tc_5lvCxvA9IEOzJkicNMUxTA_2_11"></a><a id="Tc_NC7qrD5Hf0a8ul-CmtzJSw_2_14"></a><a id="Tc_wmdg32GIsUW_mz9zsJn13A_3_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" name="ecd:AdjToNonPeoNeoCompFnTextBlock" id="Tb_HCAwXev6XkG1PhcHuEphbQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Average Compensation Actually Paid to Non-PEO NEO (all amounts are averages):</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:27.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:27.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Summary Compensation Table Total for Non-PEO NEO</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:14.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deduct Option Awards </b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(A)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:14.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Equity Award Adjustment </b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(B)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:15.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Compensation Actually Paid to Non-PEO NEO</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" decimals="0" format="ixt:numdotdecimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" id="Tc_zGv9eqSsCkmk-nQSmjDVkA_2_3">735,807</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsValueInCompensationTableForApplicableYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_cEC076xukUytfkW6cWT2KA" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" sign="-" scale="0" id="Tc_oDl4SGf7d0Gmrm8giPd2RA_2_6">303,946</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_6WX4KT36CUuWW8akt2OzpQ" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_Xu46Ul4kukCfECHUEpAkwQ_2_9">322,802</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" decimals="0" format="ixt:numdotdecimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" id="Tc_UpyzVSH0QkCJQjn5UxSVjQ_2_12">754,663</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:27.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng" decimals="0" format="ixt:numdotdecimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" id="Tc_l2clkAklxEqByT0y4ZNT2Q_3_3">796,066</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsValueInCompensationTableForApplicableYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_jBy47SmJK0WpDadoHCHhRQ" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" sign="-" scale="0" id="Tc_VdLCyE2AS0y8VEQakyf3Bg_3_6">349,225</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_VZO4GqyxeE-CglPDohkklg" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_1F-OtnGslEaP1rnLrLC8JA_3_9">374,149</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng" decimals="0" format="ixt:numdotdecimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" id="Tc_STEjA7SNuU2_uny_DzfnIg_3_12">820,990</ix:nonFraction></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(A)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Represents the amounts reported in the Option Awards column in the Summary Compensation Table for the applicable year. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(B)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Represents the stock award adjustments (deductions and additions) for Non-PEO NEO stock awards for each applicable year calculated as follows:</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Average Non-PEO NEO Equity Award Adjustment: </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:25.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:25.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year-End Fair Value of Outstanding and Unvested Equity Awards Granted during the Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> Change in Fair Value of Outstanding and Unvested Equity Awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Equity Award Adjustments</b></p></td></tr><tr><td style="vertical-align:bottom;width:25.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_vivQmo6mSEqaFXP36wEMAQ" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_mOlQzAANDEu9PP6D03rqqw_2_3">250,306</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_iZz8cM0530OzLK0ZzEASJg" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" sign="-" scale="0" id="Tc_oXohGRL240i19t1bNhzuLQ_2_6">11,570</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_GMfsyW9GaUCnLGYWUh9fgw" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_C3MJMvnN3E-e3HyqiH0bfA_2_9">86,764</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_YRkU1KZG4UO6jQ9ifR2OSw" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" sign="-" scale="0" id="Tc_8MFSOAy4jUa-TZhbxVNS-g_2_12">2,698</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_6WX4KT36CUuWW8akt2OzpQ" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_HckVJt1zDEK7j4BYrcb-dg_2_15">322,802</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:25.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_2uiDN3rZh0q31boqSbzn8w" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_7K4Xjya22UG7IVunGnU1PQ_3_3">309,254</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_STUyIoqE2EGW3AifSYCqjw" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" sign="-" scale="0" id="Tc_c9loC9kCt02a5aho-JNOEg_3_6">106,570</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_3WyJGzK71kS8TSaL8PNShA" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_-mew2D0R6keEWYAMNTZVpA_3_9">109,127</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_w4nlAZfmVkuUTMVwdrsohA" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_pk9hAVTAVk2vzutkUwqj4w_3_12">62,338</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A" contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_VZO4GqyxeE-CglPDohkklg" decimals="0" format="ixt:numdotdecimal" name="ecd:AdjToCompAmt" scale="0" id="Tc_jP5Mr0vutkevVRKHUggYgA_3_15">374,149</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">28</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:190.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 8pt 0pt;">Pay Versus Performance Comparative Disclosure</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The Company uses several measures to reward achievement of our specific annual and long-term strategic goals, however, all of those performance measures are not presented in the Pay Versus Performance Table set forth above. The Company does not specifically align the Company&#8217;s performance measures with compensation that is actually paid (as calculated in accordance with Item 402(v) of Regulation S-K) for a particular year. In accordance with Item 402(v) of Regulation S-K, the Company is providing the following descriptions of the relationships between information presented in the Pay Versus Performance Table. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="Tb_KYKw00gKyUyG1im49GrFpA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Compensation Actually Paid and Net Loss</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></span>The SEC&#8217;s rules require that net loss be presented as a performance measure in the Pay Versus Performance Table above. The graph below shows the relationship between compensation actually paid to our PEO and the average of the compensation actually paid to our other NEOs and net loss attributable to the Company over the two fiscal years ending December 31, 2023, as reported in the Company consolidated financial statements. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><img src="capr-20240514xpre14a009.jpg" alt="Graphic" style="display:inline-block;height:189.85pt;left:0%;padding-bottom:0.65pt;position:relative;top:0pt;width:339.84pt;"/></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="Tb_ZAJHrsHHuUONMqN11NJCgA" continuedAt="Tb_ZAJHrsHHuUONMqN11NJCgA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Compensation Actually Paid and Company TSR</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></span>The SEC&#8217;s rules require that TSR be presented as a performance measure in the Pay Versus Performance Table above. The graph below shows the relationship between (1) compensation actually paid to our PEO and the average of the compensation actually paid to our other NEOs and (2) our cumulative TSR, over the two fiscal years ending December 31, 2023. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><img src="capr-20240514xpre14a010.jpg" alt="Graphic" style="display:inline-block;height:189.48pt;width:339.17pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">29</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><ix:continuation id="Tb_ZAJHrsHHuUONMqN11NJCgA_cont1"></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Securities Authorized for Issuance Under Equity Compensation Plans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have three equity-incentive plans that have been approved by stockholders: (i)&#160;the 2012 Restated Equity Incentive Plan; (ii)&#160;the 2020 Equity Incentive Plan (the &#8220;2020 Plan&#8221;); and (iii)&#160;the 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;). The Company also maintains the 2012 Non-Employee Director Stock Option Plan, which has not been approved by stockholders. At this time, the Company only issues options under the 2020 Plan and 2021 Plan. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following table sets forth additional information with respect to the shares of common stock that may be issued upon the exercise of options and other rights under our existing equity compensation plans and arrangements in effect as of December&#160;31, 2023. The information includes the number of shares covered by, and the weighted average exercise price of, outstanding options, warrants and rights, and the number of shares remaining available for future grant, excluding the shares to be issued upon exercise of outstanding options, warrants and rights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Equity Compensation Plan Information</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:56.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:56.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">securities&#160;to</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of&#160;securities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">be&#160;issued</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">remaining&#160;available&#160;for</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">upon&#160;exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">price&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">future&#160;issuance</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">of&#160;outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">under&#160;equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">options,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">options,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">compensation&#160;plans</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">warrants&#160;and</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(excluding&#160;securities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">rights</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">and&#160;rights</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">reflected&#160;in&#160;column</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Plan Category</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(A)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(B)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(A))(C)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Equity compensation plans approved by security holders:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">The 2012 Restated Equity Incentive Plan<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 282,503</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.43</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">The 2020 Equity Incentive Plan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,819,188</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.72</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 485,588</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">The 2021 Equity Incentive Plan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5,125,713</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3.99</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 746,730</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 8,227,404</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3.46</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,232,318</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The 2012 Restated Equity Incentive Plan expired in November 2022, therefore, no additional stock option awards may be granted from the 2012 Restated Equity Incentive Plan.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The number of shares available for future issuance under the 2021 Plan shall automatically increase on January&#160;1 of each&#160;year by an amount equal to 5% of the outstanding shares of our common stock as of the last day of the immediately preceding fiscal&#160;year (rounded down to the nearest whole share). &#160;</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">30</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_5e3a9974_9ad8_4b7f_88f0_69468497f0a3"></a><a id="NONEMPLOYEEDIRECTORCOMPENSATION_370719"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">NON-EMPLOYEE DIRECTOR COMPENSATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Compensation of Directors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The following table sets forth the compensation received by our directors in fiscal&#160;year 2023. Dr.&#160;Marb&#225;n is not listed below because she is an employee of the Company and receives no additional compensation for serving on our Board or its committees.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fees&#160;Earned&#160;or</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">All&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Paid&#160;in&#160;Cash</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Option&#160;Awards</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Frank Litvack, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 639,545</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 120,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 759,545</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Earl M. (Duke) Collier Jr., J.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 222,369</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 222,369</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">David B. Musket</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 237,360</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 237,360</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">George W. Dunbar Jr., M.B.A.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 211,134</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 211,134</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Karimah Es Sabar</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 196,143</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 196,143</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Louis Manzo <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 207,378</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 207,378</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Paul Auwaerter, M.D., M.B.A.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 459,425</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 459,425</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Philip Gotwals, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 467,360</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 467,360</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Michael Kelliher</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 681,375</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 681,375</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Amounts reflect the grant date fair value of awards granted under the 2021 Equity Incentive Plan computed pursuant to Financial Accounting Standards Board&#8217;s Accounting Standards Codification 718 &#8220;Compensation&#160;&#8211; Stock Compensation.&#8221; Assumptions used in the calculation of these amounts are included in Note&#160;4&#160;&#8211; &#8220;Stock Awards, Warrants and Options&#8221; of the Notes&#160;to the Consolidated Financial Statements included in the Annual Report on Form&#160;10-K as filed with the Securities and Exchange Commission on March&#160;11, 2024.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Options granted for the following number of shares were outstanding as of December&#160;31, 2023: Dr.&#160;Litvack&#160;&#8211; 990,532 shares; Mr.&#160;Collier&#160;&#8211; 300,494 shares; Mr. Musket &#8211; 378,752 shares; Mr.&#160;Dunbar&#160;&#8211; 296,934 shares; Ms.&#160;Es Sabar&#160;&#8211; 183,020 shares; Mr. Manzo &#8211; 316,452 shares; Dr. Auwaerter &#8211; 115,000 shares; Dr. Gotwals &#8211; 115,000 shares; and Mr. Kelliher &#8211; 115,000 shares.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Pursuant to the terms of a Consulting Agreement, dated March&#160;24, 2014, Capricor,&#160;Inc. paid to Dr.&#160;Litvack $10,000 per&#160;month, for an aggregate of $120,000, during the&#160;year ended December&#160;31, 2023, as consideration. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Mr. Manzo resigned from the Board effective July 11, 2023. </span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Risk Assessment of Compensation Programs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We do not believe that our compensation programs create risks that are reasonably likely to have a material adverse effect on our Company. We believe that the combination of different types of compensation as well as the overall amount of compensation, together with our internal controls and oversight by our Board, mitigates potential risks.</p><a id="CertainRelationshipsandRelatedPartyTrans"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Certain Relationships and Related Party Transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Except as reported below, there have not been transactions since January 1, 2023, in which we were a party, where the amount involved exceeded or will exceed $120,000 and in which any related party had a direct or indirect material interest.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Nippon Shinyaku Co., Ltd.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Commercialization and Distribution Agreement with Nippon Shinyaku (Territory: United States)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On January 24, 2022, Capricor entered into a Commercialization and Distribution Agreement (the &#8220;<span style="font-style:italic;font-weight:bold;">U.S. Distribution Agreement</span>&#8221;) with Nippon Shinyaku Co. Ltd., (&#8220;<span style="font-style:italic;font-weight:bold;">Nippon Shinyaku</span>&#8221;), a Japanese corporation and a shareholder of the Company. Under the terms of the U.S. Distribution Agreement, Capricor appointed Nippon Shinyaku as its exclusive distributor in the United States of CAP-1002 for the treatment of DMD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Under the terms of the U.S. Distribution Agreement, Capricor will be responsible for the conduct of the HOPE-3 trial as well as the manufacturing of CAP-1002. Nippon Shinyaku will be responsible for the distribution of CAP-1002 in the United States. Pursuant to the U.S Distribution Agreement, Capricor received an upfront payment of $30.0 million </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">31</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">in the first quarter of 2022. The first milestone payment of $10.0 million was paid in the first quarter of 2024 upon completion of the interim futility analysis of the HOPE-3 trial whereby the outcome was determined to be not futile. Additionally, there are potential milestones totaling up to $90.0 million leading up to and including the Biologics License Application approval. Further, there are various potential sales-based milestones, if commercialized, tied to the achievement of certain sales thresholds for annual net sales of CAP-1002 of up to $605.0 million. Further, pursuant to the U.S. Distribution Agreement, Capricor has the obligation to sell commercial product to Nippon Shinyaku, subject to regulatory approval, and Capricor will have the right to receive a meaningful mid-range double-digit share of product revenue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Commercialization and Distribution Agreement with Nippon Shinyaku (Territory: Japan)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On February 10, 2023, Capricor entered into a Commercialization and Distribution Agreement (the &#8220;<span style="font-style:italic;font-weight:bold;">Japan Distribution Agreement</span>&#8221;) with Nippon Shinyaku. Under the terms of the Japan Distribution Agreement, Capricor appointed Nippon Shinyaku as its exclusive distributor in Japan of CAP-1002 for the treatment of DMD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Under the terms of the Japan Distribution Agreement, Capricor received an upfront payment of $12.0 million in the first quarter of 2023 and in addition, Capricor may potentially receive additional development and sales-based milestone payments of up to approximately $89.0 million, subject to foreign currency exchange rates, and a meaningful double-digit share of product revenue. Nippon Shinyaku will be responsible for the distribution of CAP-1002 in Japan. Capricor will be responsible for the conduct of clinical development in Japan, as may be required, as well as the manufacturing of CAP-1002. Subject to regulatory approval, Capricor will sell commercial product to Nippon Shinyaku in Japan. In addition, Capricor or its designee will hold the Marketing Authorization in Japan if the product is approved in that territory.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Employment Agreements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Information regarding our executive employment agreements for certain officers is located under the caption, &#8220;Employment Agreements and Potential Payments Upon Termination or Change in Control&#8221; above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Director and Officer Indemnification Agreements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition to the indemnification provisions contained in our Certificate of Incorporation and Bylaws, we generally enter into separate indemnification agreements with our directors and executive officers. These agreements require us, among other things, to indemnify the director or executive officer against specified expenses and liabilities, such as attorneys&#8217; fees, judgments, fines and settlements, paid by the individual in connection with any action, suit or proceeding arising out of the individual&#8217;s status or service as our director or executive officer, other than liabilities arising from willful misconduct or conduct that is knowingly fraudulent or deliberately dishonest, and to advance expenses incurred by the individual in connection with any proceeding against the individual with respect to which the individual may be entitled to indemnification by us. We also intend to enter into these agreements with our future directors and executive officers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Policies and Procedures for Related Party Transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Although we have adopted a Code of Business Conduct and Ethics, we rely on the Board to review related party transactions on an ongoing basis to prevent conflicts of interest. The Board reviews a transaction in light of the affiliations of the director, officer or employee and the affiliations of such person&#8217;s immediate family. Transactions are presented to the Board for approval before they are entered into or, if this is not possible, for ratification after the transaction has occurred. If the Board finds that a conflict of interest exists, then it will determine the appropriate remedial action, if any. The Board approves or ratifies a transaction if it determines that the transaction is consistent with the best interests of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">32</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_5a7293a8_4dcb_4087_aa58_5f0243d807f7"></a><a id="PROPOSALNO2_635199"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">PROPOSAL NO.&#160;2: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">RATIFICATION OF THE SELECTION OF THE INDEPENDENT REGISTERED ACCOUNTING FIRM</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Audit Committee of the Board has selected Rose, Snyder&#160;&amp; Jacobs LLP as our independent registered public accounting firm for the fiscal&#160;year ending December&#160;31, 2024 and has further directed that management seek stockholder ratification of the selection of the independent registered public accounting firm at the Annual Meeting. Rose, Snyder&#160;&amp; Jacobs LLP was appointed our registered public accounting firm on January&#160;17, 2014, and has served as our independent registered public accounting firm for each year since the&#160;year ended December&#160;31, 2013.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Representatives of Rose, Snyder&#160;&amp; Jacobs LLP are expected to be present at the Annual Meeting. They will have an opportunity to make a statement if they so desire and will be available to respond to appropriate questions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Neither our Bylaws nor other governing documents or law requires stockholder ratification of the selection of Rose, Snyder&#160;&amp; Jacobs LLP as our independent registered public accounting firm. However, the Audit Committee is submitting the selection of Rose, Snyder&#160;&amp; Jacobs LLP to our stockholders for ratification as a matter of good corporate practice. If our stockholders fail to ratify the selection, the Audit Committee will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee of the Board in its discretion may direct the appointment of different independent auditors at any time during the&#160;year if they determine that such a change would be in our best interests as well as the best interest of our stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Services provided to the Company and its subsidiaries by Rose, Snyder &amp; Jacobs LLP for the years ended December 31, 2023 and 2022 are described below and under &#8220;Audit Committee Report.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Principal Accountant Fees and Services</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In connection with the audit of the 2023 financial statements, we entered into an engagement agreement with Rose, Snyder&#160;&amp; Jacobs LLP which sets forth the terms by which Rose, Snyder&#160;&amp; Jacobs LLP would perform audit services for us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The following is a summary of the approximate fees billed to us by Rose, Snyder&#160;&amp; Jacobs LLP, our independent registered public accounting firm, for professional services rendered for the fiscal&#160;years ended December&#160;31, 2023 and 2022 which includes Capricor,&#160;Inc. and Capricor Therapeutics,&#160;Inc.:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fiscal&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Service Category</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Audit Fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 89,050</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 86,300</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Audit-Related Fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 45,250</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 8,000</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Tax Fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 11,500</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 12,500</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">All Other Fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,600</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4,050</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total Fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.59%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 147,400</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.59%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 110,850</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the above table, in accordance with the SEC&#8217;s definitions and rules, &#8220;audit fees&#8221; are fees for professional services for the audit and review of our annual financial statements, as well as the audit and review of our financial statements included in our registration statements filed under the Securities Act and issuance of consents and for services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements, except those not required by statute or regulation; &#8220;audit-related fees&#8221; are fees for assurance and related services that were reasonably related to the performance of the audit or review of our financial statements, including attestation services that are not required by statute or regulation, due diligence and services related to acquisitions; &#8220;tax fees&#8221; are fees for tax compliance, tax advice and tax planning; and &#8220;all other fees&#8221; are fees for any services not included in the first three categories which include foreign tax research and consents necessary for applicable filings with the SEC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Pre-Approval Policies and Procedures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Pursuant to our Audit Committee Charter, before the independent registered public accounting firm is engaged by the Company or its subsidiaries to render audit or non-audit services, the Audit Committee pre-approves the </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">33</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">engagement. Audit Committee pre-approval of audit and non-audit services is not required if the engagement for the services is entered into pursuant to pre-approval policies and procedures established by the Audit Committee regarding the Company&#8217;s engagement of the independent registered public accounting firm, provided the policies and procedures are detailed as to the particular service, the Audit Committee is informed of each service provided and such policies and procedures do not include delegation of the Audit Committee&#8217;s responsibilities under the Exchange Act to the Company&#8217;s management. The Audit Committee may delegate to one or more designated members of the Audit Committee the authority to grant pre-approvals, provided such approvals are presented to the full Audit Committee at a subsequent meeting. If the Audit Committee elects to establish pre-approval policies and procedures regarding non-audit services, the Audit Committee must be informed of each non-audit service provided by the independent registered public accounting firm. Audit Committee pre-approval of non-audit services (other than review and attest services) also is not required if such services fall within available exceptions established by the SEC. None of the services provided by our independent registered public accounting firm for fiscal 2023 or 2022 were obtained in reliance on the waiver of the pre-approval requirement afforded in SEC regulations. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The affirmative vote of a majority of the shares cast on Proposal No.&#160;2 at the Annual Meeting will be required to ratify the selection of Rose, Snyder&#160;&amp; Jacobs&#160;LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2024. Abstentions will have no effect on whether this proposal is approved. Under the rules of the New York Stock Exchange, brokers have discretionary authority to vote shares on this proposal. Therefore, we do not expect any broker non-votes on Proposal No. 2. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">FOR</b>&#8221; PROPOSAL NO.&#160;2</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">34</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_e4c82519_d3c2_4198_a454_57bd5aac8fc7"></a><a id="AUDITCOMMITTEEREPORT_712392"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">AUDIT COMMITTEE REPORT*</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Audit Committee has reviewed and discussed the audited financial statements for the fiscal&#160;year ended December&#160;31, 2023, with our management. The Audit Committee has discussed with the independent registered public accounting firm the matters required to be discussed by Auditing Standard No.&#160;1301 adopted by the Public Company Accounting Oversight Board (United States) (the &#8220;<span style="font-style:italic;font-weight:bold;">PCAOB</span>&#8221;) regarding "<i style="font-style:italic;">Communications with Audit Committees</i>." The Audit Committee has also received the written disclosures and the letter from the independent registered public accounting firm required by applicable requirements of the PCAOB regarding the accounting firm&#8217;s communications with the Audit Committee concerning independence, and has discussed with the independent registered public accounting firm the firm&#8217;s independence. Based on the foregoing, the Audit Committee has recommended to the Board that the audited financial statements be included in our Annual Report on Form&#160;10-K for the fiscal&#160;year ended December&#160;31, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:90pt;margin:0pt 0pt 0pt 18pt;"><b style="font-weight:bold;">Respectively submitted by:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:90pt;margin:0pt 0pt 0pt 18pt;">Mr.&#160;Musket</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:90pt;margin:0pt 0pt 0pt 18pt;">Ms.&#160;Es Sabar</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:90pt;margin:0pt 0pt 12pt 18pt;">Mr.&#160;Dunbar</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">*The material in this report is not &#8220;soliciting material,&#8221; is not deemed &#8220;filed&#8221; with the SEC and is not to be incorporated by reference in any of our filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">35</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_22e015d9_0fe7_4d50_8b44_106b6d9d72da"></a><a id="PROPOSALNO3_761835"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">PROPOSAL NO.&#160;3:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">TO APPROVE, BY NON-BINDING ADVISORY VOTE, THE RESOLUTION APPROVING NAMED EXECUTIVE OFFICER COMPENSATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Under the Dodd-Frank Wall Street Reform and Consumer Protection Act and Section&#160;14A of the Exchange Act, our stockholders are entitled to vote to approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement in accordance with SEC rules. Consistent with the preference expressed by our stockholders at the last advisory vote on the frequency of our &#8220;say-on-pay&#8221; vote, we are conducting such vote annually. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and the philosophy, policies and practices described in this proxy statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our compensation policies are designed to align our key executives&#8217; compensation with both our business objectives and the interests of our stockholders. We also seek to provide compensation policies that attract, motivate and retain key executives who are critical to our success.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We recommend that our stockholders review the application of our compensation philosophy and the elements of compensation provided to each named executive officer as reflected in the discussion and tables included in the &#8220;2023 Executive Compensation&#8221; section of this proxy statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We believe our executive compensation policies are designed appropriately and are functioning as intended to produce long-term value for our stockholders. Accordingly, we are asking our stockholders to approve the overall application of our compensation policies to our named executive officers through this advisory vote.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Accordingly, the Board is asking our stockholders to indicate their support for the compensation of our named executive officers as described in this proxy statement by casting a non-binding advisory vote &#8220;FOR&#8221; the following resolution:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">&#8220;RESOLVED, that the compensation paid to Capricor Therapeutics&#8217; named executive officers, as disclosed in the proxy statement for the 2024 Annual Meeting of Stockholders of Capricor Therapeutics pursuant to the compensation disclosure rules&#160;of the Securities and Exchange Commission, including the 2023 Executive Compensation, compensation tables and related narrative discussion, is hereby APPROVED on an advisory, non-binding basis.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Because the vote is advisory, it is not binding on the Board or us. Nevertheless, the views expressed by our stockholders, whether through this vote or otherwise, are important to management and the Board and, accordingly, the Board and the Compensation Committee intend to consider the results of this vote in making determinations in the future regarding executive compensation arrangements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Advisory approval of this Proposal No.&#160;3 requires the affirmative vote of a majority of the shares cast on Proposal No.&#160;3 at the Annual Meeting. Abstentions and broker non-votes will have no effect on whether this proposal is approved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">FOR</b>&#8221; PROPOSAL NO.&#160;3.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">36</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_f8c4f8e4_b0c8_4e8d_937c_e631617ea911"></a><a id="PROPOSALNO4_737675"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">PROPOSAL NO. 4:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">TO APPROVE AN AMENDMENT TO THE CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF OUR COMMON STOCK FROM 50,000,000 TO 100,000,000</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Background of the Proposal</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The Board has unanimously adopted and declared advisable, and has recommended that the Company&#8217;s stockholders approve, the Charter Amendment, which would amend the Certificate of Incorporation to increase the number of authorized shares of our common stock from 50,000,000 to 100,000,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The following table sets forth certain information with respect to the Company's common stock as of March 18, 2024: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:normal;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:24.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Common Stock </b></p></td><td style="vertical-align:bottom;white-space:normal;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;">&#160;&#160;&#160;&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:24.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As of March 18, 2024</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Shares presently authorized for issuance</p></td><td style="vertical-align:bottom;white-space:normal;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:24.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 50,000,000</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Shares issued and outstanding</p></td><td style="vertical-align:bottom;white-space:normal;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:24.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 31,502,972</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Shares reserved for issuance under outstanding warrants and pursuant to equity compensation plans</p></td><td style="vertical-align:bottom;white-space:normal;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:24.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 16,053,216</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Shares presently available for issuance</p></td><td style="vertical-align:bottom;white-space:normal;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:24.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,443,812</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Shares that will be available for issuance if this proposal is adopted</p></td><td style="vertical-align:bottom;white-space:normal;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:24.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 52,443,812</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Reasons for the Charter Amendment</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The Board and management believe that the limited number of currently authorized but unissued and unreserved shares of common stock may restrict the Company&#8217;s ability to respond to its business needs and opportunities. The availability of additional shares of common stock for issuance will afford the Company flexibility by assuring that there will be sufficient authorized but unissued shares of common stock for business and financial purposes in the future. The additional shares may be used for various purposes without further stockholder approval. These purposes may include raising capital; providing equity incentives to employees, officers or directors; establishing strategic relationships with other companies; expanding the Company's business or product lines through the acquisition of other businesses or products; stock splits and other corporate purposes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Except as described above, the Company currently has no plans for the use of the additional authorized shares of common stock that would become available upon stockholder approval of the Charter Amendment. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Timing and Effect</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">If adopted by our stockholders at the Annual Meeting, the Charter Amendment will become effective upon the filing with the Delaware Secretary of State of the Charter Amendment, which would be done as soon as practicable following the Annual Meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The additional common stock to be authorized by adoption of the Charter Amendment would have rights identical to the currently outstanding common stock. A description of our common stock is contained in Exhibit 4.1 to our Annual Report on Form 10-K. Adoption of the Charter Amendment would not affect the rights of the holders of currently outstanding common stock. Effects incidental to potential dilution (such as dilution of the earnings per share and voting rights of current holders of common stock) could occur, and potential downward pressure on the market price of our common stock could occur if we elect to issue and sell common stock into the public market or otherwise. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">If the Charter Amendment is approved and filed, the increased number of authorized shares of common stock will be available for issuance, from time to time, for such purposes and consideration, and on such terms, as the Board may approve, and no further vote of the stockholders of the Company will be sought, although certain issuances of shares may require stockholder approval in accordance with the requirements of Nasdaq or the General Corporation Law of the State of Delaware.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The existence of additional authorized shares of common stock could have the effect of rendering more difficult or discouraging hostile takeover attempts. For example, without further stockholder approval, the Board could adopt a </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">37</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#8220;poison pill&#8221; which would, under certain circumstances related to an acquisition of shares not approved by the Board, give certain holders the right to acquire additional shares of common stock at a low price, or the Board could strategically sell shares of common stock in a private transaction to purchasers who would oppose a takeover or favor the current Board. The Board is not aware of any existing or planned effort on the part of any party to accumulate material amounts of voting stock, or to acquire or control the Company by means of a merger, tender offer, solicitation of proxies in opposition to management or otherwise, or to change the Company&#8217;s management, nor is the Board aware of any person having made any offer to acquire the voting stock or assets of the Company. Although this proposal to increase the authorized common stock has been prompted by business and financial considerations and not by the threat of any hostile takeover attempt (nor is the Board currently aware of any such attempts directed at the Company), nevertheless, stockholders should be aware that approval of this proposal could facilitate future efforts by the Company to deter or prevent changes in control of the Company, including transactions in which the stockholders might otherwise receive a premium for their shares over then current market prices.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">If approved and filed, the Charter Amendment will have no effect on the number of shares of preferred stock the Company is authorized to issue. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Vote Required</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The affirmative vote of a majority of the shares cast on Proposal No. 4 at the Annual Meeting will be required to approve the Charter Amendment. Abstentions will have no effect on whether this proposal is approved. Under the rules of the New York Stock Exchange, brokers have discretionary authority to vote shares on this proposal. Therefore, we do not expect any broker non-votes on Proposal No. 4. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">At any time prior to the effectiveness of the filing of the Charter Amendment with the Delaware Secretary of State, notwithstanding authorization of the Charter Amendment by the stockholders of the Company, the Board may abandon the Charter Amendment without further action by the stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;</b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">FOR</b><b style="font-weight:bold;">&#8221; PROPOSAL NO. 4.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">38</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_81ab2842_e3f6_4111_901f_77b1456dd54f"></a><a id="STOCKOWNERSHIPINFORMATION_372723"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">STOCK OWNERSHIP INFORMATION</p><a id="SecurityOwnershipofCertainBeneficialOwne"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Security Ownership of Certain Beneficial Owners and Management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following table sets forth certain information known to us regarding the beneficial ownership of our common stock as of March&#160;18, 2024 by:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each of our current directors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each named executive officer as defined and named in this proxy statement, and included in the Summary Compensation Table;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all of our current directors and executive officers as a group; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each person known by us to beneficially own more than five&#160;percent of our common stock (based on information supplied in Schedules 13D and 13G filed with the SEC).</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Except as indicated by footnote, and subject to applicable community property laws, each person identified in the table possesses sole voting and dispositive power with respect to all capital stock shown to be held by that person. The address of each named executive officer and director, unless indicated otherwise, is c/o Capricor Therapeutics,&#160;Inc., 10865 Road to the Cure, Suite 150, San Diego, California 92121.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares&#160;of&#160;Common</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Percentage&#160;of&#160;Common</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stock&#160;Beneficially</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stock&#160;Beneficially</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Name of Beneficial Owner</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Owned</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Owned</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:58.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Named Executive Officers and Directors:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Frank Litvack, M.D.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 897,225</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.8</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Earl M. (Duke) Collier Jr., J.D.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 321,143</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.0</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">David B. Musket<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 405,529</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.3</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">George W. Dunbar Jr., M.B.A.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(5)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 302,267</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td></tr><tr><td style="vertical-align:bottom;width:58.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Karimah Es Sabar<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(6)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 172,367</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td></tr><tr><td style="vertical-align:bottom;width:58.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Paul Auwaerter, M.D., M.B.A.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(7)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 22,400</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td></tr><tr><td style="vertical-align:bottom;width:58.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Philip Gotwals, Ph.D.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(8)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 17,450</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td></tr><tr><td style="vertical-align:bottom;width:58.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Michael Kelliher<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(9)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 45,370</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td></tr><tr><td style="vertical-align:bottom;width:58.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Anthony Bergmann, M.B.A.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(10)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 372,641</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.2</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Linda Marb&#225;n, Ph.D.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(11)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,326,080</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4.1</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Karen Krasney, J.D.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(12)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 334,095</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.1</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Directors and executive officers as a group (11 individuals)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4,216,567</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 12.0</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">5% Stockholders:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Highbridge Capital Management, LLC and affiliated entities<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(13)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5,579,398</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 16.3</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Nippon Shinyaku Co., Ltd.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(14)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4,291,844</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 12.8</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;">*Represents less than 1%.</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We have based&#160;percentage ownership of our common stock on 31,502,972 shares of our common stock outstanding as of March&#160;18, 2024. Beneficial ownership is determined in accordance with Rule&#160;13d-3 under the Exchange Act and includes any shares as to which the security holder has sole or shared voting power or dispositive power, and also any shares which the security holder has the right to acquire within sixty (60)&#160;days of March&#160;18, 2024, whether through the exercise or conversion of any stock option, convertible security, warrant or other right. The indication herein that shares are beneficially owned is not an admission on the part of the security holder that he, she or it is a direct or indirect beneficial owner of those shares.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Includes (i)&#160;133,269 shares held by Dr.&#160;Litvack; (ii)&#160;743,565 shares issuable upon the exercise of stock options held directly by Dr.&#160;Litvack that are exercisable or will become exercisable within sixty (60)&#160;days of March 18, 2024; and (iii)&#160;20,391 shares issuable upon the exercise of warrants held directly by Dr.&#160;Litvack which are exercisable or will become exercisable within sixty (60)&#160;days of March 18, 2024. The shares issuable upon the exercise of stock options </span></td></tr></table></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">39</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"/><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">issued to Dr.&#160;Litvack are subject to early exercise under the 2021 Plan, the 2020 Plan, and the Capricor Therapeutics,&#160;Inc. 2012 Restated Equity Incentive Plan. As of March 18, 2024, Dr.&#160;Litvack has not indicated his intent to exercise early. If the option holder elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Company if the option holder&#8217;s service to the Company terminates prior to vesting.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Includes (i) 26,856 shares held by Mr. Collier; and (ii) 294,287 shares issuable upon the exercise of stock options which are exercisable or will become exercisable within sixty (60)&#160;days of March&#160;18, 2024. The shares issuable upon the exercise of stock options issued to Mr.&#160;Collier are subject to early exercise under the 2021 Plan, the 2020 Plan, and the Capricor Therapeutics,&#160;Inc. 2012 Restated Equity Incentive Plan. As of March&#160;18, 2024, Mr.&#160;Collier has not indicated his intent to exercise early. If the option holder elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Company if the option holder&#8217;s service to the Company terminates prior to vesting.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Includes (i)&#160;7,096 shares held by SEP FBO David B. Musket, Pershing LLC as Custodian; (ii)&#160;31,536 held by David B. Musket; and (iii)&#160;366,897 shares issuable upon the exercise of stock options held directly by David B. Musket, which are exercisable or will become exercisable within sixty (60)&#160;days of March&#160;18, 2024. The shares issuable upon the exercise of stock options issued to Mr.&#160;Musket are subject to early exercise under the 2021 Plan, the 2020 Plan, and the Capricor Therapeutics,&#160;Inc. 2012 Restated Equity Incentive Plan. As of March&#160;18, 2024, Mr.&#160;Musket has not indicated his intent to exercise early. If the option holder elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Company if the option holder&#8217;s service to the Company terminates prior to vesting.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(5)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Includes (i) 10,556 shares held by Mr. Dunbar; and (ii) 291,711 shares issuable upon the exercise of stock options that are exercisable or will become exercisable within sixty (60)&#160;days of March&#160;18, 2024. The shares issuable upon the exercise of stock options issued to Mr.&#160;Dunbar are subject to early exercise under the 2021 Plan, the 2020 Plan, and the Capricor Therapeutics,&#160;Inc. 2012 Restated Equity Incentive Plan. As of March&#160;18, 2024, Mr.&#160;Dunbar has not indicated his intent to exercise early. If the option holder elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Company if the option holder&#8217;s service to the Company terminates prior to vesting.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(6)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Includes 172,367 shares issuable upon the exercise of stock options which are exercisable or will become exercisable within sixty (60) days of March&#160;18, 2024. The shares issuable upon the exercise of stock options issued to Ms. Es Sabar are subject to early exercise under the 2021 Plan. As of March&#160;18, 2024, Ms. Es Sabar has not indicated her intent to exercise early. If the option holder elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Company if the option holder&#8217;s service to the Company terminates prior to vesting.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(7)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Includes 17,400 shares issuable upon the exercise of stock options which are exercisable or will become exercisable within sixty (60) days of March&#160;18, 2024. The shares issuable upon the exercise of stock options issued to Dr. Auwaerter are subject to early exercise under the 2021 Plan. As of March&#160;18, 2024, Dr. Auwaerter has not indicated his intent to exercise early. If the option holder elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Company if the option holder&#8217;s service to the Company terminates prior to vesting.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(8)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Includes 17,450 shares issuable upon the exercise of stock options which are exercisable or will become exercisable within sixty (60) days of March&#160;18, 2024. The shares issuable upon the exercise of stock options issued to Dr. Gotwals are subject to early exercise under the 2021 Plan. As of March&#160;18, 2024, Dr. Gotwals has not indicated his intent to exercise early. If the option holder elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Company if the option holder&#8217;s service to the Company terminates prior to vesting.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(9)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Includes 45,370 shares issuable upon the exercise of stock options which are exercisable or will become exercisable within sixty (60) days of March&#160;18, 2024. The shares issuable upon the exercise of stock options issued to Mr. Kelliher are subject to early exercise under the 2021 Plan. As of March&#160;18, 2024, Mr. Kelliher has not indicated his intent to exercise early. If the option holder elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Company if the option holder&#8217;s service to the Company terminates prior to vesting.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(10)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Includes (i)&#160;2,381 shares held by Mr.&#160;Bergmann and (ii)&#160;370,260 shares issuable upon the exercise of stock options held directly by Mr.&#160;Bergmann that are exercisable or will become exercisable within sixty (60)&#160;days of March&#160;18, 2024. The shares issuable upon the exercise of stock options issued to Mr.&#160;Bergmann are subject to early exercise under the 2021 Plan, the 2020 Plan, and the Capricor Therapeutics,&#160;Inc. 2012 Restated Equity Incentive Plan. As of March&#160;18, 2024, Mr.&#160;Bergmann has not indicated his intent to exercise early. If the option holder elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be </span></td></tr></table></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">40</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"/><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">deemed restricted stock and will be subject to a repurchase option in favor of the Company if the option holder&#8217;s service to the Company terminates prior to vesting.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(11)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Includes (i)&#160;198,604 shares held by Dr.&#160;Linda Marb&#225;n; (ii)&#160;920 shares held by Linda and Eduardo Marb&#225;n as joint tenants with rights of survivorship; and (iii)&#160;1,126,556 shares issuable upon the exercise of stock options held directly by Dr.&#160;Linda Marb&#225;n which are exercisable or will become exercisable within sixty (60)&#160;days of March&#160;18, 2024. Certain shares issuable upon the exercise of stock options issued to Dr.&#160;Linda Marb&#225;n are subject to early exercise under the 2021 Plan, the 2020 Plan, and the Capricor Therapeutics,&#160;Inc. 2012 Restated Equity Incentive Plan. As of March&#160;18, 2024, Dr.&#160;Linda Marb&#225;n has not indicated her intent to exercise early. If the option holder elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Company if the option holder&#8217;s service to the Company terminates prior to vesting.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(12)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Includes (i)&#160;20,047 shares held by Ms.&#160;Krasney and (ii) 314,048 shares issuable upon the exercise of stock options held directly by Ms.&#160;Krasney that are exercisable or will become exercisable within sixty (60)&#160;days of March&#160;18, 2024. The shares issuable upon the exercise of stock options issued to Ms.&#160;Krasney are subject to early exercise under the 2021 Plan, the 2020 Plan, and the Capricor Therapeutics,&#160;Inc. 2012 Restated Equity Incentive Plan. As of March&#160;18, 2024, Ms.&#160;Krasney has not indicated her intent to exercise early. If the option holder elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Company if the option holder&#8217;s service to the Company terminates prior to vesting.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(13)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Includes (i) 2,789,699 shares held by Highbridge Capital Management, LLC and affiliated entities; and (ii) 2,789,699 shares issuable upon the exercise of warrants held directly by Highbridge Capital Management, LLC and affiliated entities which are exercisable or will become exercisable within sixty (60)&#160;days of March 18, 2024. Highbridge Capital Management, LLC reports that it holds shared voting power and shared dispositive power with respect to all shares held by it. The address for Highbridge Capital Management, LLC is 277 Park Avenue, 23rd Floor, New York, New York 10172. Based on information set forth in a Schedule 13G filed with the SEC on February 7, 2024.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(14)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Includes (i) 2,145,922 shares held by Nippon Shinyaku Co., Ltd.; and (ii) 2,145,922 shares issuable upon the exercise of warrants held directly by Nippon Shinyaku Co., Ltd. which are exercisable or will become exercisable within sixty (60)&#160;days of March 18, 2024. Nippon Shinyaku Co., Ltd reports that it holds sole voting power and sole dispositive power with respect to all shares held by it. The address for Nippon Shinyaku Co., Ltd. is 14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto 601-8550, Japan. Based on information set forth in a Schedule 13G filed with the SEC on October 17, 2023.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Delinquent Section&#160;16(a)&#160;Reports</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">None.</p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">41</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_000db422_9547_47b4_8926_aaac605e3f6f"></a><a id="OTHERINFORMATION_374960"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">OTHER INFORMATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Householding of Proxy Materials</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The SEC has adopted rules&#160;that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for Notices and other Annual Meeting materials with respect to two or more stockholders sharing the same address by delivering a single Notice, Proxy Statement, Annual Report and other Annual Meeting materials addressed to those stockholders. This process, which is commonly referred to as &#8220;householding,&#8221; potentially means extra convenience for stockholders and cost savings for companies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">This&#160;year, a number of brokers with account holders who are our stockholders will be &#8220;householding&#8221; our proxy materials. A single Notice, Proxy Statement and Annual Report will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that they will be &#8220;householding&#8221; communications to your address, &#8220;householding&#8221; will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in &#8220;householding&#8221; and would prefer to receive a separate Notice, Proxy Statement and Annual Report, please notify your broker or us. Direct your written request to the Company&#8217;s Corporate Secretary at 10865 Road to the Cure, Suite 150, San Diego, California 92121 or contact the Company&#8217;s Corporate Secretary at (858) 727-1755. Stockholders who currently receive multiple copies of the Notices, Proxy Statements, Annual Reports and other Annual Meeting materials at their addresses and would like to request &#8220;householding&#8221; of their communications should contact their broker or our Corporate Secretary in the same manner described above. In addition, we will promptly deliver, upon written or oral request to the address or telephone number above, a separate copy of the Notice, Proxy Statement, Annual Report and other Annual Meeting materials to a stockholder at a shared address to which a single copy of the documents was delivered.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Where You Can Find More Information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We file annual, quarterly and current reports, proxy statements and other information with the SEC. You may read and copy any reports, statements or other information that we have filed with the SEC at the SEC&#8217;s public reference room at the following location:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;">Public Reference Room</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;">100 F Street, N.E.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Washington, DC 20549</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Please call the SEC at 1-800-SEC-0330 for further information on the public reference room. These SEC filings are also available to the public from commercial document retrieval services and at the Internet World Wide Web site maintained by the SEC at &#8220;http://www.sec.gov.&#8221; Copies of our SEC filings are also available through our website (www.capricor.com) as soon as reasonably practicable after we electronically file the material with, or furnish it to, the SEC. The information contained on, or that can be accessed through, our website is not incorporated by reference and is not a part of this proxy statement. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the Annual Meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By Order of the Board of Directors</p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">CAPRICOR THERAPEUTICS, INC. </b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:50%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Linda Marb&#225;n, Ph.D.</p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Linda Marb&#225;n, Ph.D.</p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer and a Director</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">42</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_c42c379b_33a0_4358_8df3_cc150cedadfd"></a><a id="ANNEXA_478450"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">ANNEX A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATE OF AMENDMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OF</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATE OF INCORPORATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OF</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CAPRICOR THERAPEUTICS, INC.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Capricor Therapeutics, Inc. (the &#8220;<b style="font-weight:bold;">Corporation</b>&#8221;), a corporation organized and existing under the General Corporation Law of the State of Delaware (the &#8220;<b style="font-weight:bold;">DGCL</b>&#8221;), does hereby certify that:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;">FIRST</b>: The name of the Corporation is Capricor Therapeutics, Inc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;">SECOND</b>: The original Certificate of Incorporation of the Corporation (formerly known as SMI Products, Inc. and Nile Therapeutics, Inc., respectively) was filed with the Secretary of State of the State of Delaware on January 26, 2007, which was amended by a Certificate of Amendment of Certificate of Incorporation thereafter filed with the Secretary of State of the State of Delaware on November 20, 2013 and a Certificate of Amendment of Certificate of Incorporation thereafter filed with the Secretary of State of the State of Delaware on June 4, 2019 (the &#8220;<b style="font-weight:bold;">Certificate of Incorporation</b>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;">THIRD</b>: The Board of Directors of the Corporation duly adopted resolutions setting forth proposed amendments (the &#8220;<b style="font-weight:bold;">Certificate of Amendment</b>&#8221;) to the Certificate of Incorporation amending the Certificate of Incorporation as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The Certificate of Incorporation shall be amended by deleting and substituting the text of the two paragraphs of Article Fourth thereof with the following one paragraph.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">&#8220;(a) <i style="font-style:italic;">Authorized Capital</i>. The total number of shares of all classes of stock which the Corporation shall have authority to issue shall be One Hundred Five Million (105,000,000) shares, consisting of (i) One Hundred Million (100,000,000) shares of common stock, par value $0.001 per share (&#8220;Common Stock&#8221;), and (ii) Five Million (5,000,000) shares of preferred stock, par value $0.001 per share (&#8220;Preferred Stock&#8221;).&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;">FOURTH</b>: The Board of Directors of the Corporation declared the Certificate of Amendment to be advisable and directed that the Certificate of Amendment be submitted to the stockholders of the Corporation for consideration thereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;">FIFTH</b>: That, pursuant to resolution of its Board of Directors of the Corporation, a meeting of stockholders of the Corporation was duly called and held upon notice in accordance with Section 222 of the Delaware General Corporation Law at which meeting the necessary number of shares as required by statute were voted in favor of the Certificate of Amendment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;">SIXTH</b>: That the foregoing Certificate of Amendment was duly adopted in accordance with the provisions of Section 222 of the Delaware General Corporation Law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;">IN WITNESS WHEREOF</b>, the Corporation has caused this Certificate of Amendment to be signed by its President and Chief Executive Officer this [&#9679;] day of [&#9679;], 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"></span><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">CAPRICOR THERAPEUTICS, INC. </b></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:50%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 0pt 1pt 0pt;"/></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Linda Marb&#225;n, Ph.D.</p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">43</p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_0242aa2d_68b2_44b1_9af4_e1e7660e0c4c"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:13.2pt;"><td style="vertical-align:top;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">PROXY</b></p></td><td style="vertical-align:top;width:69.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">CAPRICOR THERAPEUTICS, INC.</b></p></td><td style="vertical-align:top;width:15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><b style="font-weight:bold;">PROXY</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The undersigned, a stockholder of Capricor Therapeutics, Inc., hereby appoints Linda Marb&#225;n, Ph.D. and Karen Krasney, Esq., and each of them, as proxies, with full power of substitution, to vote on behalf of the undersigned the number of shares which the undersigned is then entitled to vote, at the Annual Meeting of Stockholders of Capricor Therapeutics, Inc., to be held on May 14, 2024 at 10:00 a.m. (PDT) with a physical location at the Company&#8217;s principal executive offices located at 10865 Road to the Cure, Suite 150, San Diego, California 92121 and at any and all adjournments thereof, with all the powers which the undersigned would possess if personally present, in the manner directed herein.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">This proxy will be voted as directed, or if no direction is indicated, will be voted in accordance with the recommendations of the Board of the Directors.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">The Board of Directors recommends you vote &#8220;</b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">FOR</b><b style="font-weight:bold;">&#8221; each of the following:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">1.&#160;&#160;ELECTION OF DIRECTORS</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:25.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 36pt;">Frank Litvack</p></td><td style="vertical-align:top;width:24.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span><span style="font-family:'Segoe UI Symbol';"> </span>FOR</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span> WITHHOLD</p></td></tr><tr><td style="vertical-align:bottom;width:25.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 36pt;">Linda Marb&#225;n</p></td><td style="vertical-align:top;width:24.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span><span style="font-family:'Segoe UI Symbol';"> </span>FOR</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span> WITHHOLD</p></td></tr><tr><td style="vertical-align:bottom;width:25.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 36pt;">David Musket</p></td><td style="vertical-align:top;width:24.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span><span style="font-family:'Segoe UI Symbol';"> </span>FOR</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span> WITHHOLD</p></td></tr><tr><td style="vertical-align:bottom;width:25.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 36pt;">George Dunbar</p></td><td style="vertical-align:top;width:24.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span><span style="font-family:'Segoe UI Symbol';"> </span>FOR</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span> WITHHOLD</p></td></tr><tr><td style="vertical-align:bottom;width:25.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 36pt;">Earl Collier, Jr.</p></td><td style="vertical-align:top;width:24.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span><span style="font-family:'Segoe UI Symbol';"> </span>FOR</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span> WITHHOLD</p></td></tr><tr><td style="vertical-align:bottom;width:25.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 36pt;">Karimah Es Sabar </p></td><td style="vertical-align:top;width:24.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span><span style="font-family:'Segoe UI Symbol';"> </span>FOR</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span> WITHHOLD</p></td></tr><tr><td style="vertical-align:bottom;width:25.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 36pt;">Paul Auwaerter </p></td><td style="vertical-align:top;width:24.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span><span style="font-family:'Segoe UI Symbol';"> </span>FOR</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span> WITHHOLD</p></td></tr><tr><td style="vertical-align:bottom;width:25.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 36pt;">Philip Gotwals </p></td><td style="vertical-align:top;width:24.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span><span style="font-family:'Segoe UI Symbol';"> </span>FOR</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span> WITHHOLD</p></td></tr><tr><td style="vertical-align:bottom;width:25.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 0pt 36pt;">Michael Kelliher </p></td><td style="vertical-align:top;width:24.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span><span style="font-family:'Segoe UI Symbol';"> </span>FOR</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span> WITHHOLD</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">The Board of Directors recommends you vote &#8220;</b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">FOR</b><b style="font-weight:bold;">&#8221; the following proposal:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">2. &#160;RATIFICATION OF THE SELECTION OF ROSE, SNYDER &amp; JACOBS LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2024</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span><span style="font-family:'Segoe UI Symbol';"> </span>FOR</p></td><td style="vertical-align:top;width:14.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span><span style="font-family:'Segoe UI Symbol';"> </span>AGAINST </p></td><td style="vertical-align:bottom;width:35.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span>ABSTAIN</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">The Board of Directors recommends you vote &#8220;</b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">FOR</b><b style="font-weight:bold;">&#8221; the following proposal:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">3. &#160;APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span><span style="font-family:'Segoe UI Symbol';"> </span>FOR</p></td><td style="vertical-align:top;width:14.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span><span style="font-family:'Segoe UI Symbol';"> </span>AGAINST </p></td><td style="vertical-align:bottom;width:35.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span>ABSTAIN</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">The Board of Directors recommends you vote &#8220;</b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">FOR</b><b style="font-weight:bold;">&#8221; the following proposal:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">4. APPROVAL OF AN AMENDMENT TO THE CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF THE COMPANY&#8217;S COMMON STOCK FROM 50,000,000 TO 100,000,000</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:10%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:14.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:bottom;width:35.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span><span style="font-family:'Segoe UI Symbol';"> </span>FOR</p></td><td style="vertical-align:top;width:14.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span><span style="font-family:'Segoe UI Symbol';"> </span>AGAINST </p></td><td style="vertical-align:bottom;width:35.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span>ABSTAIN</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Dated:<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>, 2024</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Signature</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;margin:0pt;">Signature of jointly held</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Mark, sign and date your proxy card and return it in the postage-paid envelope provided.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">The proxy statement and proxy card are available at</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.27;text-align:center;margin:0pt;"><b style="font-weight:bold;">https://www.capricor.com/investors/sec-filings</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>capr-20240514xpre14a002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 capr-20240514xpre14a002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ") 5X# 2(  A$! Q$!_\0
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M4*RKPYK6>J:?1K1A1116!T!1110 4444 %%%% !1110 4444 %%%% !1110
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M[#"3CR2G?3FEK\SVJBO@*Z_X*[^$DNG6V^'^LRVX/RR2WD2.1ZE0"!^=>O\
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M48:U*J:\MP]I-Z1C]Y^B\,T=S#'-$ZRQ2*'1T.58$9!![BOR,^"_A.;_ (*
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M\$^?B[I7Q*_9Q\.:7;SQ+K/AJW72[ZS5OGC"$B%\=<.@!SZAAVKZ*UW7-/\
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M^T[]WRC'^M3'XU]@TL;.,Z\I1=UI^2"BG&FDPHHHKB-PHHHH **** "BBB@
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(4 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>capr-20240514xpre14a009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 capr-20240514xpre14a009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %_ JP# 2(  A$! Q$!_\0
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MC^R+'_GRMO\ OTO^%7** *?]D6/_ #Y6W_?I?\*/[(L?^?*V_P"_2_X5<HH
MI_V18_\ /E;?]^E_PH_LBQ_Y\K;_ +]+_A5RDS0!4_LBQ_Y\K;_OTO\ A1_9
M%C_SY6W_ 'Z7_"N8\4_&+PAX-\26?A[4M6SX@NXC<0Z38VTUY=F($ RF&%'=
M8P2/G8!?>MSPQXMT;QIH\6K:#J5MJ^F2LZQW=G()(G*L5;##@X8$?4&@"W_9
M%C_SY6W_ 'Z7_"C^R+'_ )\K;_OTO^%6@P.:-XH J_V18_\ /E;?]^E_PH_L
MBQ_Y\K;_ +]+_A5K=1O'_P!>@"K_ &18_P#/E;?]^E_PH_LBQ_Y\K;_OTO\
MA5K<*-PH J_V18_\^5M_WZ7_  H_LBQ_Y\K;_OTO^%6M_L:-XH J_P!D6/\
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M%C_SY6W_ 'Z7_"C^R+'_ )\K;_OTO^%7** *?]D6/_/E;?\ ?I?\*/[(L?\
MGRMO^_2_X5<HH I_V18_\^5M_P!^E_PH_LBQ_P"?*V_[]+_A5RB@"G_9%C_S
MY6W_ 'Z7_"C^R+'_ )\K;_OTO^%7** *?]D6/_/E;?\ ?I?\*/[(L?\ GRMO
M^_2_X5<HH I_V18_\^5M_P!^E_PH_LBQ_P"?*V_[]+_A5RB@"G_9%C_SY6W_
M 'Z7_"N/\80):ZG$D$$<:F$$A% &=S5WE<3XU_Y"L7_7$?\ H34 =7I'_()L
MO^N"?^@BK=5-(_Y!-E_UP3_T$5;H **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ IK?G3J* /E+P'I^M?!O]JSXQ:[XKT'7-
M4TGQD-/GT37M(TBXU&.&*"-T>TD$".\1#,&&X!3R<U6\?>"8I?V@M-U[Q9X'
MU37OA9-X:NOLFD0Z-)J*6>KR70DDEEM85D*R2H6(E*_*21N4FOK7:#VHP!VH
M _/'P#\.?B-X,U'X3>*9=!UNX^(&C6O]F7PFTZ>8G2[N6=$2XN@ACDDMP;1F
M&\LJA^.#CD/#'P!E\8:%\/O#P\%7NE:I<^)?$@U#6_$O@"^NQ':W!D%O-,S)
M#\S!D9'>3"M@D<$5^GN!Z4;1Z4 ? OPH^"VE?#G]J?QS#K'@_5/$'ABVTK2+
M*RUC5/!EW>2W]Q#:RQW$R7BPF,=2)!@^;N0 G;AN@\+? K4_!B3V%GH>HZC\
M-=0\.W][HYM[!X==\,WTUOY=S:VPE4/&)22Z [-K KC')^VMH]*,#TH ^,_A
M+9^-O 6D^+/",OAJ/4)+TV6BZ3XAT_P]?Z);W,9\XRBYA6*5;=HP[DW,:>4S
M2H<L0QK.TG0+SQ3^Q)XT\&>-O FKZGXJ\&6&IZ+I277AZ\N3>/Y<L=E<6>^
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MU 'RAX.^%47A?]LWQG:P>'[E_!>LVMGXL%U+H4OV2+7(S)$PCNC'Y>[RV67
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M&_$O@Z_\/:]/'?WTLEII]RNFX%XX#;YOF@:8.)5MY#O56(Q\M>X[1Z4;1Z4
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M/2C % "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/3_GK/\ ]_F_QH M455_L]/^>L__ '^;_&C^ST_YZS_]_F_QH M455_L]/\
MGK/_ -_F_P :/[/3_GK/_P!_F_QH M455_L]/^>L_P#W^;_&C^ST_P">L_\
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M@FR_ZX)_Z"*L[1G-5M(_Y!-E_P!<$_\ 015N@!NP8[T;13J* &[10$ -.HH
M;M%*.!2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5Q/C7_D*Q?]<1_Z$U=M7$^-?^0K
M%_UQ'_H34 =7I'_()LO^N"?^@BK=5-(_Y!-E_P!<$_\ 015N@ HHHH ****
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MIT;72!KP8SF(9^?@]LT ;U%9.F>+-%UK4M0T[3]5L[V_T]Q'>6UO.KR6[$9
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MHVCB^S]E*SJ?M&!D^7S\W'/&:OT %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4A[4M(: .0^+H'_"J/&A_Z@M[_P"B'K\7Z_:#XN_\DH\:?]@6
M]_\ 1#U^+]?;\.?#5^1\YFOQ0"BBBOL3P@HHHH$?3/\ P3V /[0/3_F$W/\
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M .?E/^_7_P!>K5% %7R;O_GY3_OU_P#7H\F[_P"?E/\ OU_]>K5% %7R;O\
MY^4_[]?_ %Z/)N_^?E/^_7_UZM44 5?)N_\ GY3_ +]?_7H\F[_Y^4_[]?\
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M .?E/^_7_P!>K5% %7R;O_GY3_OU_P#7H\F[_P"?E/\ OU_]>K5% %7R;O\
MY^4_[]?_ %Z/)N_^?E/^_7_UZM44 5?)N_\ GY3_ +]?_7H\F[_Y^4_[]?\
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M2W_QNCS=0_Y];;_P);_XW0!=HJEYNH?\^MM_X$M_\;H\W4/^?6V_\"6_^-T
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MZ/-U#_GUMO\ P);_ .-T 7:*I>;J'_/K;?\ @2W_ ,;H\W4/^?6V_P# EO\
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M= %VBJ7FZA_SZVW_ ($M_P#&Z/-U#_GUMO\ P);_ .-T 7:*I>;J'_/K;?\
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M0 4444 %(:6D- '(?%W_ ))1XT_[ M[_ .B'K\7Z_:#XN_\ )*/&G_8%O?\
MT0]?B_7V_#OPU?D?.9K\4/0****^Q/""BBB@#Z9_X)Z?\G G_L$W/_H4=?IL
M*_,G_@GI_P G G_L$W/_ *%'7Z;"OSC//]\?HCZO+?X/S%HHHKYX]4**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH ***0C(H \E_:"UB.[\ ^)='DU:_P#"
M"16J7+^(I$>*Q55=6,3SJZ%0^-C$,I 8X85R.B?$6RN[+X#7JZW/HUMJ]Y/:
MI976J[UOL6<X4;V(-P-ZH4;^+*'&2*^A984FC:.11)&P*LK#((/4$4JQA%"J
M JC@ #@4 >+>&?$>CZ+\6_%M[+X_M-;TRY,<$Z7.J#R]'O3*L4=EM$GDHSY7
M:A19=P.2^[CRG6_&&I1ZOJ"R^*M1MX%U%D\9E=0E3^R+;^U%6+Y0_P#HBFU_
MY:)MS$3+G^*OK75-'M=9MEM[M&DA$B2[ [+DHP90=I&1D#*G@C(((-6]@SG)
MH ^3)?%GB :;X(-WKVHPZY-;6C:#;"\D5M4)U$+(73=BX/V/:SAPVU69^"-P
MZOXH^.8[_P >:<=$\4&2[#V<&B6FFZ@?*O+I;\1W\11&V3LD(8.C F,!F^4C
M(^B-OO533=(MM)ADBM4*+)*\SEG9V9W8LQ+,2>IXYX& ,  4 ?(W_"8ZM_:&
MK+J?BG48-/%^Z>,99+^6 :0@U5UB5<.#:H;;8-R;<Q;9<_-N/T5\$+W5M3^%
M'AFYUQYI=1DLPSRW'^MD3)\MW_VF38QSW8UW6RDVX'4F@#Y$^(D/CK5?B)J.
MCV@^)>E>![=YI]0U2W"7,NIEG8FTLX@O[J$#(\USNQM"+_&/KFW 6%  0
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MXT_[ M[_ .B'K\7Z^WX=^&K\CYS-?BAZ!1117V)X04444 ?3/_!/3_DX$_\
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M%\7]E^(KBTN+RXOM<U-?##S221"<FQTRR$4&9XG9A++*F_:H.YU=LK]BV_\
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MX_\ '/\ XJC[;)_SYW'_ (Y_\55JB@"K]MD_Y\[C_P <_P#BJ/MLG_/G<?\
MCG_Q56J* *OVV3_GSN/_ !S_ .*H^VR?\^=Q_P".?_%5:HH J_;9/^?.X_\
M'/\ XJC[;)_SYW'_ (Y_\55JB@"K]MD_Y\[C_P <_P#BJ/MLG_/G<?\ CG_Q
M56J* *OVV3_GSN/_ !S_ .*H^VR?\^=Q_P".?_%5:HH J_;9/^?.X_\ '/\
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M?^.?_%4?;9/^?.X_\<_^*JU10!5^VR?\^=Q_XY_\51]MD_Y\[C_QS_XJK5%
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M]_\ 1#U^+]?;\._#5^1\YFOQ0] HHHK[$\(**** /IG_ ()Z?\G G_L$W/\
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MT@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+3?V?-&643ZQ?7NLS=2'D**?R^;]:[G2/!>AZ"BC3]*M;4C^)8P6_%CDG\Z
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M?99'3A6S&C3J).+>SVV/"/\ AK+XK?\ 0UG_ ,%]K_\ &J/^&LOBM_T-9_\
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MY2_;W_Y%[PC_ -?4_P#Z M?47]J6O_/=/SKY8_;PNX;CP_X3$4BOMNI\X/\
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MF\4Z1/HNFPS2-:</NG8J,CIV&/2OI+PUX N-/UMM9UG4GUG4@GEQNR;5B'?
M_/TZGUKPC]O;_D7O"/\ U]3_ /H"U\)G-54<#4J.*=K:/;='V&2TO;YA2I\S
M5V]5OLSYL'C71=)&W2=$0$=)9\;OZG]:S=0^(NLWJE4F6TC/\,"@'\^OY5S-
M%?C]3-\947*I\J[122_ _::>3X.F^:4.9]Y-M_B2W%Y/=N6GFDF8]6D8L3^=
M1445Y,I2F[R=V>O&,8+EBK(3%?;O[!__ "3[7_\ L*'_ -%1U\1U]N?L'_\
M)/O$'_84/_HJ.OJN&/\ D8Q]&?(<6?\ (M?JCZ:'4TZFCJ:=7[,?B84444 %
M%%% !1110 4444 <W\2O^2=^*/\ L%W7_HIJ_%.OVL^)7_)._%'_ &"[K_T4
MU?BG7VO#FU3Y?J?.YK\4/F%%%%?9G@A1110!]'_L _\ )Q5C_P!@ZZ_]!%?J
M#7Y??L _\G%6/_8.NO\ T$5^H-?G&>_[W\D?599_ ^8AKY;_ &]/^1/\,?\
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MZX)_Z"*MU4TC_D$V7_7!/_015N@ HHHH **** "BBB@ HHHH **** "BBB@
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M /D:4/7]&?%E%%%?AA^^A1110 5]\_L3?\D8;_L)S_R2O@:OOG]B;_DC#?\
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M=K'XU_\ "5Z)_P!!BP_\"D_QH_X2O1/^@Q8?^!2?XU^RG_#+'P6_Z)#X#_\
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M_P#0PZ5_X&Q?_%4?\)UX;_Z&#2O_  -C_P#BJ_4,?LL_!<?\TB\"?^$U9?\
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M3_\ 14/!G_A06G_QRJ7_  RQ\%\_\DA\!_\ A,V7_P :H_X98^"W_1(? ?\
MX3-E_P#&J^M/CR[_ ,-&_"?_ **AX,_\*"T_^.4?\-&_"?\ Z*AX,_\ "@M/
M_CE4O^&6/@M_T2'P'_X3-E_\:H_X98^"W_1(? ?_ (3-E_\ &J +O_#1OPG_
M .BH>#/_  H+3_XY1_PT;\)_^BH>#/\ PH+3_P".52_X98^"W_1(? ?_ (3-
ME_\ &J/^&6/@M_T2'P'_ .$S9?\ QJ@"[_PT;\)_^BH>#/\ PH+3_P".4?\
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MX3_]%0\&?^%!:?\ QRC_ (:-^$__ $5#P9_X4%I_\<JE_P ,L?!;_HD/@/\
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MN(_]":@#J](_Y!-E_P!<$_\ 015NJFD?\@FR_P"N"?\ H(JW0 4444 %%%%
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M2:* "BBB@ HHHH **** "BBB@ HHHH **** "DI:* $*@G..:6BB@!",C!H
MQ2T4 %%%% !1110 5Q/C7_D*Q?\ 7$?^A-7;5Q/C7_D*Q?\ 7$?^A-0!U>D?
M\@FR_P"N"?\ H(JW532/^039?]<$_P#015N@ HHHH **** "BBB@ I*6D- "
M%@*4'(S7R[^UG\1?C)X,\6:+;_#72]3O].FLFDNGL=%-\JR[R "P1L';CC(]
M:\+'QW_:MQ_R+OB#_P )(_\ QFO4HY?4KTU44XJ_=ZG#4Q<:<G%Q?W'Z+9I"
MP'6OSJ_X7O\ M6_]"[X@_P#"2;_XS7M'[*?Q*^-?C+Q_J5G\2=*U2PT6/3'E
M@DOM#-BAN!+$ H?RUR=I?Y<]B>U.KEU2C!U'.+2[/4*>+A4DHJ+^X^K=XIU?
M.'P9UO1=8UMEUG7[V;XK6NH7LNJ^'X-2?S8HQ)((Q):LV%MA&8MDFT*Q*'<2
MV*X;1OVO_&FN:>9(Y_!=A#=7=K$-4OHYTATB26&Z>?3[J(S@RW=K]GC:3$D.
M5F7*19!/E'<?9%%?(5A^V%X@O?AY::O<ZIX$T6[EURPL+S4=0FE6RTRUO-.C
MNHI9$\X%BLDC)EI(U?RR 4)RNE<_M2^-K/6/"EK-IOAFS@O= FU6XGU&=K:/
M467SQYEHQD++$@ABE?Y)2([A264+N8 ^JZ:7 _/%?#Z_MO\ BF!=/AOO$OPW
M@N;W3=*UE?LZM(ZQ70E\RUCB>^C-Q*IC1@RL&VR "%SC+Y?VO/$_B365M[+Q
MMX%TRQM?$.GI->?9SB"TF^UJT%V/MI,3B2WC0L_E,3,F8UR X!]O!LTM?(%]
M^U9KFD?#'P-JVC2>%;>\U339[];>]>:>WUBXCN1&VFV4_G!EN#EB&82GC_58
M!QUW[.O[2FL?%#5=/B\1:EX/\K5/#IUV&VT&9V>S\NX:"99)'E82#<N<A$V$
M,AWXW$ ^CRP!HWC]<5\M_P##0EII?QAT7Q5<ZQ9GX=^+1<Z#I5]_;-N]I<74
M!+0M&HD.TL\=S&Q('S/"IP<"L;5_V@_&^M0^#[K2O'O@.TCOO$]OI^I10Z9/
M*^C^;:W+BPOPUVNV9)8HXB<Q,[NO[N/[K@'U\3BDW8KX.\3?\%!-4TK1M+2+
MQ-\/8=?GT.WO;FSNHW MM019S=VKAKU C9BC549@Z%^1*2JGH-&^*]EX@^(^
MAMHOQ!MII;[X@7D%K$VL&ZM7671&D6,QK*/-B68Q[4! !8 $$B@#[1+8[4;O
M:O%_A3XV\9>*(-53QY-HFFPZ):2V.OI:Z;<6:"]#LQD@N)+AA]G%OL;."27!
MWIM*#Y^^&'C77OAW\%S\2K#QOX?M]&U*VM]*M&U759M6LWNA<RYNKEY9H%@?
M9MC\M9@O<N2%! /NG=[&C=7R'X%_:YN?%7PY\1^*DO/"FGWJR:''/J"74EY9
M:6MW;1&2XNT\U=J1R-*NT/&/DPSY#,.@^#GB>Z\2_ KP5I\WB<:^-4\07>EZ
MCK.GW;MYT:3W#$))O=D#B-5'SDA6P&[T ?3@<&C?7PS91Q7/PF^)GCBU\:6%
MGX-T^QU^P%U:^*[BZ>ZNO-S9EV9@ELT1"A CLS^:HZ8!Z7PYX^T6[^%FD3V?
MB+3F\,KKMN/%U]X:\1W&JVUE9O P4RWI(,(+I$9L;1&K$MM5MQ /L'<*4'(S
M7S+\//$%[;Z_/J?A[5[G5_ DGBJWT[P].UTUQ#>6D]JGVH12LQ\Z*.=6=),G
M&R0*Q6OIE.E #J:6QVIU,?!%(!0X.:-U?-/[0WC_ .+/ACQ[%:>"=/U&YT<V
M4<C/::2;I/-+.&&_8W. O&?YUYC_ ,+@_:)_Z ^M?^$Z?_C5?/5\[HX>K*E*
MG)M=EH?14,DK8BE&K&I!)ZZRLS[DW4!P?6OAH_&#]H@\?V/K7_A.M_\ &J]#
M^'?CKXR>(?AY\29=4T^_A\06NE[M#6XTLVS/<%)?N JN]@0G'KCUJ\-G-+%5
M8T8PDF^ZT(Q635L)2=:=2#2Z*5WV/J+>*7.:^;-$^(7@WPQ\.-=\8_#[7K[Q
M;/IFDI]N$VH37\%K,S*6DNHV;?',@)>2+*,$0@A,J:XK4/VO_&>GZKHMA%J7
MP_U&UN4NI%UV%IEMM52/4+.UCEMHQ<,(T873C=YDP+028R%P??/ /LFBOCSQ
M?^U]XNT2S\+1V5]X&:\U"PUIMUSYV=7U'3[R.!;*SA6;*27 ;Y%+RL&<<,$P
M]OXB?M<^,/!7BCQ?;_9/!]A8://9P+9Z[?FUNK823VZ&:<K(Y,3I-(5?RHU4
MQ_>EY  /KBFEL'%?&%]^VGKVA:UJ>G:CXD\!7$NAC4H;Y;"WD>>YE@$S)((/
MMID@B58E+D"?JV3$,,<#Q+^UWXLN_ Z>(U\6> ;RQCT;Q%'<6L(:.UU&[M6B
M$*QS17LA1VBF5Q$KNQPV'&\-& ?>%(3@9KX\^-O[8WB7X;W^NKH">%'ATK3H
MYX=+UIYH[B\A>R-PNIQ3K)M:U$F+?8(R6D&/.4L%'I?PI_:+BU?1/B/=^-/$
M'A1(?"%_%'+JFDS^1:?9Y;2"XC+>9*^"'E>+?N <Q\*IRH /> P:D+ '%?*'
MAOXW:I\.?$/CJQUB>*34]>TU?%GAW2[[5(KJ23$7EW A6-V8P 1+.$7G!FV]
M.,_Q#^T+XZLY;35-+\??#[7+)?#NI:C#)INESRV6LR6TX+&V;[:"&6#(8*TP
M1DD)+8PH!]@9XH!S7P]J/[>1F^(>I:%;^-?A]<Z#;ZY;6?VB&7RI;G3KD6P$
ML,YO=OF0F>3<Z)(&\EB4B )K1^#GQ&U_7='TI? WB_3M>\7O\.K>[M;35[Q]
M1@FGAO&29GB2=&9S@QEPP(8KNSC! /M L!2;A7SSX^^(L_B;]G#QWXLU75;7
M2_#\UIOTF>2*?1IXMJHK&:1Y2P)N X4A4^7:,/D%O//$'Q<U[]G#2-!DF\3>
M%+?3_$UZ=4M;+4]2FO[:.Q M4:*UO9YH-S-YKS;MLF,X6(KEP ?9.\?A1N]C
M7P_\3_VE]5U#]GJ[DT_6?#WA>?7+CQ+:MXCBNY[FRBFM99?)M8)A-&PN;A/G
MC<L%Q&Y6(@J@]>\=^*M/\1Z;HEK?:^EOX0;P9=>(VU*WU!H([MT%ND4AN489
MC43%^&PQ=#R!0!]!;Q]!ZT!P?QKX[U_5;;3/!GB%-9URZN=,T[P1?WN@^,?[
M7ECMM0LW\K[(3.L@1[B)GV%\[F#QMD[Z=X5^(&DWGP?L;C3_ !#IDNAIK-D/
M%=[X;\23ZM!9V+Q8+2WC$&'+*IEQM\M22< [B ?86[K0&!->+? [Q'9HOCV_
ML-:COOAE;7:3:)K%S>^=;^4+=6NC'<NQWP+(&P^X@'> <+7F_P#PN/6;/XDO
MJ^DZ_I%EI_Q!TR2U\*SZWJ4=WIMU?VSL;8PQ13JP$L<NQPI4EECZDX(!]9T5
M\O\ C7]H3X@>&/ VA>((E\-PKK5[';0'6K&33XH&2']]#*\EV 'EG61(B,[0
M!A)B1GC_ !;^V7XJT+PAJWB'^W/A]8?9=;U#3(=,N%DD+?9&+-$]P]W"HGDC
M:/:@0L#R$DWA4 /M"F[O8U\JC]J?Q!??$?QKIVEZOX,UBPT/3M0O+;P[9[7U
M:X:",&';(+XLX?EV_P!%0*N &<$.>Q^$7Q)USQJW@/7=1N]-N[G78[^TNSH4
MYDT^XCAR\-S"/,D"G^!@LCX9RI8[> #WH4M(HP*6@ HI"<"O*=2\6_%!-0N5
ML_"M@;59&$1=MS%<\$GS1G\A0!ZM1FO#]8\9>.\6T?B&WC\,V$DH5KRQB+MT
MS@_O&_I3]%\:?$J;3H6TS1[;5[+D1WERA5Y!GK_K%_E^= 'MI.!2;N<5X_K7
MB+7[WX>^,'\?6-IX<TBWTR6;^T([LVH0A<@EQ+E<'G.X>E<)X3\0:CX8NKFZ
MCM=2\;RZ'X3O-2\/:G;7<DT.OV68FMH]P8I)<+DQLV"Q#H_.^@#Z;+@&C>*^
M6_A=\<?&OCCQI\+FU3Q+X231-=M=6$R:3;%X]2F@-N8Q#+]K=5?;*^8P9"IA
MESG.(^K^#'Q1\&)XI\?>'[/Q9I^K>*#XAOI$T--7%S>"-$0X6(NS1H"&'0*#
MQ0![W17Q8/VS?%K:')J#ZGX)M;-KFT(OY+9Q]GDE60S:2T$E['YE_ 40OMD#
M;9D(@S@-[;\-OC)J/B_XS>-/"MUJF@75GI*[K>RTN,/=6H#["+J3[2Q5R03L
M>"+'9G )H ]FHI <C-+0 4444 %%%% !1110 5Q/C7_D*Q?]<1_Z$U=M7$^-
M?^0K%_UQ'_H34 =7I'_()LO^N"?^@BK=8&F^)M-@TZUC>YVND2*P\MN" /:K
M/_"5:7_S]?\ D-_\* -:BLG_ (2K2_\ GZ_\AO\ X4?\)5I?_/U_Y#?_  H
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M\*/^$JTO_GZ_\AO_ (4 :NT>E&!Z5E?\)5I?_/U_Y#?_  H_X2K2_P#GZ_\
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MC,MU8*XMBSG;&7&&8+G&[&1G&0"P[FM,#%97_"5:7_S]?^0W_P */^$JTO\
MY^O_ "&_^% &M2;1Z5E?\)5I?_/U_P"0W_PH_P"$JTO_ )^O_(;_ .% &KM'
MH*-H]!65_P )5I?_ #]?^0W_ ,*/^$JTO_GZ_P#(;_X4K(#4V#T% 11V%9?_
M  E6E_\ /U_Y#?\ PH_X2K2_^?K_ ,AO_A18#5P/2@*!VK*_X2K2_P#GZ_\
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MI]Y<P;KNPE,MM,C%7C)&&&1U4C@J>#@9' IG_"5:7_S]?^0W_P */^$JTO\
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M^O\ R&_^%'_"5:7_ ,_7_D-_\* -:D Q65_PE6E_\_7_ )#?_"C_ (2K2_\
MGZ_\AO\ X4 :<L*3(5D19%/56&0:<JA5    Z 5E?\)5I?\ S]?^0W_PH_X2
MK2_^?K_R&_\ A0!JD T8'I65_P )5I?_ #]?^0W_ ,*/^$JTO_GZ_P#(;_X4
M :N!1@>E97_"5:7_ ,_7_D-_\*/^$JTO_GZ_\AO_ (4 :N!1@'M65_PE6E_\
M_7_D-_\ "C_A*M+_ .?K_P AO_A0!J]*6LG_ (2K2_\ GZ_\AO\ X4?\)5I?
M_/U_Y#?_  H UJ*R?^$JTO\ Y^O_ "&_^%'_  E6E_\ /U_Y#?\ PH UJ*R?
M^$JTO_GZ_P#(;_X4?\)5I?\ S]?^0W_PH UJ*R?^$JTO_GZ_\AO_ (4?\)5I
M?_/U_P"0W_PH UJXGQK_ ,A6+_KB/_0FKH/^$JTO_GZ_\AO_ (5ROBG4[:_U
2".2"3S$$04G:1SD^H]Z /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>capr-20240514xpre14a010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 capr-20240514xpre14a010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %_ JT# 2(  A$! Q$!_\0
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M &18_P#/E;?]^E_PH_LBQ_Y\K;_OTO\ A5K<* X/3F@"K_9%C_SY6W_?I?\
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M10!3_LBQ_P"?*V_[]+_A7,>-+6*T^Q^1;Q1;M^[8@&?NXKLZY3QUULO^!_\
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MQ#!X3\36^F72>![W3)]*O)6_T475Y+NC9V(?8^V+8">N\&OU3"@=!BC:/04
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M^&K+Q#'/I6LW%Y<:WH^@3ZC%IJM 4CEDVPR)]_&5/..>.#7V$  ..*" >HH
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MQ2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5RGCKK9?\#_\
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M/3_GK/\ ]_F_QH M455_L]/^>L__ '^;_&C^ST_YZS_]_F_QH M455_L]/\
MGK/_ -_F_P :/[/3_GK/_P!_F_QH M455_L]/^>L_P#W^;_&C^ST_P">L_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHI%8,,@@CU% "T444 %%%% !7*>.NME_P #_P#9:ZNN4\==;+_@?_LM '0:
M1_R";+_K@G_H(JW532/^039?]<$_]!%6Z "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD+8H 6BO)?B/^U'\/?A
M/XE;0?$VJSV.I+$D_EI9RR@HV<'**1V-<Q_PW=\&_P#H8KG_ ,%MQ_\ $5V0
MP>(J14HTVT_(YWB*479R5SZ!HKY^_P"&[O@W_P!#%<_^"VX_^(H_X;N^#?\
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M'_[+75URGCKK9?\  _\ V6@#H-(_Y!-E_P!<$_\ 015NJ>D_\@FR_P"N"?\
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M>B/B,3_&GZA1117HG,%%%% 'Z#_\$T_^2?>+_P#L*1_^BA7V37QM_P $T_\
MDGWB_P#["D?_ **%?9-?EV;?[[4]?T1]E@?]W@%%%%>0=P4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2WGG4J!C>D8^7H"SD=>.B^'GP^7P)#J+RZC/K&I:A+')<WTZ*C,(XDAB4*O
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M!R?]@NV_]GKYJK]8R[_<Z7HCXC$_QI^H4445Z)S!1110!^@__!-/_DGWB_\
M["D?_HH5]DU\;?\ !-/_ ))]XO\ ^PI'_P"BA7V37Y=FW^^U/7]$?98'_=X!
M1117D'<%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ/-U#_GUMO\ P);_ .-T 7:*I>;J'_/K;?\ @2W_ ,;H\W4/^?6V_P# EO\
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MO^3@Y/\ L%VW_L]?-5?K&7?[G2]$?$8G^-/U"BBBO1.8**** /T'_P"":?\
MR3[Q?_V%(_\ T4*^R:^-O^":?_)/O%__ &%(_P#T4*^R:_+LV_WVIZ_HC[+
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MN)7/?=ALG/(!ZC-=4.@H KO=NCE1:S.!W&W!_P#'J3[;)_SYW'_CG_Q56J*
M*OVV3_GSN/\ QS_XJC[;)_SYW'_CG_Q56J* *OVV3_GSN/\ QS_XJC[;)_SY
MW'_CG_Q56J* *OVV3_GSN/\ QS_XJC[;)_SYW'_CG_Q56J* *OVV3_GSN/\
MQS_XJC[;)_SYW'_CG_Q56J* *OVV3_GSN/\ QS_XJC[;)_SYW'_CG_Q56J*
M*OVV3_GSN/\ QS_XJC[;)_SYW'_CG_Q56J* *OVV3_GSN/\ QS_XJC[;)_SY
MW'_CG_Q56J* *OVV3_GSN/\ QS_XJC[;)_SYW'_CG_Q56J* *OVV3_GSN/\
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M52WD0PQ;BKKD)&BYSQW(!WE<IXZZV7_ _P#V6NKKE/'76R_X'_[+0!T&D?\
M()LO^N"?^@BK=5-(_P"039?]<$_]!%6Z "BBB@ HHHH **** "BBB@ HHHH
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M=I_S\)^= %JBJO\ :=I_S\)^=']IVG_/PGYT 6J*J_VG:?\ /PGYT?VG:?\
M/PGYT 6J*J_VG:?\_"?G1_:=I_S\)^= %JBJO]IVG_/PGYT?VG:?\_"?G0!:
MIJ]:K_VG:?\ /PGYTBZG:Y_UZ?G2 _,__@H-_P G!R?]@NV_]GKYJKZ3_P""
M@4JS?M NR$,ITJVP1T/+U\V5^L9=_NE+T1\1B?XT_4****]$Y@HHHH _0?\
MX)I_\D^\7_\ 84C_ /10K[)KXR_X)M7,5O\ #WQ:9'";M43&3_TR%?8?]IVG
M_/PGYU^79M_OM3U_1'V.!_W>!9/2OF;]N_\ Y)SX?_["H_\ 1,E?1YU.TQ_K
MT_.OFO\ ;INX;GX=Z L<BN1JHR!_URDKXO/?^1;6]/U/K<A_Y&=#U_0^)C10
M:*_"C]_"BBBD 5ZW^R=_R<!X4^MS_P"DLU>25ZS^RG*L/Q]\*N[!5!N<D_\
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MHHK]M/PP**** "BBB@ HHHH **** "BBB@ KE/'76R_X'_[+75URGCKK9?\
M _\ V6@#H-(_Y!-E_P!<$_\ 015NJFD?\@FR_P"N"?\ H(JW0 4444 %%%%
M!1110!Q?B#XU_#WPEK%QI.N>._#.BZI;[?.LM0UBW@GCW*&7<CN&&58$9'((
M/0UG_P##1OPG_P"BH>#/_"@M/_CE3^)O@#\,/&NN7.M>(?ASX2U[6+K;Y^H:
MGH=K<W$NU0B[I'C+-A551D\  =!67_PRQ\%O^B0^ _\ PF;+_P"-4 7?^&C?
MA/\ ]%0\&?\ A06G_P <H_X:-^$__14/!G_A06G_ ,<JE_PRQ\%O^B0^ _\
MPF;+_P"-4?\ #+'P6_Z)#X#_ /"9LO\ XU0!=_X:-^$__14/!G_A06G_ ,<H
M_P"&C?A/_P!%0\&?^%!:?_'*I?\ #+'P6_Z)#X#_ /"9LO\ XU1_PRQ\%O\
MHD/@/_PF;+_XU0!=_P"&C?A/_P!%0\&?^%!:?_'*/^&C?A/_ -%0\&?^%!:?
M_'*I?\,L?!;_ *)#X#_\)FR_^-4?\,L?!;_HD/@/_P )FR_^-4 7?^&C?A/_
M -%0\&?^%!:?_'*/^&C?A/\ ]%0\&?\ A06G_P <JE_PRQ\%O^B0^ __  F;
M+_XU1_PRQ\%O^B0^ _\ PF;+_P"-4 7?^&C?A/\ ]%0\&?\ A06G_P <H_X:
M-^$__14/!G_A06G_ ,<JE_PRQ\%O^B0^ _\ PF;+_P"-4?\ #+'P6_Z)#X#_
M /"9LO\ XU0!=_X:-^$__14/!G_A06G_ ,<H_P"&C?A/_P!%0\&?^%!:?_'*
MI?\ #+'P6_Z)#X#_ /"9LO\ XU1_PRQ\%O\ HD/@/_PF;+_XU0!=_P"&C?A/
M_P!%0\&?^%!:?_'*/^&C?A/_ -%0\&?^%!:?_'*I?\,L?!;_ *)#X#_\)FR_
M^-4?\,L?!;_HD/@/_P )FR_^-4 7?^&C?A/_ -%0\&?^%!:?_'*/^&C?A/\
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MLK'CU,MC4FYN6Y^-?_"5Z)_T&+#_ ,"D_P :/^$KT3_H,6'_ (%)_C7[*?\
M#+'P6_Z)#X#_ /":LO\ XU1_PRQ\%O\ HD/@/_PFK+_XU71_K%4_Y]K[S/\
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M_"=>&_\ H8=*_P# V+_XJC_A.O#?_0PZ5_X&Q_\ Q5?J)_PRS\&/^B1>!/\
MPFK+_P"-4?\ #+7P8_Z)'X$_\)JR_P#C5?&?ZGX?_GZ_P/N?]=*__/I?>S\N
M_P#A.O#?_0PZ5_X&Q_\ Q5'_  G7AO\ Z&'2O_ V/_XJOU$_X9:^#'_1(_ G
M_A-67_QJC_AEKX,?]$C\"?\ A-67_P :H_U/P_\ S]?X!_KI7_Y]+[S\N_\
MA.O#?_0PZ5_X&Q__ !5>I?LP_$_P=HOQR\,WNH>+-#L;.(W.^XN=2ACC3-M*
M!EF8 <D#ZFOO+_AEKX,?]$C\"?\ A-67_P :I/\ AECX+_\ 1(O ?_A-67_Q
MJNC#\+4</6A6C4=XM/9=#FQ7%M;%4)T'224DUN^I<'[1OPG_ .BG^#/_  H+
M3_XY2_\ #1OPG_Z*AX,_\*"T_P#CE4O^&6/@M_T2'P'_ .$S9?\ QJC_ (98
M^"W_ $2'P'_X3-E_\:K[@^"+O_#1OPG_ .BH>#/_  H+3_XY1_PT;\)_^BH>
M#/\ PH+3_P".52_X98^"W_1(? ?_ (3-E_\ &J/^&6/@M_T2'P'_ .$S9?\
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M_P"-4?\ #+'P6_Z)#X#_ /":LO\ XU5_ZQ5/^?:^\7]E0_F9^-?_  E>B?\
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M'_#+7P8_Z)'X$_\ ":LO_C5?*?ZGX?\ Y^O[D?8?ZZ5_^?2^\_+O_A.O#?\
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M.52_X98^"W_1(? ?_A,V7_QJC_AECX+?]$A\!_\ A,V7_P :H N_\-&_"?\
MZ*AX,_\ "@M/_CE:WACXO^!/&VI_V;X=\:>'M?U#89?LFEZK!<R[!C+;$<G
MR.<=ZYS_ (98^"W_ $2'P'_X3-E_\:K;\(_ _P"'/P_U?^U?"_@'POX:U/RV
MA^VZ1HUM:S;#C*[XT!P<#(SC@4 =M1110 4444 %%%% !7*>.NME_P #_P#9
M:ZNN4\==;+_@?_LM '0:1_R";+_K@G_H(JW532/^039?]<$_]!%6Z "BBB@
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M\?[2WB[2K3Q9H%_J$&I&&RMO^$MFFOWO?L42R0IIX<IY8E:X+G)V,K JNTD
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MI>@:<=7B\00>>(=>MQ-$C"VA-S^Y :;R#)YLP$L+C:<[5 /M\MBDW5X?\?\
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M)_Z"*MU@:;XFTV#3K6-[G:Z1(K#RVX( ]JL_\)5I?_/U_P"0W_PH UJ*R?\
MA*M+_P"?K_R&_P#A1_PE6E_\_7_D-_\ "@#6HK)_X2K2_P#GZ_\ (;_X4?\
M"5:7_P _7_D-_P#"@#6HK)_X2K2_^?K_ ,AO_A1_PE6E_P#/U_Y#?_"@#5Q1
M@5E?\)5I?_/U_P"0W_PH_P"$JTO_ )^O_(;_ .% &KBC K*_X2K2_P#GZ_\
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M_P#GZ_\ (;_X4 :NT'M1M'H*RO\ A*M+_P"?K_R&_P#A1_PE6E_\_7_D-_\
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MPE6E_P#/U_Y#?_"C_A*M+_Y^O_(;_P"% &K@48%97_"5:7_S]?\ D-_\*/\
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M\*/^$JTO_GZ_\AO_ (4 :N*1P ,UE_\ "5:7_P _7_D-_P#"C_A*M+_Y^O\
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J/_V6M7_A*M+_ .?K_P AO_A7.^+=8M-1-K]GF\S9OW?*1C./4>U '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>capr-20240514.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.5.0.8 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/20/2024 9:14:14 PM-->
<!--Modified on: 3/20/2024 9:14:14 PM-->
<xsd:schema targetNamespace="http://capricor.com/20240514" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-roles="http://fasb.org/srt-roles/2023" xmlns:attributeFormDefault="unqualified" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:capr="http://capricor.com/20240514" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2023">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://capricor.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="capr-20240514_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="capr-20240514_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="capr-20240514_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/ecd-sub/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd" />
  <xsd:element name="EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" id="capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="EquityAwardsAdjustmentsMember" id="capr_EquityAwardsAdjustmentsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="EquityAwardsValueInCompensationTableForApplicableYearMember" id="capr_EquityAwardsValueInCompensationTableForApplicableYearMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" id="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" id="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" id="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>capr-20240514_def.xml
<DESCRIPTION>EX-101.DEF
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.5.0.8 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/20/2024 9:14:14 PM-->
<!--Modified on: 3/20/2024 9:14:14 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" />
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpAdjustmentsOnly" />
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="extended" xlink:title="Pay vs Performance Adjustments">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember" xlink:label="ecd_AllAdjToCompMember" xlink:title="ecd_AllAdjToCompMember" />
    <link:loc xlink:type="locator" xlink:href="capr-20240514.xsd#capr_EquityAwardsAdjustmentsMember" xlink:label="capr_EquityAwardsAdjustmentsMember" xlink:title="capr_EquityAwardsAdjustmentsMember" />
    <link:definitionArc xlink:type="arc" xlink:from="ecd_AllAdjToCompMember" xlink:to="capr_EquityAwardsAdjustmentsMember" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:ecd_AllAdjToCompMember To capr_EquityAwardsAdjustmentsMember" order="2" priority="0" />
    <link:loc xlink:type="locator" xlink:href="capr-20240514.xsd#capr_EquityAwardsValueInCompensationTableForApplicableYearMember" xlink:label="capr_EquityAwardsValueInCompensationTableForApplicableYearMember" xlink:title="capr_EquityAwardsValueInCompensationTableForApplicableYearMember" />
    <link:definitionArc xlink:type="arc" xlink:from="ecd_AllAdjToCompMember" xlink:to="capr_EquityAwardsValueInCompensationTableForApplicableYearMember" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:ecd_AllAdjToCompMember To capr_EquityAwardsValueInCompensationTableForApplicableYearMember" order="1" priority="0" />
    <link:loc xlink:type="locator" xlink:href="capr-20240514.xsd#capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" xlink:label="capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" xlink:title="capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" />
    <link:definitionArc xlink:type="arc" xlink:from="capr_EquityAwardsAdjustmentsMember" xlink:to="capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:capr_EquityAwardsAdjustmentsMember To capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" order="1" priority="0" />
    <link:loc xlink:type="locator" xlink:href="capr-20240514.xsd#capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" xlink:label="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" xlink:title="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" />
    <link:definitionArc xlink:type="arc" xlink:from="capr_EquityAwardsAdjustmentsMember" xlink:to="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:capr_EquityAwardsAdjustmentsMember To capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" order="2" priority="0" />
    <link:loc xlink:type="locator" xlink:href="capr-20240514.xsd#capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xlink:label="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xlink:title="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" />
    <link:definitionArc xlink:type="arc" xlink:from="capr_EquityAwardsAdjustmentsMember" xlink:to="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:capr_EquityAwardsAdjustmentsMember To capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" order="3" priority="0" />
    <link:loc xlink:type="locator" xlink:href="capr-20240514.xsd#capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" xlink:label="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_1" xlink:title="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xlink:to="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember To capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_1" order="1" priority="0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>capr-20240514_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.5.0.8 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/20/2024 9:14:14 PM-->
<!--Modified on: 3/20/2024 9:14:14 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
    <loc xlink:type="locator" xlink:href="capr-20240514.xsd#capr_EquityAwardsValueInCompensationTableForApplicableYearMember" xlink:label="capr_EquityAwardsValueInCompensationTableForApplicableYearMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="capr_EquityAwardsValueInCompensationTableForApplicableYearMember" xlink:to="capr_EquityAwardsValueInCompensationTableForApplicableYearMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="capr_EquityAwardsValueInCompensationTableForApplicableYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member presents the adjustment (deduction) for equity awards value from summary compensation table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="capr_EquityAwardsValueInCompensationTableForApplicableYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Awards Value In Compensation Table For The Applicable Year Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="capr_EquityAwardsValueInCompensationTableForApplicableYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deduct Option Awards</label>
    <loc xlink:type="locator" xlink:href="capr-20240514.xsd#capr_EquityAwardsAdjustmentsMember" xlink:label="capr_EquityAwardsAdjustmentsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="capr_EquityAwardsAdjustmentsMember" xlink:to="capr_EquityAwardsAdjustmentsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="capr_EquityAwardsAdjustmentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member presents the total equity awards adjustments, which may be comprised of adjustments for (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the change in fair value from the end of the prior fiscal year of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards granted in prior years that vest in the applicable year, the amount equal to the change in value as of the vesting date (from the end of the prior fiscal year); (iv) adjustments for equity awards that failed to meet performance conditions; and (v) dividends or other earnings paid on equity awards not otherwise reflected in fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="capr_EquityAwardsAdjustmentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Awards Adjustments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="capr_EquityAwardsAdjustmentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Equity Awards Adjustments</label>
    <loc xlink:type="locator" xlink:href="capr-20240514.xsd#capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" xlink:label="capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" xlink:to="capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member presents the adjustment (deduction) for equity awards value from summary compensation table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Awards Adjustments Year End Fair Value Of Awards Granted In Current Year [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Year-End Fair Value of Outstanding and Unvested Equity Awards Granted during the Year</label>
    <loc xlink:type="locator" xlink:href="capr-20240514.xsd#capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" xlink:label="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" xlink:to="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member presents the equity awards adjustments on the change in fair value from the end of the prior fiscal year of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Awards Adjustments Change In Fair Value As Of Year End Of Outstanding And Unvested Awards Granted In Prior Years Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in Fair Value of Outstanding and Unvested Equity Awards</label>
    <loc xlink:type="locator" xlink:href="capr-20240514.xsd#capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xlink:label="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xlink:to="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member presents the equity awards adjustments on the change in fair value (as of vesting date) of awards vested during current year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Awards Adjustments Change In Fair Value As Of Vesting Date Of Vested Awards During Current Year Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year</label>
    <loc xlink:type="locator" xlink:href="capr-20240514.xsd#capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" xlink:label="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" xlink:to="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member presents the equity awards adjustments on the change in fair value (as of vesting date) of prior year awards vested during current year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Awards Adjustments Change In Fair Value As Of Vesting Date Of Prior Year Awards Vested During Current Year Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>capr-20240514_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.5.0.8 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/20/2024 9:14:14 PM-->
<!--Modified on: 3/20/2024 9:14:14 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="capr-20240514.xsd#DocumentDocumentAndEntityInformation" roleURI="http://capricor.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://capricor.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638465660543234223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_638465660543234223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638465660543234223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_638465660543234223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638465660543234223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638465660543234223" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638465660543234223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_638465660543234223" order="4" use="optional" />
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure" xmlns="http://www.xbrl.org/2003/linkbase">
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember_638465660543242808" xlink:to="capr_EquityAwardsValueInCompensationTableForApplicableYearMember_638465660543242808" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember_638465660543242808" xlink:to="capr_EquityAwardsAdjustmentsMember_638465660543251585" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember" xlink:label="ecd_AllAdjToCompMember_638465660543242808" />
    <loc xlink:type="locator" xlink:href="capr-20240514.xsd#capr_EquityAwardsValueInCompensationTableForApplicableYearMember" xlink:label="capr_EquityAwardsValueInCompensationTableForApplicableYearMember_638465660543242808" />
    <loc xlink:type="locator" xlink:href="capr-20240514.xsd#capr_EquityAwardsAdjustmentsMember" xlink:label="capr_EquityAwardsAdjustmentsMember_638465660543251585" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="capr_EquityAwardsAdjustmentsMember_638465660543251585" xlink:to="capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_638465660543251585" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="capr_EquityAwardsAdjustmentsMember_638465660543251585" xlink:to="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_638465660543251585" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="capr_EquityAwardsAdjustmentsMember_638465660543251585" xlink:to="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_638465660543251585" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="capr-20240514.xsd#capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" xlink:label="capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_638465660543251585" />
    <loc xlink:type="locator" xlink:href="capr-20240514.xsd#capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" xlink:label="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_638465660543251585" />
    <loc xlink:type="locator" xlink:href="capr-20240514.xsd#capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xlink:label="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_638465660543251585" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_638465660543251585" xlink:to="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_638465660543251585" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="capr-20240514.xsd#capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" xlink:label="capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_638465660543251585" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140401808474896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">PRE 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Capricor Therapeutics,&#160;Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001133869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140401806833040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:5.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:22.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:15.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:13.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:23.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value&#160;of&#160;Initial&#160;Fixed $100&#160;Investment </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:11.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:15.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:13.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:23.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Based&#160;On:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:9.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Summary</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:9.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average&#160;Summary</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:14.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average&#160;Compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:23.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Compensation&#160;Table</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Actually</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Compensation&#160;Table&#160;Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Actually&#160;Paid&#160;to</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:23.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stockholder</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total&#160;for&#160;PEO </b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Paid&#160;to&#160;PEO </b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">for&#160;Non-PEO NEO </b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-PEO&#160;NEO </b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:23.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Return </b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Income/(Loss) </b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 747,315</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,123,804</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 735,807</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 754,663</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 167</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (22,287,542)</p></td></tr><tr><td style="vertical-align:bottom;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,333,423</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,190,786</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 796,066</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 820,990</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 132</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (29,019,532)</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Linda Marb&#225;n</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> served as our CEO for the entirety of 2023 and 2022. The other NEOs for 2023 and 2022 were Anthony Bergmann and Karen Krasney.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The SEC&#8217;s rules require certain adjustment be made to the &#8220;Summary Compensation Table&#8221; totals to determine &#8220;compensation actually paid&#8221; as reported in the &#8220;Pay Versus Performance Table&#8221; above. For purposes of the equity award adjustments shown below, no equity awards were cancelled due to a failure to meet vesting conditions and no dividends or other earnings paid on stock or option awards in the covered fiscal year prior to the vesting date were not otherwise included in the total compensation for the covered fiscal year. In calculating the &#8220;compensation actually paid&#8221; amounts reflected in these columns, the fair value or change in fair value, as applicable, of the equity award adjustments included in such calculations was computed in accordance with FASB ASC Topic 718. The valuation assumptions used to calculate such fair values did not materially differ from those disclosed at the time of grant. The following tables detail the applicable adjustments that were made to the determine &#8220;compensation actually paid&#8221; (all amounts are averages for the NEOs other than the PEO).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Cumulative total shareholder return (&#8220;TSR&#8221;) assumes an initial investment of $100 on December 31, 2021.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Net loss attributable to the Company is reflected as reported in the Company&#8217;s consolidated financial statements included in our 2023 Annual Report on Form 10-K.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </span></td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote</a></td>
<td class="text"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Linda Marb&#225;n</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> served as our CEO for the entirety of 2023 and 2022. The other NEOs for 2023 and 2022 were Anthony Bergmann and Karen Krasney.</span></td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 747,315<span></span>
</td>
<td class="nump">$ 1,333,423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 1,123,804<span></span>
</td>
<td class="nump">2,190,786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Compensation Actually Paid to PEO:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:34.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:34.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:13.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Summary Compensation Table Total for PEO</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:13.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deduct Option Awards </b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(A)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:13.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Equity Award Adjustment </b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(B)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:13.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Compensation Actually Paid to PEO</b></p></td></tr><tr><td style="vertical-align:bottom;width:34.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 747,315</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 466,695</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 843,184</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,123,804</p></td></tr><tr><td style="vertical-align:bottom;width:34.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,333,423</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,051,123</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,908,486</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,190,786</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(A)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Represents the amounts reported in the Option Awards column in the Summary Compensation Table for the applicable year. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(B)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Represents the stock award adjustments (deductions and additions) for PEO stock awards for each applicable year calculated as follows:</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">PEO Equity Award Adjustment:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:29.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year-End Fair Value of Outstanding and Unvested Equity Awards Granted during the Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> Change in Fair Value of Outstanding and Unvested Equity Awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Equity Award Adjustments</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 409,592</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 328,818</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 111,307</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,533)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 843,184</p></td></tr><tr><td style="vertical-align:bottom;width:29.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 930,816</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 301,185</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 328,436</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 348,049</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,908,486</p></td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 735,807<span></span>
</td>
<td class="nump">796,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 754,663<span></span>
</td>
<td class="nump">820,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Average Compensation Actually Paid to Non-PEO NEO (all amounts are averages):</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:27.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:27.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Summary Compensation Table Total for Non-PEO NEO</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:14.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deduct Option Awards </b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(A)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:14.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Equity Award Adjustment </b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(B)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:15.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Compensation Actually Paid to Non-PEO NEO</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 735,807</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 303,946</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 322,802</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 754,663</p></td></tr><tr><td style="vertical-align:bottom;width:27.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 796,066</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 349,225</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 374,149</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 820,990</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(A)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Represents the amounts reported in the Option Awards column in the Summary Compensation Table for the applicable year. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(B)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Represents the stock award adjustments (deductions and additions) for Non-PEO NEO stock awards for each applicable year calculated as follows:</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Average Non-PEO NEO Equity Award Adjustment: </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:25.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:25.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year-End Fair Value of Outstanding and Unvested Equity Awards Granted during the Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> Change in Fair Value of Outstanding and Unvested Equity Awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Equity Award Adjustments</b></p></td></tr><tr><td style="vertical-align:bottom;width:25.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 250,306</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (11,570)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 86,764</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,698)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 322,802</p></td></tr><tr><td style="vertical-align:bottom;width:25.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 309,254</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (106,570)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 109,127</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 62,338</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 374,149</p></td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Compensation Actually Paid and Company TSR</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></span>The SEC&#8217;s rules require that TSR be presented as a performance measure in the Pay Versus Performance Table above. The graph below shows the relationship between (1) compensation actually paid to our PEO and the average of the compensation actually paid to our other NEOs and (2) our cumulative TSR, over the two fiscal years ending December 31, 2023. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><img alt="Graphic" src="capr-20240514xpre14a010.jpg" style="display:inline-block;height:189.48pt;width:339.17pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Compensation Actually Paid and Net Loss</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></span>The SEC&#8217;s rules require that net loss be presented as a performance measure in the Pay Versus Performance Table above. The graph below shows the relationship between compensation actually paid to our PEO and the average of the compensation actually paid to our other NEOs and net loss attributable to the Company over the two fiscal years ending December 31, 2023, as reported in the Company consolidated financial statements. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><img alt="Graphic" src="capr-20240514xpre14a009.jpg" style="display:inline-block;height:189.85pt;left:0%;padding-bottom:0.65pt;position:relative;top:0pt;width:339.84pt;"/></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 167<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (22,287,542)<span></span>
</td>
<td class="num">(29,019,532)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Linda Marb&#225;n<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Deduct Option Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">$ (466,695)<span></span>
</td>
<td class="num">(1,051,123)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Total Equity Awards Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">843,184<span></span>
</td>
<td class="nump">1,908,486<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-End Fair Value of Outstanding and Unvested Equity Awards Granted during the Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">409,592<span></span>
</td>
<td class="nump">930,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Change in Fair Value of Outstanding and Unvested Equity Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">328,818<span></span>
</td>
<td class="nump">301,185<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">111,307<span></span>
</td>
<td class="nump">328,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(6,533)<span></span>
</td>
<td class="nump">348,049<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Deduct Option Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(303,946)<span></span>
</td>
<td class="num">(349,225)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Total Equity Awards Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">322,802<span></span>
</td>
<td class="nump">374,149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-End Fair Value of Outstanding and Unvested Equity Awards Granted during the Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">250,306<span></span>
</td>
<td class="nump">309,254<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change in Fair Value of Outstanding and Unvested Equity Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(11,570)<span></span>
</td>
<td class="num">(106,570)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">86,764<span></span>
</td>
<td class="nump">109,127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">$ (2,698)<span></span>
</td>
<td class="nump">$ 62,338<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=capr_EquityAwardsValueInCompensationTableForApplicableYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=capr_EquityAwardsValueInCompensationTableForApplicableYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=capr_EquityAwardsAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=capr_EquityAwardsAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MIC76V! J,G(K##-'<B^:9F/59K[!2ZRKG[:"RT8P>D<PC,B#%*;0J)9!]K>
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MA@:C*393-5.N,8RLW&392H-SRBT+_#" L@YXOI/2G Q[0?>I25X!4$L#!!0
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M4,CF?A'G7]*G?[!*(5O@!6G,Y4_T5/4U3U!0\#Q=5H-!@F64E+_];Y4A7C*
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M:0IT(;,X$R)LGGT\1T-T^R#JNH-NVS7=MK5T^Y._!.G??6-!(1?M\WP>0:Z
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MZS\8C]LG-H][I7$<AE&$933+G HR+&]1!%]W-$P;>& \P/1[N<9W&Z^0I^L
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "7BG18<]"^(.X    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "7
MBG18F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( )>*=%CI1O/J< (  '8&   8
M  " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "7
MBG18.Z!]EI,,   (20  &               @(&S"@  >&PO=V]R:W-H965T
M<R]S:&5E=#(N>&UL4$L! A0#%     @ EXIT6++WPF_N @  B0X   T
M         ( !?!<  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "7BG18EXJ[
M',     3 @  "P              @ &5&@  7W)E;',O+G)E;'-02P$"% ,4
M    " "7BG18E"-1/V$!  #? @  #P              @ %^&P  >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ EXIT6(WW+%JT    B0(  !H
M     ( !#!T  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ EXIT6&ZG)+P> 0  5P0  !,              ( !^!T  %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&      H "@"$ @  1Q\

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>26</ContextCount>
  <ElementCount>18</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>8</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="capr-20240514xpre14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://capricor.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="capr-20240514xpre14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>capr-20240514.xsd</File>
    <File>capr-20240514_def.xml</File>
    <File>capr-20240514_lab.xml</File>
    <File>capr-20240514_pre.xml</File>
    <File doctype="PRE 14A" isUsgaap="true" original="capr-20240514xpre14a.htm">capr-20240514xpre14a.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>capr-20240514xpre14a002.jpg</File>
    <File>capr-20240514xpre14a009.jpg</File>
    <File>capr-20240514xpre14a010.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="53">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "capr-20240514xpre14a.htm": {
   "nsprefix": "capr",
   "nsuri": "http://capricor.com/20240514",
   "dts": {
    "schema": {
     "local": [
      "capr-20240514.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "capr-20240514_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "capr-20240514_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "capr-20240514_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "capr-20240514xpre14a.htm"
     ]
    }
   },
   "keyStandard": 18,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 2,
   "memberCustom": 6,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 26,
   "entityCount": 1,
   "segmentCount": 8,
   "elementCount": 104,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2023": 53,
    "http://xbrl.sec.gov/dei/2023": 4,
    "http://fasb.org/us-gaap/2023": 2
   },
   "report": {
    "R1": {
     "role": "http://capricor.com/role/DocumentDocumentAndEntityInformation",
     "longName": "00090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "capr-20240514xpre14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "capr-20240514xpre14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "capr-20240514xpre14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "capr-20240514xpre14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r69",
      "r80",
      "r90",
      "r114"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r72",
      "r83",
      "r93",
      "r117"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r84",
      "r94",
      "r110",
      "r118",
      "r122",
      "r130"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://capricor.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://capricor.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://capricor.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://capricor.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://capricor.com/20240514",
     "localname": "EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member presents the equity awards adjustments on the change in fair value (as of vesting date) of prior year awards vested during current year.",
        "label": "Equity Awards Adjustments Change In Fair Value As Of Vesting Date Of Prior Year Awards Vested During Current Year Member",
        "terseLabel": "Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year"
       }
      }
     },
     "auth_ref": []
    },
    "capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://capricor.com/20240514",
     "localname": "EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member presents the equity awards adjustments on the change in fair value (as of vesting date) of awards vested during current year.",
        "label": "Equity Awards Adjustments Change In Fair Value As Of Vesting Date Of Vested Awards During Current Year Member",
        "terseLabel": "Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year"
       }
      }
     },
     "auth_ref": []
    },
    "capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://capricor.com/20240514",
     "localname": "EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member presents the equity awards adjustments on the change in fair value from the end of the prior fiscal year of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year.",
        "label": "Equity Awards Adjustments Change In Fair Value As Of Year End Of Outstanding And Unvested Awards Granted In Prior Years Member",
        "terseLabel": "Change in Fair Value of Outstanding and Unvested Equity Awards"
       }
      }
     },
     "auth_ref": []
    },
    "capr_EquityAwardsAdjustmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://capricor.com/20240514",
     "localname": "EquityAwardsAdjustmentsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member presents the total equity awards adjustments, which may be comprised of adjustments for (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the change in fair value from the end of the prior fiscal year of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards granted in prior years that vest in the applicable year, the amount equal to the change in value as of the vesting date (from the end of the prior fiscal year); (iv) adjustments for equity awards that failed to meet performance conditions; and (v) dividends or other earnings paid on equity awards not otherwise reflected in fair value.",
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Total Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": []
    },
    "capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://capricor.com/20240514",
     "localname": "EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member presents the adjustment (deduction) for equity awards value from summary compensation table.",
        "label": "Equity Awards Adjustments Year End Fair Value Of Awards Granted In Current Year [Member]",
        "terseLabel": "Year-End Fair Value of Outstanding and Unvested Equity Awards Granted during the Year"
       }
      }
     },
     "auth_ref": []
    },
    "capr_EquityAwardsValueInCompensationTableForApplicableYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://capricor.com/20240514",
     "localname": "EquityAwardsValueInCompensationTableForApplicableYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member presents the adjustment (deduction) for equity awards value from summary compensation table.",
        "label": "Equity Awards Value In Compensation Table For The Applicable Year Member",
        "terseLabel": "Deduct Option Awards"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r69",
      "r80",
      "r90",
      "r114"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r66",
      "r77",
      "r87",
      "r111"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r84",
      "r94",
      "r110",
      "r118",
      "r122",
      "r130"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r65",
      "r134"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r65",
      "r134"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r65",
      "r134"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r135"
     ]
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r110",
      "r118"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r82",
      "r92",
      "r116"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r85",
      "r95",
      "r119"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r85",
      "r95",
      "r119"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r66",
      "r77",
      "r87",
      "r111"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r67",
      "r78",
      "r88",
      "r112"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r68",
      "r79",
      "r89",
      "r113"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r75",
      "r86",
      "r96",
      "r120"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r70",
      "r81",
      "r91",
      "r115"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001558370-24-003640-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-24-003640-xbrl.zip
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M/]_/FVN:>PGWN#&-RR4^G;Y(OR0(3O\#4$L#!!0    ( )J*=%AT.93?(@0
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M2>A;KO:EZ&<XR$E>,.9H<('G1^,8C@K_#H!G ^S BKF5A ,NN&^ TAP7D3B
MXX[@QV@E"6=JDE707.LE6I9U CM1=@^XIPF><Q_+(@0Z,B,W0LW:E9<R[V@J
M]#." J;[.2&;T$/IS@E"C/.7 PX9.9FFUL\$6^,$?H3^<D/PE@>,/DPI/.2.
M%2YP$B0@8'ON.9<V+AI'^@7RZU07A[447F^L;KRQUIOKU<;ZZFKMJ6*U\FST
M[@6'GV;Q )E#!%T")[Q5%5E&1 _N8<R0Z;IC)F!@]EHPB(_YY_0RJE)3X33
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MYV"URL[/!#A'[%HG(:Q;]3.I6'M[VX0BOJX/RDRJD!*%FM6.YOV6%JJ\D0X
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MDP:L7R$(6$4R@*78?T4_;>+<U:1;A/X6O;=@N)H+@)L%&MB"_+(]8!B-9OS
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M 9KU1&YR-(B-T+Z#%Q()VQA"UN+8Q@[G9Z:B(<%(]I$)K<*CHXU75^2MXIN
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MD.Y=BXQYF$7Q52#&=1A@3$.A!]@N!) /_7JA]CV/@PD/9954;505G8-RE,+
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M-?*A[)4[\\\;;+T('Z^'@?'E,D# D<3C* L&UR,&P<,\K+!MSN?>_L.1AXS
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MN6-74B2L88S<ETU@RFQ5<-]JCP#+;?CC,S%V8)Y8RYLN[SN("P-8]@4P''?
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MVS<2PHH%VW<X1!<)X8P+T!!]0:YR56,&G%^+_!\QWFYH=9(05,U+M+NAX7C
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ME1[ '5ZX<-KP! .\B6*2(UR@7S19$J6*W8RV7V+5"\<JT%D1()4.3/J&5&:
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M!(#+$F]9''B[+&&7<\*&;Q-]25U 5>]/"KXLC,NL60MU'O,V?D5$', L(BM
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M.S;=P.E05JDKQ:P<)#4)]IX]8NB24B[++E9L!=EAO 4,5VP3AAAL7JRB.%"
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M1J$$GB.?Z=BBHC #'1 20VN^,VT=$O"DZ]<?V<& S9C& Y*Z/&H+3 ;/>,3
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MP!,_3,.BZ? N1KP;T;.[;&8C"X>/8:2_E+__4E1PLV'$$0"-/_X93*V$A[(
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MBR!*\HA2%C[E/.GRR<M6WCLV7M@>%+L3\NR^Z=Z5-X7Y0G=DIAOPH8/0%0;
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M@2N_.G".9/))<+/>B9#-ZX-F'D)8'30'( X0+>3RVB!YU7+(+]A%I?.';U;
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MM>O;K?W]YB0$W%S<'A]?W:?)-6G)^Z^Y"[]?A4V8@(#^6?.Q>+]=/FY7GP_
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M]T2;,5S-,V)=T1^O[#-JHPTWZ2#CJ'=HG'5*.VHM?9TM[IST&F[[N3EVD+$
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M57?WW>O;A\YK^=4]L)1L)8:K(7DWDXOY1B3WB6V!5CBA3(3O6%<P_)9I:^U
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M(5^[4VDCYI-I]5/<K7/N5)KXZY(R-^D.JT$S=1SI3PJ2OK+YN ,JC"[;7HX
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MWKGI>RYZ.,,8F,-7CLR8F"PA'$T-"9%,:=/HY@F,=I7SQT;:H1UJC[8J6PB
M+>N!)1<P8-L)D%<[-T(TR\B+"[AQ['N2A)))QX!N 0X3G08LGO@2](H?(K"=
MD.2;)AX22L)*DOZ:F@@KQ0]')HJ3^R&/3^66H%*+08!Q*[(.(\!K,1SB,&6N
M.8TT)3^F<!/ID)TA[#4W'@C)65Y,X!1>5Y.T$=$2HQ@)>)8R"J&^0M')[":
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MV'KK=-@O=MB]$Z6KU4HU_3.,\V.AUEM4RXL*_^GLM9A-5A><G9DZ?(V@W 1
M#JWM!"1_E'P:=N_ J=&CRJ'VX#;(CGP2"$I%#,\PJVT9C6IM;X\47Q$S;7/.
M?U\;Y-D]%C8K];WBW_4)I5=/@+JF%:6:R=;^QCEL'I,4#)%=/5@><E]QZ+K1
M1<&LT6<"#J-M=@RSW2Z-D+?@N5D?,-D/[J^TK#UG_'7#E[U8]WJ[831*F;=O
MCI=E-:KW K*6SI&&85H-HV7NE7E9ND?>EGND5NET]HE_2_=(J]XT6K7J/BWJ
M&@\H+'U D9-S\X^^.2?,@Z$X5W[$W7T.K"F=,0LD2=NPK)91K]9+PZ1TQKPY
M9TRM4F_N.>.7SIA%!X:&5;.,FEFZ8QZ".S]%F*8_5X_X^2.MI&/5H>GT#7S4
MR*YB=L1X04GD?)WC;'7DA-H'MN_ZP4<=XIXIQ3S?'(''2E-HK&8U*E4=-0]K
MZHF$I(S'D<^JK(K]9FL7$V&24<AX>QB!RR>A^*C_^+2&9<V12GZCL2^-X<#E
M4S^./@Z='V*0W2A_QF'D#*=9VJD9*L[(8]D7#7466N,H$%\O%R7MN<U 447Y
M#3BS6^9N6SQWN/(C-@2C"L;<S5W74%^M'%C%Q(^)$\"OCL=._3N!!;30+V@9
M+!J)0 S]0!C,\QG.!AF1NS +W[YE,FD8X_<\&(1LS*>L+]@-IOV UH:!/\8&
M5AE")=F^<UNW9-2U,ZI51$;UJ' ;\X<L'/$ >DFJK#!@0"8SI#.=')U1>E/%
M7I8I^1A>=%V2>&-.5'*GP--V('@H&/#I+]R+>3"5>,+$K@2W1_+C5/  +VI
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M\U['+7 5Z%)H?EWI+G"SUC$:]<:Z'8G;7N-M\+:U'0&V=MZ6@1*[S]JF534
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M5M4R6>^O&.0L._:P0@JP(#MW82ZV/Y[$^/0D#L(8&P9F^^)XW+,=[K*N;>,
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MTQ ]IX$$Y-J1S.^XXY+^(!L#O<J#Q(.N .A?,: ^Q-_%(?>I<&@?4I@Q.80
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M;O$_;,^L)A_7'%"Q7/)O.S1O]<7ZG C-))Y)8:7-A3HN'F61Z/?P->NKQ,#
MT*?8XYXS]N,0O54J5(_"&87M<HS (M-*9L'0X5NY<"EMS\_>!\D?0>@C%7I2
MWN-F76P"30E#W;>_]V-W(&,=Y(.HS8?2%0/+>YP+5R _C8W)$Z0IZ,5T:82N
M7-+EC/_%.VOJ5D;BYAI3 @N\YT&A=9F]!NUE]MJ&C9M=YIW4WT3 BX5"AK1&
M(V;#@J&C7EZGRYPFJ!B4F?N._R?,+PFGE3JA] IF6U[^^;CA^UHO7@E%! 7B
M9-(A ' NGX3BH_XC.Q DJL([J/EMB1CR"*LZB6;@%0V?@"Y 7C^./@*7^S-
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MP]+WMVC'&#6K:53;^X[ZWIC[;S6X7YG7?KL'_7[E@?#8KP$//3%=>V2R6=[
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MQ0&Q1?A%4*%#'B4$#L1<H4I<R9!Y/BX+XX.Q$\KQR!*)$QY0N<I%I**61\*
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MNGE\+ LB$4*RI24\I>,6HC^&6H"=C9N6HD;T4!:44%*P#Q'7G_'@AA;MJ17
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M(6Y *.MJN]T[[KA<+A@JLW,2VR<@Q@,';Y5C>>?YC-;KCL-9ZXRO9#'9'[)
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MUBL5)\-;%B[YGUQ09,'1 ]*5[X.>USU746]_B.N><-RK67_V4(@J[37H3]:
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M7XKTE^/H\YI.W4(9VUUGFT]TF%08#UD%_8'O?#SA">):0?>H<YGA16.J0!2
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M%^CI@:6[8@;,IA#B<6 U*_-L&\&@;TK. ]1*2L:92DIT<(PHN^V6'0B75\X
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MS29"8I L\11EH3?F9.$@3@RZM[S*S8Z/W)LY_E/7(1/"8;-EDN7;2I!.2[C
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M>2I?DZQXJ?BQ<=^:<9MJ0?]UO;E+_;)O#NP/:DTRUXK>/YD@,L'3\S;.P,R
M+LXH-+'';$Y+ZYTQ5?M8!/^21 K+?6NR?2 /^J5,+ ZZB79VUGUI_G!07SR>
MUB(HXRJ%:Z:.K)&@1UZ)MX%FI:M)9D_IGH"Y<>(C7S,QS+E5RCM@;TI,<+>@
M11DG19)X<&GHK;ZW?B<_S/7=WSG&_X71>NX!7&)F=L][[VX;5W(&5!D]\?2J
MBRW_)P,WS[N^U+U:"!&YBY]ZJ^4HS<JG60[,/'O1TZ/.)X<UT*RV-70@SY5@
MUH!DMTYGK)4PF9^%8@'6)!4FB^>G,6/G8K3"!?5230Y>E1 $Z*Z9FJ@S#U-T
MG<TT9SAUS/'_\HTBI]1&^>6]]9UJ;/(T+%A)-\0!/?C6X\/)A1=BUZA-UQER
MU?<&BOJW$+&MUU,#4T]H&Z8/[PL*<;]59!-4%4.<7/C\,/TH\BP8E5\O"?O<
M#T-#7$A :S8)""[&%I  32L2T, ((2I CA'+IV#QD'LD0&X%UH]OVDO=16Z
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M12FLE_H]:YC%Y$17M^O26 I4<A]OO^.QPNZB7&5&):WF!VX)TI0]7>W&=0;
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M\=S^T9SQNVK?^'<S&@"Y-I$13SYU95]N^J-$&I()[/<3U;B%'3&RF9Z:W.&
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M[*>0!'80!5E$"C=_W@R_G OK+ML-V3$#OX*_@1>&-'<?\':92:T=P)NG.5G
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MM4I,+%[-#GM3XSO\H"T5KD\#G 57Q#JAF<:?WC\/>"^W>_1/-!8D1[).58=
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MRABQ=H=A,=9,GE;;$*>O"BJ=C=$\GOHO4$L#!!0    ( )J*=%B68?RG>E4
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M\);:%B)PXZTS/KG:#ID!'T\96[_C O\H"E(I:V1"[E;86WQ'7*HB-R/.=B^
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MTQZGY]ZM$6([S9:%INUUMB4MK^X4V:]V[9SJ'#JO65ZLK6QE\[<YHJ ,$5[
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MA>B%K *1SZV<K;8CT\%2%$.OFV9JCS,H<4;_HX.3;M>^HY+_[O-&IW('DL#
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MY&2=>>ODNJOZH;5&7E_W88:AG;'/H+6S6]GJ;K?0U$*D'@.+A*XN3<YIIH.
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MXF(WK3DI8=A\W;"74/L,/J^C/Z;[2W(@_M?D #\3$6A^M_<;:23[&]((^T,
MWGMG#A>6C0-U<,8#05!V4]"?C4#.IX;@BW&G_RR+]$\_F)SS/29^M]E_W/R)
MHB1. 1U;<#=]*5D.W1&:8[RR\;KDT*U1ZJG/+^-<Y )9]<AONQQ0^)+3J%?!
M\8,Z\'*\$R<@ L7.P":=?:$'Y>WS39;,3F+O38@\-*@<GEMD2PZROW=7M/_
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M*MZP,5^9YW(P9.R!NH<<V1-:].(/B,0C'#H3 A^ 8RVG^D)$$,*S&!:CXY\
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M)C1F1+H16.UQ;O7CYQ?\9*9O-JXP>+EBVO@#^W7%NQZ+QU9Z<(.9".F,GZB
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M     &-A<'(M,C R-# U,30N>'-D4$L! A0#%     @ FHIT6'>>A(O9 P
M#AL  !4              ( !ZP0  &-A<'(M,C R-# U,31?9&5F+GAM;%!+
M 0(4 Q0    ( )J*=%@F9*@>.08  "HX   5              "  ?<(  !C
M87!R+3(P,C0P-3$T7VQA8BYX;6Q02P$"% ,4    " ":BG18=#F4WR($  !Y
M&P  %0              @ %C#P  8V%P<BTR,#(T,#4Q-%]P<F4N>&UL4$L!
M A0#%     @ FHIT6'&TJM)Z)@$ XFT- !@              ( !N!,  &-A
M<'(M,C R-# U,31X<')E,31A+FAT;5!+ 0(4 Q0    ( )J*=%B8*.>I QX
M (T@   ;              "  6@Z 0!C87!R+3(P,C0P-3$T>'!R93$T83 P
M,BYJ<&=02P$"% ,4    " ":BG18+F QZ;A5  !9?   &P
M@ &D6 $ 8V%P<BTR,#(T,#4Q-'AP<F4Q-&$P,#DN:G!G4$L! A0#%     @
MFHIT6)9A_*=Z50  RWP  !L              ( !E:X! &-A<'(M,C R-# U
F,31X<')E,31A,#$P+FIP9U!+!08     "  ( "D"  !(! (    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>capr-20240514xpre14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:capr="http://capricor.com/20240514"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="capr-20240514.xsd" xlink:type="simple"/>
    <context id="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsValueInCompensationTableForApplicableYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_wXZQP7jdBkGCt0F5kdShAQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsValueInCompensationTableForApplicableYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsValueInCompensationTableForApplicableYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_cEC076xukUytfkW6cWT2KA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsValueInCompensationTableForApplicableYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_6kMrJSUzRk-2rzXtu-uQoQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_vivQmo6mSEqaFXP36wEMAQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_jTaas2oZLUy-SpJe52-InA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_6WX4KT36CUuWW8akt2OzpQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_9g7ebvuxWUuUBmptPCym_Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_iZz8cM0530OzLK0ZzEASJg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_JVXrFv5_2EudBAVwqdyZ2A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_GMfsyW9GaUCnLGYWUh9fgw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_POPZu7IOokG--5f06Nf35Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_YRkU1KZG4UO6jQ9ifR2OSw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsValueInCompensationTableForApplicableYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_MAkj2PFc4UiOEFAPTIh5pg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsValueInCompensationTableForApplicableYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsValueInCompensationTableForApplicableYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_jBy47SmJK0WpDadoHCHhRQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsValueInCompensationTableForApplicableYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_mc5TENp2S0GocHnLHwEEAg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_2uiDN3rZh0q31boqSbzn8w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_PAfo8DhqG0yF5jcQg_sh5A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_VZO4GqyxeE-CglPDohkklg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_QawlbdeG70CMcZ9CqoR_vg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_STUyIoqE2EGW3AifSYCqjw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_lVWOxIS-1UCfBNJY-IhXHQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_3WyJGzK71kS8TSaL8PNShA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_IhAZ2jr6Qk6yvGRNYnpPNQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_w4nlAZfmVkuUTMVwdrsohA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">capr:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001133869</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <unit id="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      id="Tc_fWGd7LvZW0eeigUib6EMGQ_1_1">0001133869</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      id="Tc_gysJpaGv8ESNLTYDC1857A_2_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      id="Hidden_2U85oGuSBEi_hmh9e-qaBg">PRE 14A</dei:DocumentType>
    <dei:EntityRegistrantName
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      id="Narr_Sqc0V1gOEkGvRuuMuQFqrw">Capricor Therapeutics,&#160;Inc.</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      id="Tb_3Y0YmAeOyUG53E6LybuRLg">&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:5.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:22.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:5.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:11.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:15.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:23.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Value&#160;of&#160;Initial&#160;Fixed $100&#160;Investment &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:5.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:11.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:15.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:13.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:23.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Based&#160;On:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:5.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:12.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Summary&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:9.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Compensation&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:16.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Average&#160;Summary&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:14.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Average&#160;Compensation&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:23.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:10.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Compensation&#160;Table&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Actually&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Compensation&#160;Table&#160;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Actually&#160;Paid&#160;to&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:23.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Stockholder&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&#160;for&#160;PEO &lt;/b&gt;&lt;sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Paid&#160;to&#160;PEO &lt;/b&gt;&lt;sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;for&#160;Non-PEO NEO &lt;/b&gt;&lt;sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Non-PEO&#160;NEO &lt;/b&gt;&lt;sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:23.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Return &lt;/b&gt;&lt;sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:7pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Income/(Loss) &lt;/b&gt;&lt;sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;"&gt;(4)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 747,315&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,123,804&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 735,807&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 754,663&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:22.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 167&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (22,287,542)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:5.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,333,423&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,190,786&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 796,066&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 820,990&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:22.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 132&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (29,019,532)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Linda Marb&#xe1;n&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; served as our CEO for the entirety of 2023 and 2022. The other NEOs for 2023 and 2022 were Anthony Bergmann and Karen Krasney.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(2)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;The SEC&#x2019;s rules require certain adjustment be made to the &#x201c;Summary Compensation Table&#x201d; totals to determine &#x201c;compensation actually paid&#x201d; as reported in the &#x201c;Pay Versus Performance Table&#x201d; above. For purposes of the equity award adjustments shown below, no equity awards were cancelled due to a failure to meet vesting conditions and no dividends or other earnings paid on stock or option awards in the covered fiscal year prior to the vesting date were not otherwise included in the total compensation for the covered fiscal year. In calculating the &#x201c;compensation actually paid&#x201d; amounts reflected in these columns, the fair value or change in fair value, as applicable, of the equity award adjustments included in such calculations was computed in accordance with FASB ASC Topic 718. The valuation assumptions used to calculate such fair values did not materially differ from those disclosed at the time of grant. The following tables detail the applicable adjustments that were made to the determine &#x201c;compensation actually paid&#x201d; (all amounts are averages for the NEOs other than the PEO).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(3)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Cumulative total shareholder return (&#x201c;TSR&#x201d;) assumes an initial investment of $100 on December 31, 2021.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(4)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Net loss attributable to the Company is reflected as reported in the Company&#x2019;s consolidated financial statements included in our 2023 Annual Report on Form 10-K.&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      decimals="0"
      id="Tc_-9FlUNi4nE2VsCFvoHrurg_6_3"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">747315</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      decimals="0"
      id="Tc_yw264W7T6kGOeOhI_MchAQ_6_6"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">1123804</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      decimals="0"
      id="Tc_RqmBb7tVDEO1ooOsBHlgkQ_6_9"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">735807</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      decimals="0"
      id="Tc_wwNNQv-ZJE-FJyV-Rj4Ijw_6_12"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">754663</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      decimals="0"
      id="Tc_rYSv1f6Q4UOrtj5MdVC8_A_6_15"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">167</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      decimals="0"
      id="Tc_wKFQLOBWw06Ont1RHNJIEw_6_18"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">-22287542</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng"
      decimals="0"
      id="Tc_VIBLFXxI4UaMlW270lcHsw_7_3"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">1333423</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng"
      decimals="0"
      id="Tc_qVdQwCXYaEagt2cMdTbdzA_7_6"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">2190786</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng"
      decimals="0"
      id="Tc_Ui9YuUU3RUm0txgz7ebQfw_7_9"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">796066</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng"
      decimals="0"
      id="Tc_thy3gt1NjUOKfmbXqEVhFQ_7_12"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">820990</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng"
      decimals="0"
      id="Tc_SDskBhrjOkOuyxkwVpmI7g_7_15"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">132</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng"
      decimals="0"
      id="Tc_0zA0cDklIUGqzPumRAsZjQ_7_18"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">-29019532</us-gaap:NetIncomeLoss>
    <ecd:NamedExecutiveOfficersFnTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      id="Tb_Tm0c_p28z0auT-K5qkGoNw">&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Linda Marb&#xe1;n&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; served as our CEO for the entirety of 2023 and 2022. The other NEOs for 2023 and 2022 were Anthony Bergmann and Karen Krasney.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      id="Narr_RZ0LxXYdKkaXVmrUsWcHXw">Linda Marb&#xe1;n</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      id="Tb_LwKiPm8F2E-U37FNwfskvg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Compensation Actually Paid to PEO:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:34.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.19%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:34.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:13.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Summary Compensation Table Total for PEO&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:13.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Deduct Option Awards &lt;/b&gt;&lt;sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;"&gt;(A)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:13.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Equity Award Adjustment &lt;/b&gt;&lt;sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;"&gt;(B)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:13.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Compensation Actually Paid to PEO&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:34.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 747,315&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 466,695&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 843,184&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,123,804&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:34.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,333,423&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,051,123&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,908,486&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,190,786&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(A)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Represents the amounts reported in the Option Awards column in the Summary Compensation Table for the applicable year. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(B)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Represents the stock award adjustments (deductions and additions) for PEO stock awards for each applicable year calculated as follows:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;PEO Equity Award Adjustment:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:29.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year-End Fair Value of Outstanding and Unvested Equity Awards Granted during the Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt; Change in Fair Value of Outstanding and Unvested Equity Awards&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt; Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Equity Award Adjustments&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 409,592&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 328,818&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 111,307&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (6,533)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 843,184&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 930,816&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 301,185&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 328,436&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 348,049&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 1,908,486&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      decimals="0"
      id="Tc_sK0teNQ9v0iFfMVQYA5HwQ_2_3"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">747315</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsValueInCompensationTableForApplicableYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_wXZQP7jdBkGCt0F5kdShAQ"
      decimals="0"
      id="Tc_nLWXkardLEGj-BorqQRY0A_2_6"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">-466695</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_jTaas2oZLUy-SpJe52-InA"
      decimals="0"
      id="Tc_9g1YHW-N30G5I3ZbfQmRew_2_9"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">843184</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      decimals="0"
      id="Tc_PPm44CYEB0CiuV1RSHN9oA_2_12"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">1123804</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng"
      decimals="0"
      id="Tc_ZYkHPPENBE2qO9uQDY6x6Q_3_3"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">1333423</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsValueInCompensationTableForApplicableYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_MAkj2PFc4UiOEFAPTIh5pg"
      decimals="0"
      id="Tc_5V21Ufkr-0-CmBbP37Q-RA_3_6"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">-1051123</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_PAfo8DhqG0yF5jcQg_sh5A"
      decimals="0"
      id="Tc_ldLMwbE1ZEqHqq_9YAPrYQ_3_9"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">1908486</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng"
      decimals="0"
      id="Tc_uZqZ8ipQDkaK1pAkvghwNg_3_12"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">2190786</ecd:PeoActuallyPaidCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_6kMrJSUzRk-2rzXtu-uQoQ"
      decimals="0"
      id="Tc_tqPyhqJy3E2u69t0-D91Xg_2_3"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">409592</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_9g7ebvuxWUuUBmptPCym_Q"
      decimals="0"
      id="Tc_ffn7AMkB-ESZ9xuknOapqg_2_6"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">328818</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_JVXrFv5_2EudBAVwqdyZ2A"
      decimals="0"
      id="Tc_0JTGS6vVKU6RszEHSlN46g_2_9"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">111307</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_POPZu7IOokG--5f06Nf35Q"
      decimals="0"
      id="Tc_byVmv7fgyEyOynh2mSsILg_2_12"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">-6533</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_jTaas2oZLUy-SpJe52-InA"
      decimals="0"
      id="Tc_mZ7t07z0Z0W6Y0Zb-qnCYQ_2_15"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">843184</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_mc5TENp2S0GocHnLHwEEAg"
      decimals="0"
      id="Tc_dckGYPk0ckeLK_wvsJwprQ_3_3"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">930816</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_QawlbdeG70CMcZ9CqoR_vg"
      decimals="0"
      id="Tc_bxZhDb8GEEG8OOnxAoLtuw_3_6"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">301185</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_lVWOxIS-1UCfBNJY-IhXHQ"
      decimals="0"
      id="Tc_QmqAOF7tfEq7mesmDbEMzw_3_9"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">328436</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_IhAZ2jr6Qk6yvGRNYnpPNQ"
      decimals="0"
      id="Tc_4a_GDeE3LU-i_pqpUE5MMw_3_12"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">348049</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_PeoMember_PAfo8DhqG0yF5jcQg_sh5A"
      decimals="0"
      id="Tc_KkZEf-v5ekWB8wnBUzVERw_3_15"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">1908486</ecd:AdjToCompAmt>
    <ecd:AdjToNonPeoNeoCompFnTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      id="Tb_HCAwXev6XkG1PhcHuEphbQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Average Compensation Actually Paid to Non-PEO NEO (all amounts are averages):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:27.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:27.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:16.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Summary Compensation Table Total for Non-PEO NEO&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:14.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Deduct Option Awards &lt;/b&gt;&lt;sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;"&gt;(A)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:14.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Equity Award Adjustment &lt;/b&gt;&lt;sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;"&gt;(B)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:15.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Compensation Actually Paid to Non-PEO NEO&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:27.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 735,807&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 303,946&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 322,802&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 754,663&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:27.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 796,066&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 349,225&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 374,149&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 820,990&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(A)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Represents the amounts reported in the Option Awards column in the Summary Compensation Table for the applicable year. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(B)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Represents the stock award adjustments (deductions and additions) for Non-PEO NEO stock awards for each applicable year calculated as follows:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Average Non-PEO NEO Equity Award Adjustment: &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:25.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:25.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year-End Fair Value of Outstanding and Unvested Equity Awards Granted during the Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt; Change in Fair Value of Outstanding and Unvested Equity Awards&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt; Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total Equity Award Adjustments&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:25.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 250,306&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (11,570)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 86,764&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,698)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 322,802&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:25.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 309,254&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (106,570)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 109,127&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 62,338&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"&gt; 374,149&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      decimals="0"
      id="Tc_zGv9eqSsCkmk-nQSmjDVkA_2_3"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">735807</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsValueInCompensationTableForApplicableYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_cEC076xukUytfkW6cWT2KA"
      decimals="0"
      id="Tc_oDl4SGf7d0Gmrm8giPd2RA_2_6"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">-303946</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_6WX4KT36CUuWW8akt2OzpQ"
      decimals="0"
      id="Tc_Xu46Ul4kukCfECHUEpAkwQ_2_9"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">322802</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      decimals="0"
      id="Tc_UpyzVSH0QkCJQjn5UxSVjQ_2_12"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">754663</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng"
      decimals="0"
      id="Tc_l2clkAklxEqByT0y4ZNT2Q_3_3"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">796066</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsValueInCompensationTableForApplicableYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_jBy47SmJK0WpDadoHCHhRQ"
      decimals="0"
      id="Tc_VdLCyE2AS0y8VEQakyf3Bg_3_6"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">-349225</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_VZO4GqyxeE-CglPDohkklg"
      decimals="0"
      id="Tc_1F-OtnGslEaP1rnLrLC8JA_3_9"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">374149</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ySJv4_1210mZe8lPQnjvng"
      decimals="0"
      id="Tc_STEjA7SNuU2_uny_DzfnIg_3_12"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">820990</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_vivQmo6mSEqaFXP36wEMAQ"
      decimals="0"
      id="Tc_mOlQzAANDEu9PP6D03rqqw_2_3"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">250306</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_iZz8cM0530OzLK0ZzEASJg"
      decimals="0"
      id="Tc_oXohGRL240i19t1bNhzuLQ_2_6"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">-11570</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_GMfsyW9GaUCnLGYWUh9fgw"
      decimals="0"
      id="Tc_C3MJMvnN3E-e3HyqiH0bfA_2_9"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">86764</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_YRkU1KZG4UO6jQ9ifR2OSw"
      decimals="0"
      id="Tc_8MFSOAy4jUa-TZhbxVNS-g_2_12"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">-2698</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2023_To_12_31_2023_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_6WX4KT36CUuWW8akt2OzpQ"
      decimals="0"
      id="Tc_HckVJt1zDEK7j4BYrcb-dg_2_15"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">322802</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_2uiDN3rZh0q31boqSbzn8w"
      decimals="0"
      id="Tc_7K4Xjya22UG7IVunGnU1PQ_3_3"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">309254</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_STUyIoqE2EGW3AifSYCqjw"
      decimals="0"
      id="Tc_c9loC9kCt02a5aho-JNOEg_3_6"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">-106570</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_3WyJGzK71kS8TSaL8PNShA"
      decimals="0"
      id="Tc_-mew2D0R6keEWYAMNTZVpA_3_9"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">109127</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_w4nlAZfmVkuUTMVwdrsohA"
      decimals="0"
      id="Tc_pk9hAVTAVk2vzutkUwqj4w_3_12"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">62338</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="Duration_1_1_2022_To_12_31_2022_ecd_AdjToCompAxis_capr_EquityAwardsAdjustmentsMember_ecd_ExecutiveCategoryAxis_ecd_NonPeoNeoMember_VZO4GqyxeE-CglPDohkklg"
      decimals="0"
      id="Tc_jP5Mr0vutkevVRKHUggYgA_3_15"
      unitRef="Unit_Standard_USD_Ar1gYJptfU-1zC4ejiV33A">374149</ecd:AdjToCompAmt>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      id="Tb_KYKw00gKyUyG1im49GrFpA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Compensation Actually Paid and Net Loss&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"&gt;&lt;/span&gt;The SEC&#x2019;s rules require that net loss be presented as a performance measure in the Pay Versus Performance Table above. The graph below shows the relationship between compensation actually paid to our PEO and the average of the compensation actually paid to our other NEOs and net loss attributable to the Company over the two fiscal years ending December 31, 2023, as reported in the Company consolidated financial statements. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;img alt="Graphic" src="capr-20240514xpre14a009.jpg" style="display:inline-block;height:189.85pt;left:0%;padding-bottom:0.65pt;position:relative;top:0pt;width:339.84pt;"/&gt;&lt;/p&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_p0D5ZZuYUUeXnIDp86af-w"
      id="Tb_ZAJHrsHHuUONMqN11NJCgA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Compensation Actually Paid and Company TSR&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"&gt;&lt;/span&gt;The SEC&#x2019;s rules require that TSR be presented as a performance measure in the Pay Versus Performance Table above. The graph below shows the relationship between (1) compensation actually paid to our PEO and the average of the compensation actually paid to our other NEOs and (2) our cumulative TSR, over the two fiscal years ending December 31, 2023. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;img alt="Graphic" src="capr-20240514xpre14a010.jpg" style="display:inline-block;height:189.48pt;width:339.17pt;"/&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
